label,type,title,author,journal,abstract,year,doi,volume,issue,pages,language,issn,keywords,url,institution,DA,j2,DP,l1,l2,ST
Kuppermann_2014_JAMA,JOUR,"Effect of enhanced information, values clarification, and removal of financial barriers on use of prenatal genetic testing: a randomized clinical trial","Kuppermann, Miriam and Pena, Sherri and Bishop, Judith T. and Nakagawa, Sanae and Gregorich, Steven E. and Sit, Anita and Vargas, Juan and Caughey, Aaron B. and Sykes, Susan and Pierce, Lasha and Norton, Mary E.",JAMA,"IMPORTANCE: Prenatal genetic testing guidelines recommend providing patients with detailed information to allow informed, preference-based screening and diagnostic testing decisions. The effect of implementing these guidelines is not well understood. OBJECTIVE: To analyze the effect of a decision-support guide and elimination of financial barriers to testing on use of prenatal genetic testing and decision making among pregnant women of varying literacy and numeracy levels. DESIGN, SETTING, AND PARTICIPANTS: Randomized trial conducted from 2010-2013 at prenatal clinics at 3 county hospitals, 1 community clinic, 1 academic center, and 3 medical centers of an integrated health care delivery system in the San Francisco Bay area. Participants were English- or Spanish-speaking women who had not yet undergone screening or diagnostic testing and remained pregnant at 11 weeks' gestation (n = 710). INTERVENTIONS: A computerized, interactive decision-support guide and access to prenatal testing with no out-of-pocket expense (n = 357) or usual care as per current guidelines (n = 353). MAIN OUTCOMES AND MEASURES: The primary outcome was invasive diagnostic test use, obtained via medical record review. Secondary outcomes included testing strategy undergone, and knowledge about testing, risk comprehension, and decisional conflict and regret at 24 to 36 weeks' gestation. RESULTS: Women randomized to the intervention group, compared with those randomized to the control group, were less likely to have invasive diagnostic testing (5.9% vs 12.3%; odds ratio [OR], 0.45 [95% CI, 0.25-0.80]) and more likely to forgo testing altogether (25.6% vs 20.4%; OR, 3.30 [95% CI, 1.43-7.64], reference group screening followed by invasive testing). Women randomized to the intervention group also had higher knowledge scores (9.4 vs 8.6 on a 15-point scale; mean group difference, 0.82 [95% CI, 0.34-1.31]) and were more likely to correctly estimate the amniocentesis-related miscarriage risk (73.8% vs 59.0%; OR, 1.95 [95% CI, 1.39-2.75]) and their estimated age-adjusted chance of carrying a fetus with trisomy 21 (58.7% vs 46.1%; OR, 1.66 [95% CI, 1.22-2.28]). Significant differences did not emerge in decisional conflict or regret. CONCLUSIONS AND RELEVANCE: Full implementation of prenatal testing guidelines using a computerized, interactive decision-support guide in the absence of financial barriers to testing resulted in less test use and more informed choices. If validated in additional populations, this approach may result in more informed and preference-based prenatal testing decision making and fewer women undergoing testing. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00505596.",2014,10.1001/jama.2014.11479,312,12,1210-1217,eng,1538-3598 0098-7484,*Decision Support Techniques and *Genetic Testing/economics/statistics & numerical data and *Guideline Adherence and *Patient Participation and *Prenatal Diagnosis/economics/statistics & numerical data and Adult and Female and Health Literacy and Humans and Practice Guidelines as Topic and Pregnancy and Risk,NA,NA,2014/09/24/,JAMA,NA,NA,NA,NA
Peters_2019_ProfthNaAcofScofthUnStofAm,JOUR,"Despite high objective numeracy, lower numeric confidence relates to worse financial and medical outcomes","Peters, Ellen and Tompkins, Mary Kate and Knoll, Melissa A. Z. and Ardoin, Stacy P. and Shoots-Reinhard, Brittany and Meara, Alexa Simon",Proceedings of the National Academy of Sciences of the United States of America,"People often laugh about being ""no good at math."" Unrecognized, however, is that about one-third of American adults are likely too innumerate to operate effectively in financial and health environments. Two numeric competencies conceivably matter-objective numeracy (ability to ""run the numbers"" correctly; like literacy but with numbers) and numeric self-efficacy (confidence that provides engagement and persistence in numeric tasks). We reasoned, however, that attaining objective numeracy's benefits should depend on numeric confidence. Specifically, among the more objectively numerate, having more numeric confidence (vs. less) should lead to better outcomes because they persist in numeric tasks and have the skills to support numeric success. Among the less objectively numerate, however, having more (vs. less) numeric confidence should hurt outcomes, as they also persist, but make unrecognized mistakes. Two studies were designed to test the generalizability of this hypothesized interaction. We report secondary analysis of financial outcomes in a diverse US dataset and primary analysis of disease activity among systemic lupus erythematosus patients. In both domains, best outcomes appeared to require numeric calculation skills and the persistence of numeric confidence. ""Mismatched"" individuals (high ability/low confidence or low ability/high confidence) experienced the worst outcomes. For example, among the most numerate patients, only 7% of the more numerically confident had predicted disease activity indicative of needing further treatment compared with 31% of high-numeracy/low-confidence patients and 44% of low-numeracy/high-confidence patients. Our work underscores that having 1 of these competencies (objective numeracy or numeric self-efficacy) does not guarantee superior outcomes.",2019,10.1073/pnas.1903126116,116,39,19386-19391,eng,1091-6490 0027-8424,"*decision making and *financial and health outcomes and *Health Literacy and *Income and *Mathematics/education and *numeric confidence and *numeric self-efficacy and *objective numeracy and *Self Efficacy and Adult and Comprehension and decision making and Decision Making and Educational Measurement and Female and financial and health outcomes and Humans and Lupus Erythematosus, Systemic/therapy and Male and Middle Aged and numeric confidence and numeric self-efficacy and objective numeracy and United States",NA,NA,2019/09/24/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Thirumurthy_2014_JAMA,JOUR,Effect of providing conditional economic compensation on uptake of voluntary medical male circumcision in Kenya: a randomized clinical trial,"Thirumurthy, Harsha and Masters, Samuel H. and Rao, Samwel and Bronson, Megan A. and Lanham, Michele and Omanga, Eunice and Evens, Emily and Agot, Kawango",JAMA,"IMPORTANCE: Novel strategies are needed to increase the uptake of voluntary medical male circumcision (VMMC) in sub-Saharan Africa and enhance the effectiveness of male circumcision as an HIV prevention strategy. OBJECTIVE: To determine whether small economic incentives could increase circumcision prevalence by addressing reported economic barriers to VMMC and behavioral factors such as present-biased decision making. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial conducted between June 22, 2013, and February 4, 2014, among 1504 uncircumcised men aged 25 to 49 years in Nyanza region, Kenya. VMMC services were provided free of charge and participants were randomized to 1 of 3 intervention groups or a control group. INTERVENTIONS: Participants in the 3 intervention groups received varying amounts of compensation conditional on undergoing circumcision at 1 of 9 study clinics within 2 months of enrollment. Compensation took the form of food vouchers worth 200 Kenya shillings (<e2><89><88> US $2.50), 700 Kenya shillings (<e2><89><88> US $8.75), or 1200 Kenya shillings (<e2><89><88> US $15.00), which reflected a portion of transportation costs and lost wages associated with getting circumcised. The control group received no compensation. MAIN OUTCOMES AND MEASURES: VMMC uptake within 2 months. RESULTS: Analysis of data for 1502 participants with complete data showed that VMMC uptake within 2 months was higher in the US $8.75 group (6.6%; 95% CI, 4.3%-9.5% [25 of 381]) and the US $15.00 group (9.0%; 95% CI, 6.3%-12.4% [34 of 377]) than in the US $2.50 group (1.9%; 95% CI, 0.8%-3.8% [7 of 374]) and the control group (1.6%; 95% CI, 0.6%-3.5% [6 of 370]). In logistic regression analysis, the US $8.75 group had significantly higher VMMC uptake than the control group (adjusted odds ratio [AOR] 4.3; 95% CI, 1.7-10.7), as did the US $15.00 group (AOR 6.2; 95% CI, 2.6-15.0). Effect sizes for the US $8.75 and US $15.00 groups did not differ significantly (P = .20). CONCLUSIONS AND RELEVANCE: Among uncircumcised men in Kenya, compensation in the form of food vouchers worth approximately US $8.75 or US $15.00, compared with lesser or no compensation, resulted in a modest increase in the prevalence of circumcision after 2 months. The effects of more intense promotion or longer implementation require further investigation. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01857700.",2014,10.1001/jama.2014.9087,312,7,703-711,eng,1538-3598 0098-7484,"*Financing, Personal and *Motivation and Adult and Circumcision, Male/*economics/statistics & numerical data and Decision Making and Food/economics and HIV Infections/*prevention & control and Humans and Kenya/epidemiology and Male and Middle Aged",NA,NA,2014/08/20/,JAMA,NA,NA,NA,NA
Schuh_2014_JAMA,JOUR,Effect of oximetry on hospitalization in bronchiolitis: a randomized clinical trial,"Schuh, Suzanne and Freedman, Stephen and Coates, Allan and Allen, Upton and Parkin, Patricia C. and Stephens, Derek and Ungar, Wendy and DaSilva, Zelia and Willan, Andrew R.",JAMA,"IMPORTANCE: Routine use of pulse oximetry has been associated with changes in bronchiolitis management and may have lowered the hospitalization threshold for patients with bronchiolitis. OBJECTIVE: To examine if infants with bronchiolitis whose displayed oximetry measurements have been artificially elevated 3 percentage points above true values experience hospitalization rates at least 15% lower compared with infants with true values displayed. DESIGN, SETTING, AND PARTICIPANTS: Randomized, double-blind, parallel-group trial conducted from 2008 to 2013 in a tertiary-care pediatric emergency department in Toronto, Ontario, Canada. Participants were 213 otherwise healthy infants aged 4 weeks to 12 months with mild to moderate bronchiolitis and true oxygen saturations of 88% or higher. INTERVENTIONS: Pulse oximetry measurements with true saturation values displayed or with altered saturation values displayed that have been increased 3 percentage points above true values. MAIN OUTCOMES AND MEASURES: The primary outcome was hospitalization within 72 hours, defined as inpatient admission within this interval or active hospital care for greater than 6 hours. Secondary outcomes included the use of supplemental oxygen in the emergency department, level of physician agreement with discharge from the emergency department, length of emergency department stay, and unscheduled visits for bronchiolitis within 72 hours. RESULTS: Forty-four of 108 patients (41%) in the true oximetry group and 26 of 105 (25%) in the altered oximetry group were hospitalized within 72 hours (difference, 16% [95% CI for the difference, 3.6% to 28.4%]; P = .005). Using the emergency department physician as a random effect, the primary treatment effect remained significant (adjusted odds ratio, 4.0 [95% CI, 1.6 to 10.5]; P = .009). None of the secondary outcomes were significantly different between the groups. There were 23 of 108 (21.3%) subsequent unscheduled medical visits for bronchiolitis in the true oximetry group and 15 of 105 (14.3%) in the altered oximetry group (difference, 7% [95% CI, -0.3% to 0.2%]; P = .18). CONCLUSIONS AND RELEVANCE: Among infants presenting to an emergency department with mild to moderate bronchiolitis, those with an artificially elevated pulse oximetry reading were less likely to be hospitalized within 72 hours or to receive active hospital care for more than 6 hours than those with unaltered oximetry readings. This suggests that oxygen saturation should not be the only factor in the decision to admit, and its use may need to be reevaluated. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT00673946.",2014,10.1001/jama.2014.8637,312,7,712-718,eng,1538-3598 0098-7484,"Bronchiolitis/*diagnosis/physiopathology/therapy and Decision Making and Double-Blind Method and Emergency Service, Hospital and Female and Hospitalization/*statistics & numerical data and Humans and Infant and Male and Oximetry/*standards and Oxygen Inhalation Therapy and Oxygen/analysis and Patient Admission/statistics & numerical data and Reproducibility of Results",NA,NA,2014/08/20/,JAMA,NA,NA,NA,NA
White_2016_JAMA,JOUR,Prevalence of and Factors Related to Discordance About Prognosis Between Physicians and Surrogate Decision Makers of Critically Ill Patients,"White, Douglas B. and Ernecoff, Natalie and Buddadhumaruk, Praewpannarai and Hong, Seoyeon and Weissfeld, Lisa and Curtis, J. Randall and Luce, John M. and Lo, Bernard",JAMA,"IMPORTANCE: Misperceptions about prognosis by individuals making decisions for incapacitated critically ill patients (surrogates) are common and often attributed to poor comprehension of medical information. OBJECTIVE: To determine the prevalence of and factors related to physician-surrogate discordance about prognosis in intensive care units (ICUs). DESIGN, SETTING, AND PARTICIPANTS: Mixed-methods study comprising quantitative surveys and qualitative interviews conducted in 4 ICUs at a major US medical center involving surrogate decision makers and physicians caring for patients at high risk of death from January 4, 2005, to July 10, 2009. MAIN OUTCOMES AND MEASURES: Discordance about prognosis, defined as a difference between a physician's and a surrogate's prognostic estimates of at least 20%; misunderstandings by surrogates (defined as any difference between a physician's prognostic estimate and a surrogate's best guess of that estimate); differences in belief (any difference between a surrogate's actual estimate and their best guess of the physician's estimate). RESULTS: Two hundred twenty-nine surrogate decision makers (median age, 47 [interquartile range {IQR}, 35-56] years; 68% women) and 99 physicians were involved in the care of 174 critically ill patients (median age, 60 [IQR, 47-74] years; 44% women). Physician-surrogate discordance about prognosis occurred in 122 of 229 instances (53%; 95% CI, 46.8%-59.7%). In 65 instances (28%), discordance was related to both misunderstandings by surrogates and differences in belief about the patient's prognosis; 38 (17%) were related to misunderstandings by surrogates only; 7 (3%) were related to differences in belief only; and data were missing for 12. Seventy-five patients (43%) died. Surrogates' prognostic estimates were much more accurate than chance alone, but physicians' prognostic estimates were statistically significantly more accurate than surrogates' (C statistic, 0.83 vs 0.74; absolute difference, 0.094; 95% CI, 0.024-0.163; P = .008). Among 71 surrogates interviewed who had beliefs about the prognosis that were more optimistic than that of the physician, the most common reasons for optimism were a need to maintain hope to benefit the patient (n = 34), a belief that the patient had unique strengths unknown to the physician (n = 24), and religious belief (n = 19). CONCLUSIONS AND RELEVANCE: Among critically ill patients, discordant expectations about prognosis were common between patients' physicians and surrogate decision makers and were related to misunderstandings by surrogates about physicians' assessments of patients' prognoses and differences in beliefs about patients' prognoses.",2016,10.1001/jama.2016.5351,315,19,2086-2094,eng,1538-3598 0098-7484,*Critical Illness and *Decision Making and *Dissent and Disputes and Adult and Aged and Attitude and Comprehension and Culture and Female and Humans and Intensive Care Units and Male and Middle Aged and Physicians/*statistics & numerical data and Probability and Prognosis and Proxy/*statistics & numerical data and Qualitative Research and Terminal Care,NA,NA,2016/05/17/,JAMA,NA,NA,NA,NA
Youyou_2015_ProfthNaAcofScofthUnStofAm,JOUR,Computer-based personality judgments are more accurate than those made by humans,"Youyou, Wu and Kosinski, Michal and Stillwell, David",Proceedings of the National Academy of Sciences of the United States of America,"Judging others' personalities is an essential skill in successful social living, as personality is a key driver behind people's interactions, behaviors, and emotions. Although accurate personality judgments stem from social-cognitive skills, developments in machine learning show that computer models can also make valid judgments. This study compares the accuracy of human and computer-based personality judgments, using a sample of 86,220 volunteers who completed a 100-item personality questionnaire. We show that (i) computer predictions based on a generic digital footprint (Facebook Likes) are more accurate (r = 0.56) than those made by the participants' Facebook friends using a personality questionnaire (r = 0.49); (ii) computer models show higher interjudge agreement; and (iii) computer personality judgments have higher external validity when predicting life outcomes such as substance use, political attitudes, and physical health; for some outcomes, they even outperform the self-rated personality scores. Computers outpacing humans in personality judgment presents significant opportunities and challenges in the areas of psychological assessment, marketing, and privacy.",2015,10.1073/pnas.1418680112,112,4,1036-1040,eng,1091-6490 0027-8424,"*Computer Simulation and *Diagnosis, Computer-Assisted and *Personality and *Surveys and Questionnaires and artificial intelligence and big data and computational social science and Female and Humans and Male and personality judgment and social media and Social Media",NA,NA,2015/01/27/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Kim_2018_ProfthNaAcofScofthUnStofAm,JOUR,Prediction of inherited genomic susceptibility to 20 common cancer types by a supervised machine-learning method,"Kim, Byung-Ju and Kim, Sung-Hou",Proceedings of the National Academy of Sciences of the United States of America,"Prevention and early intervention are the most effective ways of avoiding or minimizing psychological, physical, and financial suffering from cancer. However, such proactive action requires the ability to predict the individual's susceptibility to cancer with a measure of probability. Of the triad of cancer-causing factors (inherited genomic susceptibility, environmental factors, and lifestyle factors), the inherited genomic component may be derivable from the recent public availability of a large body of whole-genome variation data. However, genome-wide association studies have so far showed limited success in predicting the inherited susceptibility to common cancers. We present here a multiple classification approach for predicting individuals' inherited genomic susceptibility to acquire the most likely phenotype among a panel of 20 major common cancer types plus 1 ""healthy"" type by application of a supervised machine-learning method under competing conditions among the cohorts of the 21 types. This approach suggests that, depending on the phenotypes of 5,919 individuals of ""white"" ethnic population in this study, (i) the portion of the cohort of a cancer type who acquired the observed type due to mostly inherited genomic susceptibility factors ranges from about 33 to 88% (or its corollary: the portion due to mostly environmental and lifestyle factors ranges from 12 to 67%), and (ii) on an individual level, the method also predicts individuals' inherited genomic susceptibility to acquire the other types ranked with associated probabilities. These probabilities may provide practical information for individuals, heath professionals, and health policymakers related to prevention and/or early intervention of cancer.",2018,10.1073/pnas.1717960115,115,6,1322-1327,eng,1091-6490 0027-8424,"*cancer risk and *Genetic Predisposition to Disease and *genomic/environmental factors and *k nearest neighbor method and *Machine Learning and *multiple assortment model and *Polymorphism, Single Nucleotide and *SNP syntax and cancer risk and Genome, Human and genomic/environmental factors and Humans and k nearest neighbor method and Life Style and multiple assortment model and Neoplasms/*genetics and Probability and SNP syntax",NA,NA,2018/02/06/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Omer_2009_ThNeEnjoofme,JOUR,"Vaccine refusal, mandatory immunization, and the risks of vaccine-preventable diseases","Omer, Saad B. and Salmon, Daniel A. and Orenstein, Walter A. and deHart, M. Patricia and Halsey, Neal",The New England journal of medicine,"Vaccines are among the most effective prevention tools available to clinicians. However, the success of an immunization program depends on high rates of acceptance and coverage. There is evidence of an increase in vaccine refusal in the United States and of geographic clustering of refusals that results in outbreaks. Children with exemptions from school immunization requirements (a measure of vaccine refusal) are at increased risk for measles and pertussis and can infect others who are too young to be vaccinated, cannot be vaccinated for medical reasons, or were vaccinated but did not have a sufficient immunologic response. Clinicians can play a crucial role in parental decision making. Health care providers are cited as the most frequent source of immunization information by parents, including parents of unvaccinated children. Although some clinicians have discontinued or have considered discontinuing their provider relationship with patients who refuse vaccines, the American Academy of Pediatrics Committee on Bioethics advises against this and recommends that clinicians address vaccine refusal by respectfully listening to parental concerns and discussing the risks of nonvaccination.",2009,10.1056/NEJMsa0806477,360,19,1981-1988,eng,1533-4406 0028-4793,"*Health Knowledge, Attitudes, Practice and Child and Health Personnel and History, 19th Century and History, 20th Century and History, 21st Century and Humans and Immunization Programs/legislation & jurisprudence and Mandatory Programs/history/*legislation & jurisprudence and Professional Role and Risk and Treatment Refusal/psychology/*statistics & numerical data and United States and Vaccination/history/*legislation & jurisprudence and Vaccines/adverse effects",NA,NA,2009/05/07/,N Engl J Med,NA,NA,NA,NA
Sun_2014_JAMA,JOUR,How to use a subgroup analysis: users' guide to the medical literature,"Sun, Xin and Ioannidis, John P. A. and Agoritsas, Thomas and Alba, Ana C. and Guyatt, Gordon",JAMA,"Clinicians, when trying to apply trial results to patient care, need to individualize patient care and, potentially, manage patients based on results of subgroup analyses. Apparently compelling subgroup effects often prove spurious, and guidance is needed to differentiate credible from less credible subgroup claims. We therefore provide 5 criteria to use when assessing the validity of subgroup analyses: (1) Can chance explain the apparent subgroup effect; (2) Is the effect consistent across studies; (3) Was the subgroup hypothesis one of a small number of hypotheses developed a priori with direction specified; (4) Is there strong preexisting biological support; and (5) Is the evidence supporting the effect based on within- or between-study comparisons. The first 4 criteria are applicable to individual studies or systematic reviews, the last only to systematic reviews of multiple studies. These criteria will help clinicians deciding whether to use subgroup analyses to guide their patient care.",2014,10.1001/jama.2013.285063,311,4,405-411,eng,1538-3598 0098-7484,"*Data Interpretation, Statistical and *Decision Making and *Guidelines as Topic and *Randomized Controlled Trials as Topic and Evidence-Based Medicine and Meta-Analysis as Topic and Patient Care and Research Design and Review Literature as Topic",NA,NA,2014/01/22/29,JAMA,NA,NA,NA,NA
Murad_2014_JAMA,JOUR,How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature,"Murad, Mohammad Hassan and Montori, Victor M. and Ioannidis, John P. A. and Jaeschke, Roman and Devereaux, P. J. and Prasad, Kameshwar and Neumann, Ignacio and Carrasco-Labra, Alonso and Agoritsas, Thomas and Hatala, Rose and Meade, Maureen O. and Wyer, Peter and Cook, Deborah J. and Guyatt, Gordon",JAMA,"Clinical decisions should be based on the totality of the best evidence and not the results of individual studies. When clinicians apply the results of a systematic review or meta-analysis to patient care, they should start by evaluating the credibility of the methods of the systematic review, ie, the extent to which these methods have likely protected against misleading results. Credibility depends on whether the review addressed a sensible clinical question; included an exhaustive literature search; demonstrated reproducibility of the selection and assessment of studies; and presented results in a useful manner. For reviews that are sufficiently credible, clinicians must decide on the degree of confidence in the estimates that the evidence warrants (quality of evidence). Confidence depends on the risk of bias in the body of evidence; the precision and consistency of the results; whether the results directly apply to the patient of interest; and the likelihood of reporting bias. Shared decision making requires understanding of the estimates of magnitude of beneficial and harmful effects, and confidence in those estimates.",2014,10.1001/jama.2014.5559,312,2,171-179,eng,1538-3598 0098-7484,*Decision Making and *Meta-Analysis as Topic and *Review Literature as Topic and Bias and Evidence-Based Practice/*methods and Humans and Patient Care/standards and Reproducibility of Results,NA,NA,2014/07//undefined,JAMA,NA,NA,NA,NA
Gussow_2020_ProfthNaAcofScofthUnStofAm,JOUR,Genomic determinants of pathogenicity in SARS-CoV-2 and other human coronaviruses,"Gussow, Ayal B. and Auslander, Noam and Faure, Guilhem and Wolf, Yuri I. and Zhang, Feng and Koonin, Eugene V.",Proceedings of the National Academy of Sciences of the United States of America,"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses an immediate, major threat to public health across the globe. Here we report an in-depth molecular analysis to reconstruct the evolutionary origins of the enhanced pathogenicity of SARS-CoV-2 and other coronaviruses that are severe human pathogens. Using integrated comparative genomics and machine learning techniques, we identify key genomic features that differentiate SARS-CoV-2 and the viruses behind the two previous deadly coronavirus outbreaks, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), from less pathogenic coronaviruses. These features include enhancement of the nuclear localization signals in the nucleocapsid protein and distinct inserts in the spike glycoprotein that appear to be associated with high case fatality rate of these coronaviruses as well as the host switch from animals to humans. The identified features could be crucial contributors to coronavirus pathogenicity and possible targets for diagnostics, prognostication, and interventions.",2020,10.1073/pnas.2008176117,117,26,15193-15199,eng,1091-6490 0027-8424,"*coronaviruses and *COVID-19 and *Evolution, Molecular and *Genome, Viral and *nucleocapsid and *pathogenicity and *spike protein and Animals and Betacoronavirus/classification/*genetics/pathogenicity and coronaviruses and COVID-19 and Host Specificity and Humans and Machine Learning and Middle East Respiratory Syndrome Coronavirus/classification/genetics/pathogenicity and Mutagenesis, Insertional and Nuclear Localization Signals/genetics and nucleocapsid and Nucleocapsid Proteins/chemistry/*genetics and pathogenicity and Phylogeny and SARS-CoV-2 and Sequence Homology and Spike Glycoprotein, Coronavirus/chemistry/*genetics and spike protein and Virulence/genetics",NA,NA,2020/06/30/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Ting_2017_JAMA,JOUR,Development and Validation of a Deep Learning System for Diabetic Retinopathy and Related Eye Diseases Using Retinal Images From Multiethnic Populations With Diabetes,"Ting, Daniel Shu Wei and Cheung, Carol Yim-Lui and Lim, Gilbert and Tan, Gavin Siew Wei and Quang, Nguyen D. and Gan, Alfred and Hamzah, Haslina and Garcia-Franco, Renata and San Yeo, Ian Yew and Lee, Shu Yen and Wong, Edmund Yick Mun and Sabanayagam, Charumathi and Baskaran, Mani and Ibrahim, Farah and Tan, Ngiap Chuan and Finkelstein, Eric A. and Lamoureux, Ecosse L. and Wong, Ian Y. and Bressler, Neil M. and Sivaprasad, Sobha and Varma, Rohit and Jonas, Jost B. and He, Ming Guang and Cheng, Ching-Yu and Cheung, Gemmy Chui Ming and Aung, Tin and Hsu, Wynne and Lee, Mong Li and Wong, Tien Yin",JAMA,"IMPORTANCE: A deep learning system (DLS) is a machine learning technology with potential for screening diabetic retinopathy and related eye diseases. OBJECTIVE: To evaluate the performance of a DLS in detecting referable diabetic retinopathy, vision-threatening diabetic retinopathy, possible glaucoma, and age-related macular degeneration (AMD) in community and clinic-based multiethnic populations with diabetes. DESIGN, SETTING, AND PARTICIPANTS: Diagnostic performance of a DLS for diabetic retinopathy and related eye diseases was evaluated using 494<e2><80><af>661 retinal images. A DLS was trained for detecting diabetic retinopathy (using 76<e2><80><af>370 images), possible glaucoma (125<e2><80><af>189 images), and AMD (72<e2><80><af>610 images), and performance of DLS was evaluated for detecting diabetic retinopathy (using 112<e2><80><af>648 images), possible glaucoma (71<e2><80><af>896 images), and AMD (35<e2><80><af>948 images). Training of the DLS was completed in May 2016, and validation of the DLS was completed in May 2017 for detection of referable diabetic retinopathy (moderate nonproliferative diabetic retinopathy or worse) and vision-threatening diabetic retinopathy (severe nonproliferative diabetic retinopathy or worse) using a primary validation data set in the Singapore National Diabetic Retinopathy Screening Program and 10 multiethnic cohorts with diabetes. EXPOSURES: Use of a deep learning system. MAIN OUTCOMES AND MEASURES: Area under the receiver operating characteristic curve (AUC) and sensitivity and specificity of the DLS with professional graders (retinal specialists, general ophthalmologists, trained graders, or optometrists) as the reference standard. RESULTS: In the primary validation dataset (n = 14<e2><80><af>880 patients; 71<e2><80><af>896 images; mean [SD] age, 60.2 [2.2] years; 54.6% men), the prevalence of referable diabetic retinopathy was 3.0%; vision-threatening diabetic retinopathy, 0.6%; possible glaucoma, 0.1%; and AMD, 2.5%. The AUC of the DLS for referable diabetic retinopathy was 0.936 (95% CI, 0.925-0.943), sensitivity was 90.5% (95% CI, 87.3%-93.0%), and specificity was 91.6% (95% CI, 91.0%-92.2%). For vision-threatening diabetic retinopathy, AUC was 0.958 (95% CI, 0.956-0.961), sensitivity was 100% (95% CI, 94.1%-100.0%), and specificity was 91.1% (95% CI, 90.7%-91.4%). For possible glaucoma, AUC was 0.942 (95% CI, 0.929-0.954), sensitivity was 96.4% (95% CI, 81.7%-99.9%), and specificity was 87.2% (95% CI, 86.8%-87.5%). For AMD, AUC was 0.931 (95% CI, 0.928-0.935), sensitivity was 93.2% (95% CI, 91.1%-99.8%), and specificity was 88.7% (95% CI, 88.3%-89.0%). For referable diabetic retinopathy in the 10 additional datasets, AUC range was 0.889 to 0.983 (n = 40<e2><80><af>752 images). CONCLUSIONS AND RELEVANCE: In this evaluation of retinal images from multiethnic cohorts of patients with diabetes, the DLS had high sensitivity and specificity for identifying diabetic retinopathy and related eye diseases. Further research is necessary to evaluate the applicability of the DLS in health care settings and the utility of the DLS to improve vision outcomes.",2017,10.1001/jama.2017.18152,318,22,2211-2223,eng,1538-3598 0098-7484,*Machine Learning and Area Under Curve and Datasets as Topic and Diabetes Mellitus/ethnology and Diabetic Retinopathy/*diagnosis/ethnology and Eye Diseases/*diagnosis/ethnology and Female and Glaucoma/diagnosis and Humans and Male and Middle Aged and Retina/diagnostic imaging/*pathology and ROC Curve and Sensitivity and Specificity,NA,NA,2017/12/12/,JAMA,NA,NA,NA,NA
Seymour_2019_JAMA,JOUR,"Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis","Seymour, Christopher W. and Kennedy, Jason N. and Wang, Shu and Chang, Chung-Chou H. and Elliott, Corrine F. and Xu, Zhongying and Berry, Scott and Clermont, Gilles and Cooper, Gregory and Gomez, Hernando and Huang, David T. and Kellum, John A. and Mi, Qi and Opal, Steven M. and Talisa, Victor and van der Poll, Tom and Visweswaran, Shyam and Vodovotz, Yoram and Weiss, Jeremy C. and Yealy, Donald M. and Yende, Sachin and Angus, Derek C.",JAMA,"IMPORTANCE: Sepsis is a heterogeneous syndrome. Identification of distinct clinical phenotypes may allow more precise therapy and improve care. OBJECTIVE: To derive sepsis phenotypes from clinical data, determine their reproducibility and correlation with host-response biomarkers and clinical outcomes, and assess the potential causal relationship with results from randomized clinical trials (RCTs). DESIGN, SETTINGS, AND PARTICIPANTS: Retrospective analysis of data sets using statistical, machine learning, and simulation tools. Phenotypes were derived among 20<e2><80><af>189 total patients (16<e2><80><af>552 unique patients) who met Sepsis-3 criteria within 6 hours of hospital presentation at 12 Pennsylvania hospitals (2010-2012) using consensus k means clustering applied to 29 variables. Reproducibility and correlation with biological parameters and clinical outcomes were assessed in a second database (2013-2014; n = 43<e2><80><af>086 total patients and n = 31<e2><80><af>160 unique patients), in a prospective cohort study of sepsis due to pneumonia (n = 583), and in 3 sepsis RCTs (n = 4737). EXPOSURES: All clinical and laboratory variables in the electronic health record. MAIN OUTCOMES AND MEASURES: Derived phenotype (<ce><b1>, <ce><b2>, <ce><b3>, and <ce><b4>) frequency, host-response biomarkers, 28-day and 365-day mortality, and RCT simulation outputs. RESULTS: The derivation cohort included 20<e2><80><af>189 patients with sepsis (mean age, 64 [SD, 17] years; 10<e2><80><af>022 [50%] male; mean maximum 24-hour Sequential Organ Failure Assessment [SOFA] score, 3.9 [SD, 2.4]). The validation cohort included 43<e2><80><af>086 patients (mean age, 67 [SD, 17] years; 21<e2><80><af>993 [51%] male; mean maximum 24-hour SOFA score, 3.6 [SD, 2.0]). Of the 4 derived phenotypes, the <ce><b1> phenotype was the most common (n = 6625; 33%) and included patients with the lowest administration of a vasopressor; in the <ce><b2> phenotype (n = 5512; 27%), patients were older and had more chronic illness and renal dysfunction; in the <ce><b3> phenotype (n = 5385; 27%), patients had more inflammation and pulmonary dysfunction; and in the <ce><b4> phenotype (n = 2667; 13%), patients had more liver dysfunction and septic shock. Phenotype distributions were similar in the validation cohort. There were consistent differences in biomarker patterns by phenotype. In the derivation cohort, cumulative 28-day mortality was 287 deaths of 5691 unique patients (5%) for the <ce><b1> phenotype; 561 of 4420 (13%) for the <ce><b2> phenotype; 1031 of 4318 (24%) for the <ce><b3> phenotype; and 897 of 2223 (40%) for the <ce><b4> phenotype. Across all cohorts and trials, 28-day and 365-day mortality were highest among the <ce><b4> phenotype vs the other 3 phenotypes (P < .001). In simulation models, the proportion of RCTs reporting benefit, harm, or no effect changed considerably (eg, varying the phenotype frequencies within an RCT of early goal-directed therapy changed the results from >33% chance of benefit to >60% chance of harm). CONCLUSIONS AND RELEVANCE: In this retrospective analysis of data sets from patients with sepsis, 4 clinical phenotypes were identified that correlated with host-response patterns and clinical outcomes, and simulations suggested these phenotypes may help in understanding heterogeneity of treatment effects. Further research is needed to determine the utility of these phenotypes in clinical care and for informing trial design and interpretation.",2019,10.1001/jama.2019.5791,321,20,2003-2017,eng,1538-3598 0098-7484,Algorithms and Biomarkers/blood and Cluster Analysis and Datasets as Topic and Hospital Mortality and Humans and Machine Learning and Organ Dysfunction Scores and Phenotype and Reproducibility of Results and Retrospective Studies and Sepsis/*classification/mortality/therapy,NA,NA,2019/05/28/,JAMA,NA,NA,NA,NA
Schwalbe_2020_Lanc.LonEngl,JOUR,Artificial intelligence and the future of global health,"Schwalbe, Nina and Wahl, Brian","Lancet (London, England)","Concurrent advances in information technology infrastructure and mobile computing power in many low and middle-income countries (LMICs) have raised hopes that artificial intelligence (AI) might help to address challenges unique to the field of global health and accelerate achievement of the health-related sustainable development goals. A series of fundamental questions have been raised about AI-driven health interventions, and whether the tools, methods, and protections traditionally used to make ethical and evidence-based decisions about new technologies can be applied to AI. Deployment of AI has already begun for a broad range of health issues common to LMICs, with interventions focused primarily on communicable diseases, including tuberculosis and malaria. Types of AI vary, but most use some form of machine learning or signal processing. Several types of machine learning methods are frequently used together, as is machine learning with other approaches, most often signal processing. AI-driven health interventions fit into four categories relevant to global health researchers: (1) diagnosis, (2) patient morbidity or mortality risk assessment, (3) disease outbreak prediction and surveillance, and (4) health policy and planning. However, much of the AI-driven intervention research in global health does not describe ethical, regulatory, or practical considerations required for widespread use or deployment at scale. Despite the field remaining nascent, AI-driven health interventions could lead to improved health outcomes in LMICs. Although some challenges of developing and deploying these interventions might not be unique to these settings, the global health community will need to work quickly to establish guidelines for development, testing, and use, and develop a user-driven research agenda to facilitate equitable and ethical use.",2020,10.1016/S0140-6736(20)30226-9,395,10236,1579-1586,eng,1474-547X 0140-6736,*Artificial Intelligence and Disease Outbreaks/prevention & control and Global Health/*trends and Health Policy and Humans and Risk Assessment,NA,NA,2020/05/16/,Lancet,NA,NA,NA,NA
Arterburn_2020_JAMA,JOUR,Benefits and Risks of Bariatric Surgery in Adults: A Review,"Arterburn, David E. and Telem, Dana A. and Kushner, Robert F. and Courcoulas, Anita P.",JAMA,"IMPORTANCE: Severe obesity and its related diseases, such as type 2 diabetes, hypertension, dyslipidemia, and sleep apnea, are very common in the United States, but currently very few patients with these conditions choose to undergo bariatric surgery. Summaries of the expanding evidence for both the benefits and risks of bariatric surgery are needed to better guide shared decision-making conversations. OBSERVATIONS: There are approximately 252<e2><80><af>000 bariatric procedures (per 2018 numbers) performed each year in the US, of which an estimated 15% are revisions. The 1991 National Institutes of Health guidelines recommended consideration of bariatric surgery in patients with a body mass index (calculated as weight in kilograms divided by height in meters squared) of 40 or higher or 35 or higher with serious obesity-related comorbidities. These guidelines are still widely used; however, there is increasing evidence that bariatric procedures should also be considered for patients with type 2 diabetes and a body mass index of 30 to 35 if hyperglycemia is inadequately controlled despite optimal medical treatment for type 2 diabetes. Substantial evidence indicates that surgery results in greater improvements in weight loss and type 2 diabetes outcomes, compared with nonsurgical interventions, regardless of the type of procedures used. The 2 most common procedures used currently, the sleeve gastrectomy and gastric bypass, have similar effects on weight loss and diabetes outcomes and similar safety through at least 5-year follow-up. However, emerging evidence suggests that the sleeve procedure is associated with fewer reoperations, and the bypass procedure may lead to more durable weight loss and glycemic control. Although safety is a concern, current data indicate that the perioperative mortality rates range from 0.03% to 0.2%, which has substantially improved since early 2000s. More long-term randomized studies are needed to assess the effect of bariatric procedures on cardiovascular disease, cancer, and other health outcomes and to evaluate emerging newer procedures. CONCLUSIONS AND RELEVANCE: Modern bariatric procedures have strong evidence of efficacy and safety. All patients with severe obesity-and especially those with type 2 diabetes-should be engaged in a shared decision-making conversation about the risks and benefits of surgery compared with continuing usual medical and lifestyle treatment, and the decision about surgery should be driven primarily by informed patient preferences.",2020,10.1001/jama.2020.12567,324,9,879-887,eng,1538-3598 0098-7484,"*Bariatric Surgery/adverse effects/methods and *Postoperative Complications and *Weight Loss and Diabetes Mellitus, Type 2/complications and Dyslipidemias/etiology and Female and Gastrectomy and Humans and Hypertension/etiology and Male and Obesity, Morbid/complications/*surgery and Sleep Apnea Syndromes/etiology",NA,NA,2020/09/01/,JAMA,NA,NA,NA,NA
Wang_2020_ProfthNaAcofScofthUnStofAm,JOUR,Methods for correcting inference based on outcomes predicted by machine learning,"Wang, Siruo and McCormick, Tyler H. and Leek, Jeffrey T.",Proceedings of the National Academy of Sciences of the United States of America,"Many modern problems in medicine and public health leverage machine-learning methods to predict outcomes based on observable covariates. In a wide array of settings, predicted outcomes are used in subsequent statistical analysis, often without accounting for the distinction between observed and predicted outcomes. We call inference with predicted outcomes postprediction inference. In this paper, we develop methods for correcting statistical inference using outcomes predicted with arbitrarily complicated machine-learning models including random forests and deep neural nets. Rather than trying to derive the correction from first principles for each machine-learning algorithm, we observe that there is typically a low-dimensional and easily modeled representation of the relationship between the observed and predicted outcomes. We build an approach for postprediction inference that naturally fits into the standard machine-learning framework where the data are divided into training, testing, and validation sets. We train the prediction model in the training set, estimate the relationship between the observed and predicted outcomes in the testing set, and use that relationship to correct subsequent inference in the validation set. We show our postprediction inference (postpi) approach can correct bias and improve variance estimation and subsequent statistical inference with predicted outcomes. To show the broad range of applicability of our approach, we show postpi can improve inference in two distinct fields: modeling predicted phenotypes in repurposed gene expression data and modeling predicted causes of death in verbal autopsy data. Our method is available through an open-source R package: https://github.com/leekgroup/postpi.",2020,10.1073/pnas.2001238117,117,48,30266-30275,eng,1091-6490 0027-8424,*interpretability and *machine learning and *Machine Learning and *postprediction inference and *statistics and Cause of Death and Computer Simulation and Humans and interpretability and machine learning and Organ Specificity and postprediction inference and statistics,NA,NA,2020/12/01/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Martin_2016_Lanc.LonEngl,JOUR,The map is not the territory: medical records and 21st century practice,"Martin, Stephen A. and Sinsky, Christine A.","Lancet (London, England)","Documentation of care is at risk of overtaking the delivery of care in terms of time, clinician focus, and perceived importance. The medical record as currently used for documentation contributes to increased cognitive workload, strained clinician-patient relationships, and burnout. We posit that a near verbatim transcript of the clinical encounter is neither feasible nor desirable, and that attempts to produce this exact recording are harmful to patients, clinicians, and the health system. In this Viewpoint, we focus on the alternative constructions of the medical record to bring them back to their primary purpose-to aid cognition, communicate, create a succinct account of care, and support longitudinal comprehensive care-thereby to support the building of relationships and medical decision making while decreasing workload.",2016,10.1016/S0140-6736(16)00338-X,388,10055,2053-2056,eng,1474-547X 0140-6736,"*Documentation and Burnout, Professional and Efficiency, Organizational and Humans and Medical History Taking/standards and Medical Records/*standards and Physician-Patient Relations and United States and Workload",NA,NA,2016/10/22/,Lancet,NA,NA,NA,NA
Jaidka_2020_ProfthNaAcofScofthUnStofAm,JOUR,Estimating geographic subjective well-being from Twitter: A comparison of dictionary and data-driven language methods,"Jaidka, Kokil and Giorgi, Salvatore and Schwartz, H. Andrew and Kern, Margaret L. and Ungar, Lyle H. and Eichstaedt, Johannes C.",Proceedings of the National Academy of Sciences of the United States of America,"Researchers and policy makers worldwide are interested in measuring the subjective well-being of populations. When users post on social media, they leave behind digital traces that reflect their thoughts and feelings. Aggregation of such digital traces may make it possible to monitor well-being at large scale. However, social media-based methods need to be robust to regional effects if they are to produce reliable estimates. Using a sample of 1.53 billion geotagged English tweets, we provide a systematic evaluation of word-level and data-driven methods for text analysis for generating well-being estimates for 1,208 US counties. We compared Twitter-based county-level estimates with well-being measurements provided by the Gallup-Sharecare Well-Being Index survey through 1.73 million phone surveys. We find that word-level methods (e.g., Linguistic Inquiry and Word Count [LIWC] 2015 and Language Assessment by Mechanical Turk [LabMT]) yielded inconsistent county-level well-being measurements due to regional, cultural, and socioeconomic differences in language use. However, removing as few as three of the most frequent words led to notable improvements in well-being prediction. Data-driven methods provided robust estimates, approximating the Gallup data at up to r = 0.64. We show that the findings generalized to county socioeconomic and health outcomes and were robust when poststratifying the samples to be more representative of the general US population. Regional well-being estimation from social media data seems to be robust when supervised data-driven methods are used.",2020,10.1073/pnas.1906364117,117,19,10165-10171,eng,1091-6490 0027-8424,*big data and *language analysis and *machine learning and *subjective well-being and *Twitter and big data and language analysis and machine learning and subjective well-being and Twitter,NA,NA,2020/05/12/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Coughlan_2019_ProfthNaAcofScofthUnStofAm,JOUR,Toward personalized cognitive diagnostics of at-genetic-risk Alzheimer's disease,"Coughlan, Gillian and Coutrot, Antoine and Khondoker, Mizanur and Minihane, Anne-Marie and Spiers, Hugo and Hornberger, Michael",Proceedings of the National Academy of Sciences of the United States of America,"Spatial navigation is emerging as a critical factor in identifying preclinical Alzheimer's disease (AD). However, the impact of interindividual navigation ability and demographic risk factors (e.g., APOE, age, and sex) on spatial navigation make it difficult to identify persons ""at high risk"" of AD in the preclinical stages. In the current study, we use spatial navigation big data (n = 27,108) from the Sea Hero Quest (SHQ) game to overcome these challenges by investigating whether big data can be used to benchmark a highly phenotyped healthy aging laboratory cohort into high- vs. low-risk persons based on their genetic (APOE) and demographic (sex, age, and educational attainment) risk factors. Our results replicate previous findings in APOE <ce><b5>4 carriers, indicative of grid cell coding errors in the entorhinal cortex, the initial brain region affected by AD pathophysiology. We also show that although baseline navigation ability differs between men and women, sex does not interact with the APOE genotype to influence the manifestation of AD-related spatial disturbance. Most importantly, we demonstrate that such high-risk preclinical cases can be reliably distinguished from low-risk participants using big-data spatial navigation benchmarks. By contrast, participants were undistinguishable on neuropsychological episodic memory tests. Taken together, we present evidence to suggest that, in the future, SHQ normative benchmark data can be used to more accurately classify spatial impairments in at-high-risk of AD healthy participants at a more individual level, therefore providing the steppingstone for individualized diagnostics and outcome measures of cognitive symptoms in preclinical AD.",2019,10.1073/pnas.1901600116,116,19,9285-9292,eng,1091-6490 0027-8424,*Alzheimer's disease and *APOE genotype and *Cognition and *Genetic Predisposition to Disease and *personalized health care and *preclinical diagnosis and *spatial navigation and Aged and Alzheimer Disease/*diagnosis/*genetics/psychology and Alzheimer's disease and APOE genotype and Apolipoprotein E4/genetics and Female and Genotype and Humans and Male and Middle Aged and Neuropsychological Tests and personalized health care and Precision Medicine and preclinical diagnosis and Risk Factors and Sex Factors and spatial navigation and Spatial Navigation,NA,NA,2019/05/07/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Luna_2019_ProfthNaAcofScofthUnStofAm,JOUR,Building more accurate decision trees with the additive tree,"Luna, Jose Marcio and Gennatas, Efstathios D. and Ungar, Lyle H. and Eaton, Eric and Diffenderfer, Eric S. and Jensen, Shane T. and Simone, Charles B. 2nd and Friedman, Jerome H. and Solberg, Timothy D. and Valdes, Gilmer",Proceedings of the National Academy of Sciences of the United States of America,"The expansion of machine learning to high-stakes application domains such as medicine, finance, and criminal justice, where making informed decisions requires clear understanding of the model, has increased the interest in interpretable machine learning. The widely used Classification and Regression Trees (CART) have played a major role in health sciences, due to their simple and intuitive explanation of predictions. Ensemble methods like gradient boosting can improve the accuracy of decision trees, but at the expense of the interpretability of the generated model. Additive models, such as those produced by gradient boosting, and full interaction models, such as CART, have been investigated largely in isolation. We show that these models exist along a spectrum, revealing previously unseen connections between these approaches. This paper introduces a rigorous formalization for the additive tree, an empirically validated learning technique for creating a single decision tree, and shows that this method can produce models equivalent to CART or gradient boosted stumps at the extremes by varying a single parameter. Although the additive tree is designed primarily to provide both the model interpretability and predictive performance needed for high-stakes applications like medicine, it also can produce decision trees represented by hybrid models between CART and boosted stumps that can outperform either of these approaches.",2019,10.1073/pnas.1816748116,116,40,19887-19893,eng,1091-6490 0027-8424,"*additive tree and *Algorithms and *CART and *decision tree and *Decision Trees and *gradient boosting and *interpretable machine learning and *Machine Learning and additive tree and CART and Databases, Factual and decision tree and gradient boosting and interpretable machine learning and Models, Statistical and Programming Languages",NA,NA,2019/10/01/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Huang_2019_ProfthNaAcofScofthUnStofAm,JOUR,Veil-of-ignorance reasoning favors the greater good,"Huang, Karen and Greene, Joshua D. and Bazerman, Max",Proceedings of the National Academy of Sciences of the United States of America,"The ""veil of ignorance"" is a moral reasoning device designed to promote impartial decision making by denying decision makers access to potentially biasing information about who will benefit most or least from the available options. Veil-of-ignorance reasoning was originally applied by philosophers and economists to foundational questions concerning the overall organization of society. Here, we apply veil-of-ignorance reasoning in a more focused way to specific moral dilemmas, all of which involve a tension between the greater good and competing moral concerns. Across 7 experiments (n = 6,261), 4 preregistered, we find that veil-of-ignorance reasoning favors the greater good. Participants first engaged in veil-of-ignorance reasoning about a specific dilemma, asking themselves what they would want if they did not know who among those affected they would be. Participants then responded to a more conventional version of the same dilemma with a moral judgment, a policy preference, or an economic choice. Participants who first engaged in veil-of-ignorance reasoning subsequently made more utilitarian choices in response to a classic philosophical dilemma, a medical dilemma, a real donation decision between a more vs. less effective charity, and a policy decision concerning the social dilemma of autonomous vehicles. These effects depend on the impartial thinking induced by veil-of-ignorance reasoning and cannot be explained by anchoring, probabilistic reasoning, or generic perspective taking. These studies indicate that veil-of-ignorance reasoning may be a useful tool for decision makers who wish to make more impartial and/or socially beneficial choices.",2019,10.1073/pnas.1910125116,116,48,23989-23995,eng,1091-6490 0027-8424,*decision making and *ethics and *fairness and *Morals and *policy making and *procedural justice and decision making and Decision Making/*ethics and ethics and fairness and Female and Humans and Judgment and Male and Motor Vehicles and policy making and Policy Making and Problem Solving/*ethics and procedural justice,NA,NA,2019/11/26/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Cassidy_2019_ProfthNaAcofScofthUnStofAm,JOUR,Tuberculosis diagnosis and treatment under uncertainty,"Cassidy, Rachel and Manski, Charles F.",Proceedings of the National Academy of Sciences of the United States of America,"In 2017, 1.6 million people worldwide died from tuberculosis (TB). A new TB diagnostic test-Xpert MTB/RIF from Cepheid-was endorsed by the World Health Organization in 2010. Trials demonstrated that Xpert is faster and has greater sensitivity and specificity than smear microscopy-the most common sputum-based diagnostic test. However, subsequent trials found no impact of introducing Xpert on morbidity and mortality. We present a decision-theoretic model of how a clinician might decide whether to order Xpert or other tests for TB, and whether to treat a patient, with or without test results. Our first result characterizes the conditions under which it is optimal to perform empirical treatment; that is, treatment without diagnostic testing. We then examine the implications for decision making of partial knowledge of TB prevalence or test accuracy. This partial knowledge generates ambiguity, also known as deep uncertainty, about the best testing and treatment policy. In the presence of such ambiguity, we show the usefulness of diversification of testing and treatment.",2019,10.1073/pnas.1912091116,116,46,22990-22997,eng,1091-6490 0027-8424,"*decision under ambiguity and *diagnosis and treatment and *medical decision making and *public health and *tuberculosis and Antibiotics, Antitubercular/administration & dosage and Decision Making and decision under ambiguity and diagnosis and treatment and Diagnostic Tests, Routine/*psychology and Humans and medical decision making and Mycobacterium tuberculosis/drug effects/physiology and Physicians/psychology and public health and Sputum/microbiology and tuberculosis and Tuberculosis/*diagnosis/*drug therapy/microbiology/psychology and Uncertainty",NA,NA,2019/11/12/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Puterman_2020_ProfthNaAcofScofthUnStofAm,JOUR,"Predicting mortality from 57 economic, behavioral, social, and psychological factors","Puterman, Eli and Weiss, Jordan and Hives, Benjamin A. and Gemmill, Alison and Karasek, Deborah and Mendes, Wendy Berry and Rehkopf, David H.",Proceedings of the National Academy of Sciences of the United States of America,"Behavioral and social scientists have identified many nonbiological predictors of mortality. An important limitation of much of this research, however, is that risk factors are not studied in comparison with one another or from across different fields of research. It therefore remains unclear which factors should be prioritized for interventions and policy to reduce mortality risk. In the current investigation, we compare 57 factors within a multidisciplinary framework. These include (i) adverse socioeconomic and psychosocial experiences during childhood and (ii) socioeconomic conditions, (iii) health behaviors, (iv) social connections, (v) psychological characteristics, and (vi) adverse experiences during adulthood. The current prospective cohort investigation with 13,611 adults from 52 to 104 y of age (mean age 69.3 y) from the nationally representative Health and Retirement Study used weighted traditional (i.e., multivariate Cox regressions) and machine-learning (i.e., lasso, random forest analysis) statistical approaches to identify the leading predictors of mortality over 6 y of follow-up time. We demonstrate that, in addition to the well-established behavioral risk factors of smoking, alcohol abuse, and lack of physical activity, economic (e.g., recent financial difficulties, unemployment history), social (e.g., childhood adversity, divorce history), and psychological (e.g., negative affectivity) factors were also among the strongest predictors of mortality among older American adults. The strength of these predictors should be used to guide future transdisciplinary investigations and intervention studies across the fields of epidemiology, psychology, sociology, economics, and medicine to understand how changes in these factors alter individual mortality risk.",2020,10.1073/pnas.1918455117,117,28,16273-16282,eng,1091-6490 0027-8424,"*behavioral and *data-driven and *Forecasting and *mortality and *social and *transdisciplinary and Aged and Aged, 80 and over and behavioral and data-driven and Female and Humans and Interdisciplinary Communication and Male and Middle Aged and mortality and Mortality/*trends and Prospective Studies and Risk Factors and social and transdisciplinary and United States/epidemiology",NA,NA,2020/07/14/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Ryu_2018_ProfthNaAcofScofthUnStofAm,JOUR,Deep learning improves prediction of drug-drug and drug-food interactions,"Ryu, Jae Yong and Kim, Hyun Uk and Lee, Sang Yup",Proceedings of the National Academy of Sciences of the United States of America,"Drug interactions, including drug-drug interactions (DDIs) and drug-food constituent interactions (DFIs), can trigger unexpected pharmacological effects, including adverse drug events (ADEs), with causal mechanisms often unknown. Several computational methods have been developed to better understand drug interactions, especially for DDIs. However, these methods do not provide sufficient details beyond the chance of DDI occurrence, or require detailed drug information often unavailable for DDI prediction. Here, we report development of a computational framework DeepDDI that uses names of drug-drug or drug-food constituent pairs and their structural information as inputs to accurately generate 86 important DDI types as outputs of human-readable sentences. DeepDDI uses deep neural network with its optimized prediction performance and predicts 86 DDI types with a mean accuracy of 92.4% using the DrugBank gold standard DDI dataset covering 192,284 DDIs contributed by 191,878 drug pairs. DeepDDI is used to suggest potential causal mechanisms for the reported ADEs of 9,284 drug pairs, and also predict alternative drug candidates for 62,707 drug pairs having negative health effects. Furthermore, DeepDDI is applied to 3,288,157 drug-food constituent pairs (2,159 approved drugs and 1,523 well-characterized food constituents) to predict DFIs. The effects of 256 food constituents on pharmacological effects of interacting drugs and bioactivities of 149 food constituents are predicted. These results suggest that DeepDDI can provide important information on drug prescription and even dietary suggestions while taking certain drugs and also guidelines during drug development.",2018,10.1073/pnas.1803294115,115,18,E4304-E4311,eng,1091-6490 0027-8424,"*Databases, Factual and *deep learning and *DeepDDI and *drug-drug interactions and *drug-food interactions and *Food-Drug Interactions and *Neural Networks, Computer and *structural similarity profile and Data Mining/*methods and deep learning and DeepDDI and drug-drug interactions and drug-food interactions and Humans and structural similarity profile",NA,NA,2018/05/01/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Yao_2020_ProfthNaAcofScofthUnStofAm,JOUR,Near-hysteresis-free soft tactile electronic skins for wearables and reliable machine learning,"Yao, Haicheng and Yang, Weidong and Cheng, Wen and Tan, Yu Jun and See, Hian Hian and Li, Si and Ali, Hashina Parveen Anwar and Lim, Brian Z. H. and Liu, Zhuangjian and Tee, Benjamin C. K.",Proceedings of the National Academy of Sciences of the United States of America,"Electronic skins are essential for real-time health monitoring and tactile perception in robots. Although the use of soft elastomers and microstructures have improved the sensitivity and pressure-sensing range of tactile sensors, the intrinsic viscoelasticity of soft polymeric materials remains a long-standing challenge resulting in cyclic hysteresis. This causes sensor data variations between contact events that negatively impact the accuracy and reliability. Here, we introduce the Tactile Resistive Annularly Cracked E-Skin (TRACE) sensor to address the inherent trade-off between sensitivity and hysteresis in tactile sensors when using soft materials. We discovered that piezoresistive sensors made using an array of three-dimensional (3D) metallic annular cracks on polymeric microstructures possess high sensitivities (> 10(7) <ce><a9> <e2><8b><85> kPa(-1)), low hysteresis (2.99 <c2><b1> 1.37%) over a wide pressure range (0-20 kPa), and fast response (400 Hz). We demonstrate that TRACE sensors can accurately detect and measure the pulse wave velocity (PWV) when skin mounted. Moreover, we show that these tactile sensors when arrayed enabled fast reliable one-touch surface texture classification with neuromorphic encoding and deep learning algorithms.",2020,10.1073/pnas.2010989117,117,41,25352-25359,eng,1091-6490 0027-8424,machine learning and Humans and robotics and Pressure and Pulse Wave Analysis and wearable and *machine learning and *robotics and *Machine Learning and *electronic skin and *sensor and *wearable and *Wearable Electronic Devices and Materials Science and sensor and electronic skin,NA,NA,2020/10/13/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Joel_2020_ProfthNaAcofScofthUnStofAm,JOUR,Machine learning uncovers the most robust self-report predictors of relationship quality across 43 longitudinal couples studies,"Joel, Samantha and Eastwick, Paul W. and Allison, Colleen J. and Arriaga, Ximena B. and Baker, Zachary G. and Bar-Kalifa, Eran and Bergeron, Sophie and Birnbaum, Gurit E. and Brock, Rebecca L. and Brumbaugh, Claudia C. and Carmichael, Cheryl L. and Chen, Serena and Clarke, Jennifer and Cobb, Rebecca J. and Coolsen, Michael K. and Davis, Jody and de Jong, David C. and Debrot, Anik and DeHaas, Eva C. and Derrick, Jaye L. and Eller, Jami and Estrada, Marie-Joelle and Faure, Ruddy and Finkel, Eli J. and Fraley, R. Chris and Gable, Shelly L. and Gadassi-Polack, Reuma and Girme, Yuthika U. and Gordon, Amie M. and Gosnell, Courtney L. and Hammond, Matthew D. and Hannon, Peggy A. and Harasymchuk, Cheryl and Hofmann, Wilhelm and Horn, Andrea B. and Impett, Emily A. and Jamieson, Jeremy P. and Keltner, Dacher and Kim, James J. and Kirchner, Jeffrey L. and Kluwer, Esther S. and Kumashiro, Madoka and Larson, Grace and Lazarus, Gal and Logan, Jill M. and Luchies, Laura B. and MacDonald, Geoff and Machia, Laura V. and Maniaci, Michael R. and Maxwell, Jessica A. and Mizrahi, Moran and Muise, Amy and Niehuis, Sylvia and Ogolsky, Brian G. and Oldham, C. Rebecca and Overall, Nickola C. and Perrez, Meinrad and Peters, Brett J. and Pietromonaco, Paula R. and Powers, Sally I. and Prok, Thery and Pshedetzky-Shochat, Rony and Rafaeli, Eshkol and Ramsdell, Erin L. and Reblin, Maija and Reicherts, Michael and Reifman, Alan and Reis, Harry T. and Rhoades, Galena K. and Rholes, William S. and Righetti, Francesca and Rodriguez, Lindsey M. and Rogge, Ron and Rosen, Natalie O. and Saxbe, Darby and Sened, Haran and Simpson, Jeffry A. and Slotter, Erica B. and Stanley, Scott M. and Stocker, Shevaun and Surra, Cathy and Ter Kuile, Hagar and Vaughn, Allison A. and Vicary, Amanda M. and Visserman, Mariko L. and Wolf, Scott",Proceedings of the National Academy of Sciences of the United States of America,"Given the powerful implications of relationship quality for health and well-being, a central mission of relationship science is explaining why some romantic relationships thrive more than others. This large-scale project used machine learning (i.e., Random Forests) to 1) quantify the extent to which relationship quality is predictable and 2) identify which constructs reliably predict relationship quality. Across 43 dyadic longitudinal datasets from 29 laboratories, the top relationship-specific predictors of relationship quality were perceived-partner commitment, appreciation, sexual satisfaction, perceived-partner satisfaction, and conflict. The top individual-difference predictors were life satisfaction, negative affect, depression, attachment avoidance, and attachment anxiety. Overall, relationship-specific variables predicted up to 45% of variance at baseline, and up to 18% of variance at the end of each study. Individual differences also performed well (21% and 12%, respectively). Actor-reported variables (i.e., own relationship-specific and individual-difference variables) predicted two to four times more variance than partner-reported variables (i.e., the partner's ratings on those variables). Importantly, individual differences and partner reports had no predictive effects beyond actor-reported relationship-specific variables alone. These findings imply that the sum of all individual differences and partner experiences exert their influence on relationship quality via a person's own relationship-specific experiences, and effects due to moderation by individual differences and moderation by partner-reports may be quite small. Finally, relationship-quality change (i.e., increases or decreases in relationship quality over the course of a study) was largely unpredictable from any combination of self-report variables. This collective effort should guide future models of relationships.",2020,10.1073/pnas.1917036117,117,32,19061-19071,eng,1091-6490 0027-8424,*ensemble methods and *Interpersonal Relations and *machine learning and *Machine Learning and *Random Forests and *relationship quality and *romantic relationships and ensemble methods and Family Characteristics and Female and Humans and Longitudinal Studies and machine learning and Male and Random Forests and relationship quality and romantic relationships and Self Report,NA,NA,2020/08/11/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Zlatev_2017_ProfthNaAcofScofthUnStofAm,JOUR,Default neglect in attempts at social influence,"Zlatev, Julian J. and Daniels, David P. and Kim, Hajin and Neale, Margaret A.",Proceedings of the National Academy of Sciences of the United States of America,"Current theories suggest that people understand how to exploit common biases to influence others. However, these predictions have received little empirical attention. We consider a widely studied bias with special policy relevance: the default effect, which is the tendency to choose whichever option is the status quo. We asked participants (including managers, law/business/medical students, and US adults) to nudge others toward selecting a target option by choosing whether to present that target option as the default. In contrast to theoretical predictions, we find that people often fail to understand and/or use defaults to influence others, i.e., they show ""default neglect."" First, in one-shot default-setting games, we find that only 50.8% of participants set the target option as the default across 11 samples (n = 2,844), consistent with people not systematically using defaults at all. Second, when participants have multiple opportunities for experience and feedback, they still do not systematically use defaults. Third, we investigate beliefs related to the default effect. People seem to anticipate some mechanisms that drive default effects, yet most people do not believe in the default effect on average, even in cases where they do use defaults. We discuss implications of default neglect for decision making, social influence, and evidence-based policy.",2017,10.1073/pnas.1712757114,114,52,13643-13648,eng,1091-6490 0027-8424,*choice architecture and *Choice Behavior and *decision making and *Decision Making and *default effect and *nudges and *social influence and choice architecture and Culture and decision making and default effect and Game Theory and Humans and nudges and social influence,NA,NA,2017/12/26/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Kassirer_2020_ProfthNaAcofScofthUnStofAm,JOUR,Decisional autonomy undermines advisees' judgments of experts in medicine and in life,"Kassirer, Samantha and Levine, Emma E. and Gaertig, Celia",Proceedings of the National Academy of Sciences of the United States of America,"Over the past several decades, the United States medical system has increasingly prioritized patient autonomy. Physicians routinely encourage patients to come to their own decisions about their medical care rather than providing patients with clearer yet more paternalistic advice. Although political theorists, bioethicists, and philosophers generally see this as a positive trend, the present research examines the important question of how patients and advisees in general react to full decisional autonomy when making difficult decisions under uncertainty. Across six experiments (N = 3,867), we find that advisers who give advisees decisional autonomy rather than offering paternalistic advice are judged to be less competent and less helpful. As a result, advisees are less likely to return to and recommend these advisers and pay them lower wages. Importantly, we also demonstrate that advisers do not anticipate these effects. We document these results both inside and outside the medical domain, suggesting that the preference for paternalism is not unique to medicine but rather is a feature of situations in which there are adviser-advisee asymmetries in expertise. We find that the preference for paternalism holds when advice is solicited or unsolicited, when both paternalism and autonomy are accompanied by expert guidance, and it persists both before and after the outcomes of paternalistic advice are realized. Lastly, we see that the preference for paternalism only occurs when decision makers perceive their decision to be difficult. These results challenge the benefits of recently adopted practices in medical decision making that prioritize full decisional autonomy.",2020,10.1073/pnas.1910572117,117,21,11368-11378,eng,1091-6490 0027-8424,*autonomy and *Decision Making and *ethics and *medical decision making and *paternalism and *Personal Autonomy and *Physician-Patient Relations/ethics and Adult and autonomy and Chicago and ethics and Female and Financial Management/ethics and Humans and Internet and Male and medical decision making and Medicine and paternalism and Paternalism and Workplace,NA,NA,2020/05/26/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Naci_2020_Lanc.LonEngl,JOUR,Generating comparative evidence on new drugs and devices before approval,"Naci, Huseyin and Salcher-Konrad, Maximilian and Kesselheim, Aaron S. and Wieseler, Beate and Rochaix, Lise and Redberg, Rita F. and Salanti, Georgia and Jackson, Emily and Garner, Sarah and Stroup, T. Scott and Cipriani, Andrea","Lancet (London, England)","Fewer than half of new drugs have data on their comparative benefits and harms against existing treatment options at the time of regulatory approval in Europe and the USA. Even when active-comparator trials exist, they might not produce meaningful data to inform decisions in clinical practice and health policy. The uncertainty associated with the paucity of well designed active-comparator trials has been compounded by legal and regulatory changes in Europe and the USA that have created a complex mix of expedited programmes aimed at facilitating faster access to new drugs. Comparative evidence generation is even sparser for medical devices. Some have argued that the current process for regulatory approval needs to generate more evidence that is useful for patients, clinicians, and payers in health-care systems. We propose a set of five key principles relevant to the European Medicines Agency, European medical device regulatory agencies, US Food and Drug Administration, as well as payers, that we believe will provide the necessary incentives for pharmaceutical and device companies to generate comparative data on drugs and devices and assure timely availability of evidence that is useful for decision making. First, labelling should routinely inform patients and clinicians whether comparative data exist on new products. Second, regulators should be more selective in their use of programmes that facilitate drug and device approvals on the basis of incomplete benefit and harm data. Third, regulators should encourage the conduct of randomised trials with active comparators. Fourth, regulators should use prospectively designed network meta-analyses based on existing and future randomised trials. Last, payers should use their policy levers and negotiating power to incentivise the generation of comparative evidence on new and existing drugs and devices, for example, by explicitly considering proven added benefit in pricing and payment decisions.",2020,10.1016/S0140-6736(19)33178-2,395,10228,986-997,eng,1474-547X 0140-6736,"*Equipment Safety and *Safety and Biomarkers, Pharmacological/analysis and Device Approval/*standards and Drug Approval/*methods and Drug Tolerance and Evidence-Based Medicine and Humans and United States and United States Food and Drug Administration",NA,NA,2020/03/21/,Lancet,NA,NA,NA,NA
Liang_2020_ProfthNaAcofScofthUnStofAm,JOUR,The 17-y spatiotemporal trend of PM(2.5) and its mortality burden in China,"Liang, Fengchao and Xiao, Qingyang and Huang, Keyong and Yang, Xueli and Liu, Fangchao and Li, Jianxin and Lu, Xiangfeng and Liu, Yang and Gu, Dongfeng",Proceedings of the National Academy of Sciences of the United States of America,"Investigations on the chronic health effects of fine particulate matter (PM(2.5)) exposure in China are limited due to the lack of long-term exposure data. Using satellite-driven models to generate spatiotemporally resolved PM(2.5) levels, we aimed to estimate high-resolution, long-term PM(2.5) and associated mortality burden in China. The multiangle implementation of atmospheric correction (MAIAC) aerosol optical depth (AOD) at 1-km resolution was employed as a primary predictor to estimate PM(2.5) concentrations. Imputation techniques were adopted to fill in the missing AOD retrievals and provide accurate long-term AOD aggregations. Monthly PM(2.5) concentrations in China from 2000 to 2016 were estimated using machine-learning approaches and used to analyze spatiotemporal trends of adult mortality attributable to PM(2.5) exposure. Mean coverage of AOD increased from 56 to 100% over the 17-y period, with the accuracy of long-term averages enhanced after gap filling. Machine-learning models performed well with a random cross-validation R (2) of 0.93 at the monthly level. For the time period outside the model training window, prediction R (2) values were estimated to be 0.67 and 0.80 at the monthly and annual levels. Across the adult population in China, long-term PM(2.5) exposures accounted for a total number of 30.8 (95% confidence interval [CI]: 28.6, 33.2) million premature deaths over the 17-y period, with an annual burden ranging from 1.5 (95% CI: 1.3, 1.6) to 2.2 (95% CI: 2.1, 2.4) million. Our satellite-based techniques provide reliable long-term PM(2.5) estimates at a high spatial resolution, enhancing the assessment of adverse health effects and disease burden in China.",2020,10.1073/pnas.1919641117,117,41,25601-25608,eng,1091-6490 0027-8424,"*Environmental Exposure/adverse effects/statistics & numerical data and *gap filling and *high resolution and *long-term trend and *mortality burden and *satellite-based PM2.5 estimation and Adult and Air Pollution/*statistics & numerical data and China and Environmental Monitoring and gap filling and Geographic Information Systems and high resolution and Humans and long-term trend and Machine Learning and Models, Statistical and mortality burden and Mortality, Premature/*trends and Particulate Matter/*analysis and satellite-based PM2.5 estimation and Spatio-Temporal Analysis",NA,NA,2020/10/13/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Imray_2015_Lanc.LonEngl,JOUR,"Extreme, expedition, and wilderness medicine","Imray, Christopher H. E. and Grocott, Michael P. W. and Wilson, Mark H. and Hughes, Amy and Auerbach, Paul S.","Lancet (London, England)","Extreme, expedition, and wilderness medicine are modern and rapidly evolving specialties that address the spirit of adventure and exploration. The relevance of and interest in these specialties are changing rapidly to match the underlying activities, which include global exploration, adventure travel, and military deployments. Extreme, expedition, and wilderness medicine share themes of providing best available medical care in the outdoors, especially in austere or remote settings. Early clinical and logistics decision making can often have important effects on subsequent outcomes. There are lessons to be learned from out-of-hospital care, military medicine, humanitarian medicine, and disaster medicine that can inform in-hospital medicine, and vice-versa. The future of extreme, expedition, and wilderness medicine will be defined by both recipients and practitioners, and empirical observations will be transformed by evidence-based practice.",2015,10.1016/S0140-6736(15)01165-4,386,10012,2520-2525,eng,1474-547X 0140-6736,*Emergency Medical Services and *Wilderness Medicine and Expeditions and Humans and Recreation and Travel,NA,NA,2015/12/19/,Lancet,NA,NA,NA,NA
Koenecke_2020_ProfthNaAcofScofthUnStofAm,JOUR,Racial disparities in automated speech recognition,"Koenecke, Allison and Nam, Andrew and Lake, Emily and Nudell, Joe and Quartey, Minnie and Mengesha, Zion and Toups, Connor and Rickford, John R. and Jurafsky, Dan and Goel, Sharad",Proceedings of the National Academy of Sciences of the United States of America,"Automated speech recognition (ASR) systems, which use sophisticated machine-learning algorithms to convert spoken language to text, have become increasingly widespread, powering popular virtual assistants, facilitating automated closed captioning, and enabling digital dictation platforms for health care. Over the last several years, the quality of these systems has dramatically improved, due both to advances in deep learning and to the collection of large-scale datasets used to train the systems. There is concern, however, that these tools do not work equally well for all subgroups of the population. Here, we examine the ability of five state-of-the-art ASR systems-developed by Amazon, Apple, Google, IBM, and Microsoft-to transcribe structured interviews conducted with 42 white speakers and 73 black speakers. In total, this corpus spans five US cities and consists of 19.8 h of audio matched on the age and gender of the speaker. We found that all five ASR systems exhibited substantial racial disparities, with an average word error rate (WER) of 0.35 for black speakers compared with 0.19 for white speakers. We trace these disparities to the underlying acoustic models used by the ASR systems as the race gap was equally large on a subset of identical phrases spoken by black and white individuals in our corpus. We conclude by proposing strategies-such as using more diverse training datasets that include African American Vernacular English-to reduce these performance differences and ensure speech recognition technology is inclusive.",2020,10.1073/pnas.1915768117,117,14,7684-7689,eng,1091-6490 0027-8424,*fair machine learning and *natural language processing and *Racism and *Speech Recognition Software and *speech-to-text and Adult and African Americans and Automation and European Continental Ancestry Group and fair machine learning and Humans and Language and natural language processing and Speech Perception and speech-to-text and Whites,NA,NA,2020/04/07/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Lupolova_2016_ProfthNaAcofScofthUnStofAm,JOUR,Support vector machine applied to predict the zoonotic potential of E. coli O157 cattle isolates,"Lupolova, Nadejda and Dallman, Timothy J. and Matthews, Louise and Bono, James L. and Gally, David L.",Proceedings of the National Academy of Sciences of the United States of America,"Sequence analyses of pathogen genomes facilitate the tracking of disease outbreaks and allow relationships between strains to be reconstructed and virulence factors to be identified. However, these methods are generally used after an outbreak has happened. Here, we show that support vector machine analysis of bovine E. coli O157 isolate sequences can be applied to predict their zoonotic potential, identifying cattle strains more likely to be a serious threat to human health. Notably, only a minor subset (less than 10%) of bovine E. coli O157 isolates analyzed in our datasets were predicted to have the potential to cause human disease; this is despite the fact that the majority are within previously defined pathogenic lineages I or I/II and encode key virulence factors. The predictive capacity was retained when tested across datasets. The major differences between human and bovine E. coli O157 isolates were due to the relative abundances of hundreds of predicted prophage proteins. This finding has profound implications for public health management of disease because interventions in cattle, such a vaccination, can be targeted at herds carrying strains of high zoonotic potential. Machine-learning approaches should be applied broadly to further our understanding of pathogen biology.",2016,10.1073/pnas.1606567113,113,40,11312-11317,eng,1091-6490 0027-8424,*cattle and *E. coli and *machine learning and *Shiga toxin and *Support Vector Machine and *zoonosis and Animals and cattle and Cattle and Cattle Diseases/epidemiology/*microbiology and Disease Outbreaks and E. coli and Escherichia coli Infections/epidemiology/*microbiology and Escherichia coli O157/*isolation & purification and Humans and machine learning and Phylogeny and Shiga toxin and Shiga Toxin 2/metabolism and United Kingdom/epidemiology and Zoonoses/epidemiology/*microbiology and zoonosis,NA,NA,2016/10/04/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Eichstaedt_2018_ProfthNaAcofScofthUnStofAm,JOUR,Facebook language predicts depression in medical records,"Eichstaedt, Johannes C. and Smith, Robert J. and Merchant, Raina M. and Ungar, Lyle H. and Crutchley, Patrick and Preotiuc-Pietro, Daniel and Asch, David A. and Schwartz, H. Andrew",Proceedings of the National Academy of Sciences of the United States of America,"Depression, the most prevalent mental illness, is underdiagnosed and undertreated, highlighting the need to extend the scope of current screening methods. Here, we use language from Facebook posts of consenting individuals to predict depression recorded in electronic medical records. We accessed the history of Facebook statuses posted by 683 patients visiting a large urban academic emergency department, 114 of whom had a diagnosis of depression in their medical records. Using only the language preceding their first documentation of a diagnosis of depression, we could identify depressed patients with fair accuracy [area under the curve (AUC) = 0.69], approximately matching the accuracy of screening surveys benchmarked against medical records. Restricting Facebook data to only the 6 months immediately preceding the first documented diagnosis of depression yielded a higher prediction accuracy (AUC = 0.72) for those users who had sufficient Facebook data. Significant prediction of future depression status was possible as far as 3 months before its first documentation. We found that language predictors of depression include emotional (sadness), interpersonal (loneliness, hostility), and cognitive (preoccupation with the self, rumination) processes. Unobtrusive depression assessment through social media of consenting individuals may become feasible as a scalable complement to existing screening and monitoring procedures.",2018,10.1073/pnas.1802331115,115,44,11203-11208,eng,1091-6490 0027-8424,*big data and *depression and *Facebook and *screening and *social media and Adult and big data and depression and Depression/*psychology and Depressive Disorder/*psychology and Electronic Health Records/*statistics & numerical data and Facebook and Female and Humans and Language and Male and screening and social media and Social Media/*statistics & numerical data and Surveys and Questionnaires,NA,NA,2018/10/30/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Charpentier_2018_ProfthNaAcofScofthUnStofAm,JOUR,Valuation of knowledge and ignorance in mesolimbic reward circuitry,"Charpentier, Caroline J. and Bromberg-Martin, Ethan S. and Sharot, Tali",Proceedings of the National Academy of Sciences of the United States of America,"The pursuit of knowledge is a basic feature of human nature. However, in domains ranging from health to finance people sometimes choose to remain ignorant. Here, we show that valence is central to the process by which the human brain evaluates the opportunity to gain information, explaining why knowledge may not always be preferred. We reveal that the mesolimbic reward circuitry selectively treats the opportunity to gain knowledge about future favorable outcomes, but not unfavorable outcomes, as if it has positive utility. This neural coding predicts participants' tendency to choose knowledge about future desirable outcomes more often than undesirable ones, and to choose ignorance about future undesirable outcomes more often than desirable ones. Strikingly, participants are willing to pay both for knowledge and ignorance as a function of the expected valence of knowledge. The orbitofrontal cortex (OFC), however, responds to the opportunity to receive knowledge over ignorance regardless of the valence of the information. Connectivity between the OFC and mesolimbic circuitry could contribute to a general preference for knowledge that is also modulated by valence. Our findings characterize the importance of valence in information seeking and its underlying neural computation. This mechanism could lead to suboptimal behavior, such as when people reject medical screenings or monitor investments more during bull than bear markets.",2018,10.1073/pnas.1800547115,115,31,E7255-E7264,eng,1091-6490 0027-8424,*decision making and *ignorance and *information seeking and *knowledge and *Knowledge and *Reward and *valence and decision making and Humans and ignorance and information seeking and knowledge and Limbic System/*physiology and Neural Pathways/physiology and Nucleus Accumbens/physiology and Prefrontal Cortex/physiology and valence and Ventral Tegmental Area/physiology,NA,NA,2018/07/31/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Mohan_2018_ProfthNaAcofScofthUnStofAm,JOUR,Serious games may improve physician heuristics in trauma triage,"Mohan, Deepika and Fischhoff, Baruch and Angus, Derek C. and Rosengart, Matthew R. and Wallace, David J. and Yealy, Donald M. and Farris, Coreen and Chang, Chung-Chou H. and Kerti, Samantha and Barnato, Amber E.",Proceedings of the National Academy of Sciences of the United States of America,"Trauma triage depends on fallible human judgment. We created two ""serious"" video game training interventions to improve that judgment. The interventions' central theoretical construct was the representativeness heuristic, which, in trauma triage, would mean judging the severity of an injury by how well it captures (or ""represents"") the key features of archetypes of cases requiring transfer to a trauma center. Drawing on clinical experience, medical records, and an expert panel, we identified features characteristic of representative and nonrepresentative cases. The two interventions instantiated both kinds of cases. One was an adventure game, seeking narrative engagement; the second was a puzzle-based game, emphasizing analogical reasoning. Both incorporated feedback on diagnostic errors, explaining their sources and consequences. In a four-arm study, they were compared with an intervention using traditional text-based continuing medical education materials (active control) and a no-intervention (passive control) condition. A sample of 320 physicians working at nontrauma centers in the United States was recruited and randomized to a study arm. The primary outcome was performance on a validated virtual simulation, measured as the proportion of undertriaged patients, defined as ones who had severe injuries (according to American College of Surgeons guidelines) but were not transferred. Compared with the control group, physicians exposed to either game undertriaged fewer such patients [difference = -18%, 95% CI: -30 to -6%, P = 0.002 (adventure game); -17%, 95% CI: -28 to -6%, P = 0.003 (puzzle game)]; those exposed to the text-based education undertriaged similar proportions (difference = +8%, 95% CI: -3 to +19%, P = 0.15).",2018,10.1073/pnas.1805450115,115,37,9204-9209,eng,1091-6490 0027-8424,"*decision making and *heuristics and *judgment and *serious games and *triage and *Triage and *Video Games and *Wounds and Injuries and decision making and Education, Medical, Continuing/*methods and Female and heuristics and Humans and judgment and Male and serious games and triage and United States",NA,NA,2018/09/11/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Guan_2017_ProfthNaAcofScofthUnStofAm,JOUR,Big data modeling to predict platelet usage and minimize wastage in a tertiary care system,"Guan, Leying and Tian, Xiaoying and Gombar, Saurabh and Zemek, Allison J. and Krishnan, Gomathi and Scott, Robert and Narasimhan, Balasubramanian and Tibshirani, Robert J. and Pham, Tho D.",Proceedings of the National Academy of Sciences of the United States of America,"Maintaining a robust blood product supply is an essential requirement to guarantee optimal patient care in modern health care systems. However, daily blood product use is difficult to anticipate. Platelet products are the most variable in daily usage, have short shelf lives, and are also the most expensive to produce, test, and store. Due to the combination of absolute need, uncertain daily demand, and short shelf life, platelet products are frequently wasted due to expiration. Our aim is to build and validate a statistical model to forecast future platelet demand and thereby reduce wastage. We have investigated platelet usage patterns at our institution, and specifically interrogated the relationship between platelet usage and aggregated hospital-wide patient data over a recent consecutive 29-mo period. Using a convex statistical formulation, we have found that platelet usage is highly dependent on weekday/weekend pattern, number of patients with various abnormal complete blood count measurements, and location-specific hospital census data. We incorporated these relationships in a mathematical model to guide collection and ordering strategy. This model minimizes waste due to expiration while avoiding shortages; the number of remaining platelet units at the end of any day stays above 10 in our model during the same period. Compared with historical expiration rates during the same period, our model reduces the expiration rate from 10.5 to 3.2%. Extrapolating our results to the <e2><88><bc>2 million units of platelets transfused annually within the United States, if implemented successfully, our model can potentially save <e2><88><bc>80 million dollars in health care costs.",2017,10.1073/pnas.1714097114,114,43,11368-11373,eng,1091-6490 0027-8424,"*blood and *Models, Statistical and *prediction and *supervised learning and *Tertiary Healthcare/economics and blood and California and Electronic Health Records and Health Care Costs and Humans and Platelet Transfusion/economics/*statistics & numerical data and prediction and supervised learning",NA,NA,2017/10/24/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Bruhn_2017_ProfthNaAcofScofthUnStofAm,JOUR,Estimating the population-level impact of vaccines using synthetic controls,"Bruhn, Christian A. W. and Hetterich, Stephen and Schuck-Paim, Cynthia and Kurum, Esra and Taylor, Robert J. and Lustig, Roger and Shapiro, Eugene D. and Warren, Joshua L. and Simonsen, Lone and Weinberger, Daniel M.",Proceedings of the National Academy of Sciences of the United States of America,"When a new vaccine is introduced, it is critical to monitor trends in disease rates to ensure that the vaccine is effective and to quantify its impact. However, estimates from observational studies can be confounded by unrelated changes in healthcare utilization, changes in the underlying health of the population, or changes in reporting. Other diseases are often used to detect and adjust for these changes, but choosing an appropriate control disease a priori is a major challenge. The ""synthetic controls"" (causal impact) method, which was originally developed for website analytics and social sciences, provides an appealing solution. With this approach, potential comparison time series are combined into a composite and are used to generate a counterfactual estimate, which can be compared with the time series of interest after the intervention. We sought to estimate changes in hospitalizations for all-cause pneumonia associated with the introduction of pneumococcal conjugate vaccines (PCVs) in five countries in the Americas. Using synthetic controls, we found a substantial decline in hospitalizations for all-cause pneumonia in infants in all five countries (average of 20%), whereas estimates for young and middle-aged adults varied by country and were potentially influenced by the 2009 influenza pandemic. In contrast to previous reports, we did not detect a decline in all-cause pneumonia in older adults in any country. Synthetic controls promise to increase the accuracy of studies of vaccine impact and to increase comparability of results between populations compared with alternative approaches.",2017,10.1073/pnas.1612833114,114,7,1524-1529,eng,1091-6490 0027-8424,"*Control Groups and *observational study and *pneumococcal conjugate vaccines and *Pneumococcal Vaccines and *program evaluation and *Streptococcus pneumoniae and *synthetic controls and *Vaccination/statistics & numerical data and Adolescent and Adult and Age Factors and Aged and Aged, 80 and over and Bias and Child and Child, Preschool and Confounding Factors, Epidemiologic and Female and Health Impact Assessment/methods/*statistics & numerical data and Hospitalization/*statistics & numerical data and Humans and Infant and Latin America/epidemiology and Male and Middle Aged and observational study and pneumococcal conjugate vaccines and Pneumococcal Infections/epidemiology/prevention & control and Pneumonia/epidemiology/etiology/*prevention & control and program evaluation and Streptococcus pneumoniae and synthetic controls and United States/epidemiology and Vaccines, Conjugate and Young Adult",NA,NA,2017/02/14/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Kundu_2020_ProfthNaAcofScofthUnStofAm,JOUR,Enabling early detection of osteoarthritis from presymptomatic cartilage texture maps via transport-based learning,"Kundu, Shinjini and Ashinsky, Beth G. and Bouhrara, Mustapha and Dam, Erik B. and Demehri, Shadpour and Shifat-E-Rabbi, Mohammad and Spencer, Richard G. and Urish, Kenneth L. and Rohde, Gustavo K.",Proceedings of the National Academy of Sciences of the United States of America,"Many diseases have no visual cues in the early stages, eluding image-based detection. Today, osteoarthritis (OA) is detected after bone damage has occurred, at an irreversible stage of the disease. Currently no reliable method exists for OA detection at a reversible stage. We present an approach that enables sensitive OA detection in presymptomatic individuals. Our approach combines optimal mass transport theory with statistical pattern recognition. Eighty-six healthy individuals were selected from the Osteoarthritis Initiative, with no symptoms or visual signs of disease on imaging. On 3-y follow-up, a subset of these individuals had progressed to symptomatic OA. We trained a classifier to differentiate progressors and nonprogressors on baseline cartilage texture maps, which achieved a robust test accuracy of 78% in detecting future symptomatic OA progression 3 y prior to symptoms. This work demonstrates that OA detection may be possible at a potentially reversible stage. A key contribution of our work is direct visualization of the cartilage phenotype defining predictive ability as our technique is generative. We observe early biochemical patterns of fissuring in cartilage that define future onset of OA. In the future, coupling presymptomatic OA detection with emergent clinical therapies could modify the outcome of a disease that costs the United States healthcare system $16.5 billion annually. Furthermore, our technique is broadly applicable to earlier image-based detection of many diseases currently diagnosed at advanced stages today.",2020,10.1073/pnas.1917405117,117,40,24709-24719,eng,1091-6490 0027-8424,"*3D transport-based morphometry and *classification and *early diagnosis and *Machine Learning and *osteoarthritis and *T2 imaging and 3D transport-based morphometry and Cartilage, Articular/diagnostic imaging/pathology and classification and Cohort Studies and Disease Progression and early diagnosis and Early Diagnosis and Female and Humans and Magnetic Resonance Imaging and Male and osteoarthritis and Osteoarthritis, Knee/*diagnosis/diagnostic imaging/pathology and T2 imaging",NA,NA,2020/10/06/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Rees.Jones_2018_ProfthNaAcofScofthUnStofAm,JOUR,An experimental investigation of preference misrepresentation in the residency match,"Rees-Jones, Alex and Skowronek, Samuel",Proceedings of the National Academy of Sciences of the United States of America,"The development and deployment of matching procedures that incentivize truthful preference reporting is considered one of the major successes of market design research. In this study, we test the degree to which these procedures succeed in eliminating preference misrepresentation. We administered an online experiment to 1,714 medical students immediately after their participation in the medical residency match-a leading field application of strategy-proof market design. When placed in an analogous, incentivized matching task, we find that 23% of participants misrepresent their preferences. We explore the factors that predict preference misrepresentation, including cognitive ability, strategic positioning, overconfidence, expectations, advice, and trust. We discuss the implications of this behavior for the design of allocation mechanisms and the social welfare in markets that use them.",2018,10.1073/pnas.1803212115,115,45,11471-11476,eng,1091-6490 0027-8424,"*behavioral economics and *Choice Behavior and *deception and *Deception and *Decision Making and *lying and *matching and *mechanism design and Adult and behavioral economics and deception and Female and Humans and Internship and Residency/*ethics and lying and Male and matching and mechanism design and Psychological Tests and Reward and Schools, Medical and Students, Medical/*psychology",NA,NA,2018/11/06/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Liu_2020_ProfthNaAcofScofthUnStofAm,JOUR,Dynamic PB2-E627K substitution of influenza H7N9 virus indicates the in vivo genetic tuning and rapid host adaptation,"Liu, William J. and Li, Jun and Zou, Rongrong and Pan, Jingcao and Jin, Tao and Li, Liqiang and Liu, Peipei and Zhao, Yingze and Yu, Xinfen and Wang, Haoqiu and Liu, Guang and Jiang, Hui and Bi, Yuhai and Liu, Lei and Yuen, Kwok-Yung and Liu, Yingxia and Gao, George F.",Proceedings of the National Academy of Sciences of the United States of America,"Avian-origin influenza viruses overcome the bottleneck of the interspecies barrier and infect humans through the evolution of variants toward more efficient replication in mammals. The dynamic adaptation of the genetic substitutions and the correlation with the virulence of avian-origin influenza virus in patients remain largely elusive. Here, based on the one-health approach, we retrieved the original virus-positive samples from patients with H7N9 and their surrounding poultry/environment. The specimens were directly deep sequenced, and the subsequent big data were integrated with the clinical manifestations. Unlike poultry/environment-derived samples with the consistent dominance of avian signature 627E of H7N9 polymerase basic protein 2 (PB2), patient specimens had diverse ratios of mammalian signature 627K, indicating the rapid dynamics of H7N9 adaptation in patients during the infection process. In contrast, both human- and poultry/environment-related viruses had constant dominance of avian signature PB2-701D. The intrahost dynamic adaptation was confirmed by the gradual replacement of 627E by 627K in H7N9 in the longitudinally collected specimens from one patient. These results suggest that host adaptation for better virus replication to new hosts, termed ""genetic tuning,"" actually occurred in H7N9-infected patients in vivo. Notably, our findings also demonstrate the correlation between rapid host adaptation of H7N9 PB2-E627K and the fatal outcome and disease severity in humans. The feature of H7N9 genetic tuning in vivo and its correlation with the disease severity emphasize the importance of testing for the evolution of this avian-origin virus during the course of infection.",2020,10.1073/pnas.2013267117,117,38,23807-23814,eng,1091-6490 0027-8424,"*dynamic substitution and *H7N9 virus and *host adaptation and *next-generation sequencing and *PB2-627 and Adaptation, Biological/*genetics and Amino Acid Substitution/*genetics and dynamic substitution and H7N9 virus and High-Throughput Nucleotide Sequencing and host adaptation and Host-Pathogen Interactions and Humans and Influenza A Virus, H7N9 Subtype/*genetics/*pathogenicity and Influenza, Human/*virology and next-generation sequencing and PB2-627 and RNA-Dependent RNA Polymerase/*genetics and RNA, Viral/genetics and Sequence Analysis, RNA and Viral Proteins/*genetics and Virus Replication/genetics",NA,NA,2020/09/22/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Juni_2017_ProfthNaAcofScofthUnStofAm,JOUR,The wisdom of crowds for visual search,"Juni, Mordechai Z. and Eckstein, Miguel P.",Proceedings of the National Academy of Sciences of the United States of America,"Decision-making accuracy typically increases through collective integration of people's judgments into group decisions, a phenomenon known as the wisdom of crowds. For simple perceptual laboratory tasks, classic signal detection theory specifies the upper limit for collective integration benefits obtained by weighted averaging of people's confidences, and simple majority voting can often approximate that limit. Life-critical perceptual decisions often involve searching large image data (e.g., medical, security, and aerial imagery), but the expected benefits and merits of using different pooling algorithms are unknown for such tasks. Here, we show that expected pooling benefits are significantly greater for visual search than for single-location perceptual tasks and the prediction given by classic signal detection theory. In addition, we show that simple majority voting obtains inferior accuracy benefits for visual search relative to averaging and weighted averaging of observers' confidences. Analysis of gaze behavior across observers suggests that the greater collective integration benefits for visual search arise from an interaction between the foveated properties of the human visual system (high foveal acuity and low peripheral acuity) and observers' nonexhaustive search patterns, and can be predicted by an extended signal detection theory framework with trial to trial sampling from a varying mixture of high and low target detectabilities across observers (SDT-MIX). These findings advance our theoretical understanding of how to predict and enhance the wisdom of crowds for real world search tasks and could apply more generally to any decision-making task for which the minority of group members with high expertise varies from decision to decision.",2017,10.1073/pnas.1610732114,114,21,E4306-E4315,eng,1091-6490 0027-8424,"*group decision rules and *ideal observer analyses and *Judgment and *Perception and *signal detection theory and *wisdom of crowds and Adult and Crowding and Decision Making/*physiology and Female and Fixation, Ocular/physiology and group decision rules and Humans and ideal observer analyses and Male and Politics and signal detection theory and Visual Perception/*physiology and wisdom of crowds and Young Adult",NA,NA,2017/05/23/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Madhavan_2018_ProfthNaAcofScofthUnStofAm,JOUR,Vision for a systems architecture to integrate and transform population health,"Madhavan, Guruprasad and Phelps, Charles E. and Rouse, William B. and Rappuoli, Rino",Proceedings of the National Academy of Sciences of the United States of America,"Entities involved in population health often share a common mission while acting independently of one another and perhaps redundantly. Population health is in everybody's interest, but nobody is really in charge of promoting it. Across governments, corporations, and frontline operations, lack of coordination, lack of resources, and lack of reliable, current information have often impeded the development of situation-awareness models and thus a broad operational integration for population health. These deficiencies may also affect the technical, organizational, policy, and legal arrangements for information sharing, a desired practice of high potential value in population health. In this article, we articulate a vision for a next-generation modeling effort to create a systems architecture for broadly integrating and visualizing strategies for advancing population health. This multipurpose systems architecture would enable different views, alerts, and scenarios to better prepare for and respond to potential degradations in population health. We draw inspiration from systems engineering and visualization tools currently in other uses, including monitoring the state of the economy (market performance), security (classified intelligence), energy (power generation), transportation (global air traffic control), environment (weather monitoring), jobs (labor market dynamics), manufacturing and supply chain (tracking of components, parts, subassemblies, and products), and democratic processes (election analytics). We envision the basic ingredients for a population health systems architecture and its visualization dashboards to eventually support proactive planning and joint action among constituents. We intend our ambitious vision to encourage the work needed for progress that the population deserves.",2018,10.1073/pnas.1809919115,115,50,12595-12602,eng,1091-6490 0027-8424,*analytics and *population health and *Population Health/statistics & numerical data and *systems architecture and *systems engineering and *visualization and analytics and Health Planning and Humans and Malaria/prevention & control and population health and Systems Analysis and systems architecture and systems engineering and Systems Theory and visualization,NA,NA,2018/12/11/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Braun_2018_ProfthNaAcofScofthUnStofAm,JOUR,Universal method for robust detection of circadian state from gene expression,"Braun, Rosemary and Kath, William L. and Iwanaszko, Marta and Kula-Eversole, Elzbieta and Abbott, Sabra M. and Reid, Kathryn J. and Zee, Phyllis C. and Allada, Ravi",Proceedings of the National Academy of Sciences of the United States of America,"Circadian clocks play a key role in regulating a vast array of biological processes, with significant implications for human health. Accurate assessment of physiological time using transcriptional biomarkers found in human blood can significantly improve diagnosis of circadian disorders and optimize the delivery time of therapeutic treatments. To be useful, such a test must be accurate, minimally burdensome to the patient, and readily generalizable to new data. A major obstacle in development of gene expression biomarker tests is the diversity of measurement platforms and the inherent variability of the data, often resulting in predictors that perform well in the original datasets but cannot be universally applied to new samples collected in other settings. Here, we introduce TimeSignature, an algorithm that robustly infers circadian time from gene expression. We demonstrate its application in data from three independent studies using distinct microarrays and further validate it against a new set of samples profiled by RNA-sequencing. Our results show that TimeSignature is more accurate and efficient than competing methods, estimating circadian time to within 2 h for the majority of samples. Importantly, we demonstrate that once trained on data from a single study, the resulting predictor can be universally applied to yield highly accurate results in new data from other studies independent of differences in study population, patient protocol, or assay platform without renormalizing the data or retraining. This feature is unique among expression-based predictors and addresses a major challenge in the development of generalizable, clinically useful tests.",2018,10.1073/pnas.1800314115,115,39,E9247-E9256,eng,1091-6490 0027-8424,"*circadian rhythms and *cross-platform prediction and *gene expression dynamics and *machine learning and *Machine Learning and Biomarkers/blood and Circadian Clocks/*genetics and Circadian Rhythm/genetics and circadian rhythms and cross-platform prediction and Gene Expression and gene expression dynamics and Gene Expression Profiling/*methods and Genes/genetics and Humans and machine learning and Models, Statistical and Reproducibility of Results and Sleep and Transcriptome",NA,NA,2018/09/25/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Manski_2016_ProfthNaAcofScofthUnStofAm,JOUR,Sufficient trial size to inform clinical practice,"Manski, Charles F. and Tetenov, Aleksey",Proceedings of the National Academy of Sciences of the United States of America,"Medical research has evolved conventions for choosing sample size in randomized clinical trials that rest on the theory of hypothesis testing. Bayesian statisticians have argued that trials should be designed to maximize subjective expected utility in settings of clinical interest. This perspective is compelling given a credible prior distribution on treatment response, but there is rarely consensus on what the subjective prior beliefs should be. We use Wald's frequentist statistical decision theory to study design of trials under ambiguity. We show that <ce><b5>-optimal rules exist when trials have large enough sample size. An <ce><b5>-optimal rule has expected welfare within <ce><b5> of the welfare of the best treatment in every state of nature. Equivalently, it has maximum regret no larger than <ce><b5> We consider trials that draw predetermined numbers of subjects at random within groups stratified by covariates and treatments. We report exact results for the special case of two treatments and binary outcomes. We give simple sufficient conditions on sample sizes that ensure existence of <ce><b5>-optimal treatment rules when there are multiple treatments and outcomes are bounded. These conditions are obtained by application of Hoeffding large deviations inequalities to evaluate the performance of empirical success rules.",2016,10.1073/pnas.1612174113,113,38,10518-10523,eng,1091-6490 0027-8424,"*Bayes Theorem and *clinical trials and *medical decision making and *Models, Statistical and *near optimality and *sample size and Biomedical Research/*statistics & numerical data and clinical trials and Humans and medical decision making and near optimality and Randomized Controlled Trials as Topic/*statistics & numerical data and sample size and Sample Size",NA,NA,2016/09/20/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Fan_2010_JAMA,JOUR,How to use an article about quality improvement,"Fan, Eddy and Laupacis, Andreas and Pronovost, Peter J. and Guyatt, Gordon H. and Needham, Dale M.",JAMA,"Quality improvement (QI) attempts to change clinician behavior and, through those changes, lead to improved patient outcomes. The methodological quality of studies evaluating the effectiveness of QI interventions is frequently low. Clinicians and others evaluating QI studies should be aware of the risk of bias, should consider whether the investigators measured appropriate outcomes, should be concerned if there has been no replication of the findings, and should consider the likelihood of success of the QI intervention in their practice setting and the costs and possibility of unintended effects of its implementation. This article complements and enhances existing Users' Guides that address the effects of interventions--Therapy, Harm, Clinical Decision Support Systems, and Summarizing the Evidence guides--with an emphasis on issues specific to QI studies. Given the potential for widespread implementation of QI interventions, there is a need for robust study methods in QI research.",2010,10.1001/jama.2010.1692,304,20,2279-2287,eng,1538-3598 0098-7484,*Quality Improvement and Biomedical Research/*standards and Randomized Controlled Trials as Topic and Research Design,NA,NA,2010/11/24/,JAMA,NA,NA,NA,NA
Anafi_2017_ProfthNaAcofScofthUnStofAm,JOUR,CYCLOPS reveals human transcriptional rhythms in health and disease,"Anafi, Ron C. and Francey, Lauren J. and Hogenesch, John B. and Kim, Junhyong",Proceedings of the National Academy of Sciences of the United States of America,"Circadian rhythms modulate many aspects of physiology. Knowledge of the molecular basis of these rhythms has exploded in the last 20 years. However, most of these data are from model organisms, and translation to clinical practice has been limited. Here, we present an approach to identify molecular rhythms in humans from thousands of unordered expression measurements. Our algorithm, cyclic ordering by periodic structure (CYCLOPS), uses evolutionary conservation and machine learning to identify elliptical structure in high-dimensional data. From this structure, CYCLOPS estimates the phase of each sample. We validated CYCLOPS using temporally ordered mouse and human data and demonstrated its consistency on human data from two independent research sites. We used this approach to identify rhythmic transcripts in human liver and lung, including hundreds of drug targets and disease genes. Importantly, for many genes, the circadian variation in expression exceeded variation from genetic and other environmental factors. We also analyzed hepatocellular carcinoma samples and show these solid tumors maintain circadian function but with aberrant output. Finally, to show how this method can catalyze medical translation, we show that dosage time can temporally segregate efficacy from dose-limiting toxicity of streptozocin, a chemotherapeutic drug. In sum, these data show the power of CYCLOPS and temporal reconstruction in bridging basic circadian research and clinical medicine.",2017,10.1073/pnas.1619320114,114,20,5312-5317,eng,1091-6490 0027-8424,"*autoencoder and *biological rhythms and *circadian rhythms and *gene expression and *machine learning and Algorithms and Animals and autoencoder and biological rhythms and Circadian Rhythm/*physiology and circadian rhythms and CLOCK Proteins/metabolism and Databases, Genetic and gene expression and Gene Expression Profiling/*methods and Humans and Liver Neoplasms/metabolism and Liver/metabolism/physiology and Lung/metabolism/physiology and machine learning and Machine Learning and Mice and Statistics as Topic/*methods and Transcription, Genetic/genetics",NA,NA,2017/05/16/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Yang_2015_ProfthNaAcofScofthUnStofAm,JOUR,Inference of seasonal and pandemic influenza transmission dynamics,"Yang, Wan and Lipsitch, Marc and Shaman, Jeffrey",Proceedings of the National Academy of Sciences of the United States of America,"The inference of key infectious disease epidemiological parameters is critical for characterizing disease spread and devising prevention and containment measures. The recent emergence of surveillance records mined from big data such as health-related online queries and social media, as well as model inference methods, permits the development of new methodologies for more comprehensive estimation of these parameters. We use such data in conjunction with Bayesian inference methods to study the transmission dynamics of influenza. We simultaneously estimate key epidemiological parameters, including population susceptibility, the basic reproductive number, attack rate, and infectious period, for 115 cities during the 2003-2004 through 2012-2013 seasons, including the 2009 pandemic. These estimates discriminate key differences in the epidemiological characteristics of these outbreaks across 10 y, as well as spatial variations of influenza transmission dynamics among subpopulations in the United States. In addition, the inference methods appear to compensate for observational biases and underreporting inherent in the surveillance data.",2015,10.1073/pnas.1415012112,112,9,2723-2728,eng,1091-6490 0027-8424,"*Influenza A virus and *Models, Biological and *Pandemics and *Seasons and asymptomatic infections and Bayes Theorem and data assimilation and Epidemiological Monitoring and Humans and influenza and Influenza, Human/*epidemiology/*transmission and spatial patterns and transmission dynamics and United States/epidemiology",NA,NA,2015/03/03/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Kurvers_2016_ProfthNaAcofScofthUnStofAm,JOUR,Boosting medical diagnostics by pooling independent judgments,"Kurvers, Ralf H. J. M. and Herzog, Stefan M. and Hertwig, Ralph and Krause, Jens and Carney, Patricia A. and Bogart, Andy and Argenziano, Giuseppe and Zalaudek, Iris and Wolf, Max",Proceedings of the National Academy of Sciences of the United States of America,"Collective intelligence refers to the ability of groups to outperform individual decision makers when solving complex cognitive problems. Despite its potential to revolutionize decision making in a wide range of domains, including medical, economic, and political decision making, at present, little is known about the conditions underlying collective intelligence in real-world contexts. We here focus on two key areas of medical diagnostics, breast and skin cancer detection. Using a simulation study that draws on large real-world datasets, involving more than 140 doctors making more than 20,000 diagnoses, we investigate when combining the independent judgments of multiple doctors outperforms the best doctor in a group. We find that similarity in diagnostic accuracy is a key condition for collective intelligence: Aggregating the independent judgments of doctors outperforms the best doctor in a group whenever the diagnostic accuracy of doctors is relatively similar, but not when doctors' diagnostic accuracy differs too much. This intriguingly simple result is highly robust and holds across different group sizes, performance levels of the best doctor, and collective intelligence rules. The enabling role of similarity, in turn, is explained by its systematic effects on the number of correct and incorrect decisions of the best doctor that are overruled by the collective. By identifying a key factor underlying collective intelligence in two important real-world contexts, our findings pave the way for innovative and more effective approaches to complex real-world decision making, and to the scientific analyses of those approaches.",2016,10.1073/pnas.1601827113,113,31,8777-8782,eng,1091-6490 0027-8424,*collective intelligence and *Decision Making and *dermatology and *groups and *Intelligence and *Judgment and *mammography and *medical diagnostics and Adult and Aged and Algorithms and Breast Neoplasms/*diagnosis and collective intelligence and dermatology and Female and groups and Humans and mammography and medical diagnostics and Middle Aged and Sensitivity and Specificity and Skin Neoplasms/*diagnosis,NA,NA,2016/08/02/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Han_2015_ProfthNaAcofScofthUnStofAm,JOUR,Rodent reservoirs of future zoonotic diseases,"Han, Barbara A. and Schmidt, John Paul and Bowden, Sarah E. and Drake, John M.",Proceedings of the National Academy of Sciences of the United States of America,"The increasing frequency of zoonotic disease events underscores a need to develop forecasting tools toward a more preemptive approach to outbreak investigation. We apply machine learning to data describing the traits and zoonotic pathogen diversity of the most speciose group of mammals, the rodents, which also comprise a disproportionate number of zoonotic disease reservoirs. Our models predict reservoir status in this group with over 90% accuracy, identifying species with high probabilities of harboring undiscovered zoonotic pathogens based on trait profiles that may serve as rules of thumb to distinguish reservoirs from nonreservoir species. Key predictors of zoonotic reservoirs include biogeographical properties, such as range size, as well as intrinsic host traits associated with lifetime reproductive output. Predicted hotspots of novel rodent reservoir diversity occur in the Middle East and Central Asia and the Midwestern United States.",2015,10.1073/pnas.1501598112,112,22,7039-7044,eng,1091-6490 0027-8424,machine learning and prediction and Humans and Regression Analysis and Geography and Animals and Artificial Intelligence and Age Factors and Computational Biology and Species Specificity and *machine learning and *prediction and *disease forecasting and *Disease Reservoirs and *generalized boosted regression trees and *pace-of-life hypothesis and Forecasting/methods and Geographic Mapping and Population Density and Public Health/*methods and Reproduction/physiology and Rodentia/*growth & development and Sexual Maturation/physiology and Zoonoses/*transmission and disease forecasting and generalized boosted regression trees and pace-of-life hypothesis,NA,NA,2015/06/02/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Siler_2015_ProfthNaAcofScofthUnStofAm,JOUR,Measuring the effectiveness of scientific gatekeeping,"Siler, Kyle and Lee, Kirby and Bero, Lisa",Proceedings of the National Academy of Sciences of the United States of America,"Peer review is the main institution responsible for the evaluation and gestation of scientific research. Although peer review is widely seen as vital to scientific evaluation, anecdotal evidence abounds of gatekeeping mistakes in leading journals, such as rejecting seminal contributions or accepting mediocre submissions. Systematic evidence regarding the effectiveness--or lack thereof--of scientific gatekeeping is scant, largely because access to rejected manuscripts from journals is rarely available. Using a dataset of 1,008 manuscripts submitted to three elite medical journals, we show differences in citation outcomes for articles that received different appraisals from editors and peer reviewers. Among rejected articles, desk-rejected manuscripts, deemed as unworthy of peer review by editors, received fewer citations than those sent for peer review. Among both rejected and accepted articles, manuscripts with lower scores from peer reviewers received relatively fewer citations when they were eventually published. However, hindsight reveals numerous questionable gatekeeping decisions. Of the 808 eventually published articles in our dataset, our three focal journals rejected many highly cited manuscripts, including the 14 most popular; roughly the top 2 percent. Of those 14 articles, 12 were desk-rejected. This finding raises concerns regarding whether peer review is ill--suited to recognize and gestate the most impactful ideas and research. Despite this finding, results show that in our case studies, on the whole, there was value added in peer review. Editors and peer reviewers generally--but not always-made good decisions regarding the identification and promotion of quality in scientific manuscripts.",2015,10.1073/pnas.1418218112,112,2,360-365,eng,1091-6490 0027-8424,"*Editorial Policies and *Peer Review, Research/methods/standards and *Publishing/standards and creativity and Databases, Bibliographic and decision making and Decision Making and innovation and peer review and publishing",NA,NA,2015/01/13/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Pokhriyal_2017_ProfthNaAcofScofthUnStofAm,JOUR,Combining disparate data sources for improved poverty prediction and mapping,"Pokhriyal, Neeti and Jacques, Damien Christophe",Proceedings of the National Academy of Sciences of the United States of America,"More than 330 million people are still living in extreme poverty in Africa. Timely, accurate, and spatially fine-grained baseline data are essential to determining policy in favor of reducing poverty. The potential of ""Big Data"" to estimate socioeconomic factors in Africa has been proven. However, most current studies are limited to using a single data source. We propose a computational framework to accurately predict the Global Multidimensional Poverty Index (MPI) at a finest spatial granularity and coverage of 552 communes in Senegal using environmental data (related to food security, economic activity, and accessibility to facilities) and call data records (capturing individualistic, spatial, and temporal aspects of people). Our framework is based on Gaussian Process regression, a Bayesian learning technique, providing uncertainty associated with predictions. We perform model selection using elastic net regularization to prevent overfitting. Our results empirically prove the superior accuracy when using disparate data (Pearson correlation of 0.91). Our approach is used to accurately predict important dimensions of poverty: health, education, and standard of living (Pearson correlation of 0.84-0.86). All predictions are validated using deprivations calculated from census. Our approach can be used to generate poverty maps frequently, and its diagnostic nature is, likely, to assist policy makers in designing better interventions for poverty eradication.",2017,10.1073/pnas.1700319114,114,46,E9783-E9792,eng,1091-6490 0027-8424,"*Gaussian process and *Geographic Mapping and *Information Storage and Retrieval and *mobile phone and *Models, Theoretical and *poverty mapping and *Poverty/economics and *remote sensing and Agriculture and Bayes Theorem and Cell Phone and Demography and Environment and Food Supply and Gaussian process and Geography and Health and Humans and Income and mobile phone and Models, Statistical and Normal Distribution and Population and poverty mapping and Predictive Value of Tests and remote sensing and Remote Sensing Technology and Satellite Imagery and Senegal and Social Planning and Social Problems and Socioeconomic Factors and Urban Population",NA,NA,2017/11/14/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Jakobsen_2018_JAMA,JOUR,Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities,"Jakobsen, Gunn Signe and Smastuen, Milada Cvancarova and Sandbu, Rune and Nordstrand, Njord and Hofso, Dag and Lindberg, Morten and Hertel, Jens Kristoffer and Hjelmesaeth, Joran",JAMA,"IMPORTANCE: The association of bariatric surgery and specialized medical obesity treatment with beneficial and detrimental outcomes remains uncertain. OBJECTIVE: To compare changes in obesity-related comorbidities in patients with severe obesity (body mass index <e2><89><a5>40 or <e2><89><a5>35 and at least 1 comorbidity) undergoing bariatric surgery or specialized medical treatment. DESIGN, SETTING, AND PARTICIPANTS: Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included). EXPOSURES: Bariatric surgery (n = 932, 92% gastric bypass) or specialized medical treatment (n = 956) including individual or group-based lifestyle intervention programs. MAIN OUTCOMES AND MEASURES: Primary outcomes included remission and new onset of hypertension based on drugs dispensed according to the Norwegian Prescription Database. Prespecified secondary outcomes included changes in comorbidities. Adverse events included complications retrieved from the Norwegian Patient Registry and a local laboratory database. RESULTS: Among 1888 patients included in the study, the mean (SD) age was 43.5 (12.3) years (1249 women [66%]; mean [SD] baseline BMI, 44.2 [6.1]; 100% completed follow-up at a median of 6.5 years [range, 0.2-10.1]). Surgically treated patients had a greater likelihood of remission and lesser likelihood for new onset of hypertension (remission: absolute risk [AR], 31.9% vs 12.4%); risk difference [RD], 19.5% [95% CI, 15.8%-23.2%], relative risk [RR], 2.1 [95% CI, 2.0-2.2]; new onset: AR, 3.5% vs 12.2%, RD, 8.7% [95% CI, 6.7%-10.7%], RR, 0.4 [95% CI, 0.3-0.5]; greater likelihood of diabetes remission: AR, 57.5% vs 14.8%; RD, 42.7% [95% CI, 35.8%-49.7%], RR, 3.9 [95% CI, 2.8-5.4]; greater risk of new-onset depression: AR, 8.9% vs 6.5%; RD, 2.4% [95% CI, 1.3%-3.5%], RR, 1.5 [95% CI, 1.4-1.7]; and treatment with opioids: AR, 19.4% vs 15.8%, RD, 3.6% [95% CI, 2.3%-4.9%], RR, 1.3 [95% CI, 1.2-1.4]). Surgical patients had a greater risk for undergoing at least 1 additional gastrointestinal surgical procedure (AR, 31.3% vs 15.5%; RD, 15.8% [95% CI, 13.1%-18.5%]; RR, 2.0 [95% CI, 1.7-2.4]). The proportion of patients with low ferritin levels was significantly greater in the surgical group (26% vs 12%, P < .001). CONCLUSIONS AND RELEVANCE: Among patients with severe obesity followed up for a median of 6.5 years, bariatric surgery compared with medical treatment was associated with a clinically important increased risk for complications, as well as lower risks of obesity-related comorbidities. The risk for complications should be considered in the decision-making process.",2018,10.1001/jama.2017.21055,319,3,291-301,eng,1538-3598 0098-7484,"*Bariatric Surgery/adverse effects and Adult and Body Mass Index and Cohort Studies and Comorbidity and Depression/complications and Diabetes Mellitus, Type 2/complications and Female and Ferritins/blood and Humans and Hypertension/complications and Male and Middle Aged and Obesity, Morbid/*complications/drug therapy/surgery and Remission Induction and Treatment Outcome",NA,NA,2018/01/16/,JAMA,NA,NA,NA,NA
Detsky_2017_JAMA,JOUR,Discriminative Accuracy of Physician and Nurse Predictions for Survival and Functional Outcomes 6 Months After an ICU Admission,"Detsky, Michael E. and Harhay, Michael O. and Bayard, Dominique F. and Delman, Aaron M. and Buehler, Anna E. and Kent, Saida A. and Ciuffetelli, Isabella V. and Cooney, Elizabeth and Gabler, Nicole B. and Ratcliffe, Sarah J. and Mikkelsen, Mark E. and Halpern, Scott D.",JAMA,"IMPORTANCE: Predictions of long-term survival and functional outcomes influence decision making for critically ill patients, yet little is known regarding their accuracy. OBJECTIVE: To determine the discriminative accuracy of intensive care unit (ICU) physicians and nurses in predicting 6-month patient mortality and morbidity, including ambulation, toileting, and cognition. DESIGN, SETTING, AND PARTICIPANTS: Prospective cohort study conducted in 5 ICUs in 3 hospitals in Philadelphia, Pennsylvania, and enrolling patients who spent at least 3 days in the ICU from October 2013 until May 2014 and required mechanical ventilation, vasopressors, or both. These patients' attending physicians and bedside nurses were also enrolled. Follow-up was completed in December 2014. MAIN OUTCOMES AND MEASURES: ICU physicians' and nurses' binary predictions of in-hospital mortality and 6-month outcomes, including mortality, return to original residence, ability to toilet independently, ability to ambulate up 10 stairs independently, and ability to remember most things, think clearly, and solve day-to-day problems (ie, normal cognition). For each outcome, physicians and nurses provided a dichotomous prediction and rated their confidence in that prediction on a 5-point Likert scale. Outcomes were assessed via interviews with surviving patients or their surrogates at 6 months. Discriminative accuracy was measured using positive and negative likelihood ratios (LRs), C statistics, and other operating characteristics. RESULTS: Among 340 patients approached, 303 (89%) consented (median age, 62 years [interquartile range, 53-71]; 57% men; 32% African American); 6-month follow-up was completed for 299 (99%), of whom 169 (57%) were alive. Predictions were made by 47 physicians and 128 nurses. Physicians most accurately predicted 6-month mortality (positive LR, 5.91 [95% CI, 3.74-9.32]; negative LR, 0.41 [95% CI, 0.33-0.52]; C statistic, 0.76 [95% CI, 0.72-0.81]) and least accurately predicted cognition (positive LR, 2.36 [95% CI, 1.36-4.12]; negative LR, 0.75 [95% CI, 0.61-0.92]; C statistic, 0.61 [95% CI, 0.54-0.68]). Nurses most accurately predicted in-hospital mortality (positive LR, 4.71 [95% CI, 2.94-7.56]; negative LR, 0.61 [95% CI, 0.49-0.75]; C statistic, 0.68 [95% CI, 0.62-0.74]) and least accurately predicted cognition (positive LR, 1.50 [95% CI, 0.86-2.60]; negative LR, 0.88 [95% CI, 0.73-1.06]; C statistic, 0.55 [95% CI, 0.48-0.62]). Discriminative accuracy was higher when physicians and nurses were confident about their predictions (eg, for physicians' confident predictions of 6-month mortality: positive LR, 33.00 [95% CI, 8.34-130.63]; negative LR, 0.18 [95% CI, 0.09-0.35]; C statistic, 0.90 [95% CI, 0.84-0.96]). Compared with a predictive model including objective clinical variables, a model that also included physician and nurse predictions had significantly higher discriminative accuracy for in-hospital mortality, 6-month mortality, and return to original residence (P < .01 for all). CONCLUSIONS AND RELEVANCE: ICU physicians' and nurses' discriminative accuracy in predicting 6-month outcomes of critically ill patients varied depending on the outcome being predicted and confidence of the predictors. Further research is needed to better understand how clinicians derive prognostic estimates of long-term outcomes.",2017,10.1001/jama.2017.4078,317,21,2187-2195,eng,1538-3598 0098-7484,"*Activities of Daily Living and *Cognition Disorders and *Intensive Care Units and *Medical Staff, Hospital and *Nursing Staff, Hospital and *Prognosis and Aged and Critical Illness/*mortality and Female and Hospitalization and Humans and Male and Middle Aged and Models, Statistical and Prospective Studies and Treatment Outcome",NA,NA,2017/06/06/,JAMA,NA,NA,NA,NA
Sokolov_2018_ProfthNaAcofScofthUnStofAm,JOUR,Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer,"Sokolov, I. and Dokukin, M. E. and Kalaparthi, V. and Miljkovic, M. and Wang, A. and Seigne, J. D. and Grivas, P. and Demidenko, E.",Proceedings of the National Academy of Sciences of the United States of America,"We report an approach in diagnostic imaging based on nanoscale-resolution scanning of surfaces of cells collected from body fluids using a recent modality of atomic force microscopy (AFM), subresonance tapping, and machine-leaning analysis. The surface parameters, which are typically used in engineering to describe surfaces, are used to classify cells. The method is applied to the detection of bladder cancer, which is one of the most common human malignancies and the most expensive cancer to treat. The frequent visual examinations of bladder (cytoscopy) required for follow-up are not only uncomfortable for the patient but a serious cost for the health care system. Our method addresses an unmet need in noninvasive and accurate detection of bladder cancer, which may eliminate unnecessary and expensive cystoscopies. The method, which evaluates cells collected from urine, shows 94% diagnostic accuracy when examining five cells per patient's urine sample. It is a statistically significant improvement (P < 0.05) in diagnostic accuracy compared with the currently used clinical standard, cystoscopy, as verified on 43 control and 25 bladder cancer patients.",2018,10.1073/pnas.1816459115,115,51,12920-12925,eng,1091-6490 0027-8424,"*atomic force microscopy and *cancer diagnostics and *diagnostic imaging and *machine learning and *noninvasive methods and atomic force microscopy and cancer diagnostics and diagnostic imaging and Humans and machine learning and Machine Learning and Microscopy, Atomic Force/*methods and noninvasive methods and Sensitivity and Specificity and Urinary Bladder Neoplasms/*diagnostic imaging/pathology and Urinary Bladder/*diagnostic imaging/pathology and Urine/*cytology",NA,NA,2018/12/18/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Pelletier_2018_ProfthNaAcofScofthUnStofAm,JOUR,Predicting plant conservation priorities on a global scale,"Pelletier, Tara A. and Carstens, Bryan C. and Tank, David C. and Sullivan, Jack and Espindola, Anahi",Proceedings of the National Academy of Sciences of the United States of America,"The conservation status of most plant species is currently unknown, despite the fundamental role of plants in ecosystem health. To facilitate the costly process of conservation assessment, we developed a predictive protocol using a machine-learning approach to predict conservation status of over 150,000 land plant species. Our study uses open-source geographic, environmental, and morphological trait data, making this the largest assessment of conservation risk to date and the only global assessment for plants. Our results indicate that a large number of unassessed species are likely at risk and identify several geographic regions with the highest need of conservation efforts, many of which are not currently recognized as regions of global concern. By providing conservation-relevant predictions at multiple spatial and taxonomic scales, predictive frameworks such as the one developed here fill a pressing need for biodiversity science.",2018,10.1073/pnas.1804098115,115,51,13027-13032,eng,1091-6490 0027-8424,*Biodiversity and *conservation and *Conservation of Natural Resources and *Ecosystem and *Endangered Species and *IUCN and *plantae and *Plants and *predictive modeling and *random forest and conservation and Geographic Mapping and IUCN and plantae and Population Dynamics and predictive modeling and random forest,NA,NA,2018/12/18/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Fisher_2018_JAMA,JOUR,Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity,"Fisher, David P. and Johnson, Eric and Haneuse, Sebastien and Arterburn, David and Coleman, Karen J. and O'Connor, Patrick J. and O'Brien, Rebecca and Bogart, Andy and Theis, Mary Kay and Anau, Jane and Schroeder, Emily B. and Sidney, Stephen",JAMA,"IMPORTANCE: Macrovascular disease is a leading cause of morbidity and mortality for patients with type 2 diabetes, and medical management, including lifestyle changes, may not be successful at lowering risk. OBJECTIVE: To investigate the relationship between bariatric surgery and incident macrovascular (coronary artery disease and cerebrovascular diseases) events in patients with severe obesity and type 2 diabetes. DESIGN, SETTING, AND PARTICIPANTS: In this retrospective, matched cohort study, patients with severe obesity (body mass index <e2><89><a5>35) aged 19 to 79 years with diabetes who underwent bariatric surgery from 2005 to 2011 in 4 integrated health systems in the United States (n = 5301) were matched to 14<e2><80><af>934 control patients on site, age, sex, body mass index, hemoglobin A1c, insulin use, observed diabetes duration, and prior health care utilization, with follow-up through September 2015. EXPOSURES: Bariatric procedures (76% Roux-en-Y gastric bypass, 17% sleeve gastrectomy, and 7% adjustable gastric banding) were compared with usual care for diabetes. MAIN OUTCOMES AND MEASURES: Multivariable-adjusted Cox regression analysis investigated time to incident macrovascular disease (defined as first occurrence of coronary artery disease [acute myocardial infarction, unstable angina, percutaneous coronary intervention, or coronary artery bypass grafting] or cerebrovascular events [ischemic stroke, hemorrhagic stroke, carotid stenting, or carotid endarterectomy]). Secondary outcomes included coronary artery disease and cerebrovascular outcomes separately. RESULTS: Among a combined 20<e2><80><af>235 surgical and nonsurgical patients, the mean (SD) age was 50 (10) years; 76% of the surgical and 75% of the nonsurgical patients were female; and the baseline mean (SD) body mass index was 44.7 (6.9) and 43.8 (6.7) in the surgical and nonsurgical groups, respectively. At the end of the study period, there were 106 macrovascular events in surgical patients (including 37 cerebrovascular and 78 coronary artery events over a median of 4.7 years; interquartile range, 3.2-6.2 years) and 596 events in the matched control patients (including 227 cerebrovascular and 398 coronary artery events over a median of 4.6 years; interquartile range, 3.1-6.1 years). Bariatric surgery was associated with a lower composite incidence of macrovascular events at 5 years (2.1% in the surgical group vs 4.3% in the nonsurgical group; hazard ratio, 0.60 [95% CI, 0.42-0.86]), as well as a lower incidence of coronary artery disease (1.6% in the surgical group vs 2.8% in the nonsurgical group; hazard ratio, 0.64 [95% CI, 0.42-0.99]). The incidence of cerebrovascular disease was not significantly different between groups at 5 years (0.7% in the surgical group vs 1.7% in the nonsurgical group; hazard ratio, 0.69 [95% CI, 0.38-1.25]). CONCLUSIONS AND RELEVANCE: In this observational study of patients with type 2 diabetes and severe obesity who underwent surgery, compared with those who did not undergo surgery, bariatric surgery was associated with a lower risk of macrovascular outcomes. The findings require confirmation in randomized clinical trials. Health care professionals should engage patients with severe obesity and type 2 diabetes in a shared decision making conversation about the potential role of bariatric surgery in the prevention of macrovascular events.",2018,10.1001/jama.2018.14619,320,15,1570-1582,eng,1538-3598 0098-7484,"*Bariatric Surgery and Adult and Aged and Cerebrovascular Disorders/*etiology/prevention & control and Coronary Disease/*etiology/prevention & control and Diabetes Mellitus, Type 2/*complications and Female and Glycated Hemoglobin A/analysis and Humans and Male and Middle Aged and Obesity, Morbid/complications/*surgery and Proportional Hazards Models and Retrospective Studies and Risk",NA,NA,2018/10/16/,JAMA,NA,NA,NA,NA
Carson_2016_JAMA,JOUR,Effect of Palliative Care-Led Meetings for Families of Patients With Chronic Critical Illness: A Randomized Clinical Trial,"Carson, Shannon S. and Cox, Christopher E. and Wallenstein, Sylvan and Hanson, Laura C. and Danis, Marion and Tulsky, James A. and Chai, Emily and Nelson, Judith E.",JAMA,"IMPORTANCE: Family caregivers of patients with chronic critical illness experience significant psychological distress. OBJECTIVE: To determine whether family informational and emotional support meetings led by palliative care clinicians improve family anxiety and depression. DESIGN, SETTING, AND PARTICIPANTS: A multicenter randomized clinical trial conducted from October 2010 through November 2014 in 4 medical intensive care units (ICUs). Adult patients (aged <e2><89><a5>21 years) requiring 7 days of mechanical ventilation were randomized and their family surrogate decision makers were enrolled in the study. Observers were blinded to group allocation for the measurement of the primary outcomes. INTERVENTIONS: At least 2 structured family meetings led by palliative care specialists and provision of an informational brochure (intervention) compared with provision of an informational brochure and routine family meetings conducted by ICU teams (control). There were 130 patients with 184 family surrogate decision makers in the intervention group and 126 patients with 181 family surrogate decision makers in the control group. MAIN OUTCOMES AND MEASURES: The primary outcome was Hospital Anxiety and Depression Scale symptom score (HADS; score range, 0 [best] to 42 [worst]; minimal clinically important difference, 1.5) obtained during 3-month follow-up interviews with the surrogate decision makers. Secondary outcomes included posttraumatic stress disorder experienced by the family and measured by the Impact of Events Scale-Revised (IES-R; total score range, 0 [best] to 88 [worst]), discussion of patient preferences, hospital length of stay, and 90-day survival. RESULTS: Among 365 family surrogate decision makers (mean age, 51 years; 71% female), 312 completed the study. At 3 months, there was no significant difference in anxiety and depression symptoms between surrogate decision makers in the intervention group and the control group (adjusted mean HADS score, 12.2 vs 11.4, respectively; between-group difference, 0.8 [95% CI, -0.9 to 2.6]; P = .34). Posttraumatic stress disorder symptoms were higher in the intervention group (adjusted mean IES-R score, 25.9) compared with the control group (adjusted mean IES-R score, 21.3) (between-group difference, 4.60 [95% CI, 0.01 to 9.10]; P = .0495). There was no difference between groups regarding the discussion of patient preferences (intervention, 75%; control, 83%; odds ratio, 0.63 [95% CI, 0.34 to 1.16; P = .14]). The median number of hospital days for patients in the intervention vs the control group (19 days vs 23 days, respectively; between-group difference, -4 days [95% CI, -6 to 3 days]; P = .51) and 90-day survival (hazard ratio, 0.95 [95% CI, 0.65 to 1.38], P = .96) were not significantly different. CONCLUSIONS AND RELEVANCE: Among families of patients with chronic critical illness, the use of palliative care-led informational and emotional support meetings compared with usual care did not reduce anxiety or depression symptoms and may have increased posttraumatic stress disorder symptoms. These findings do not support routine or mandatory palliative care-led discussion of goals of care for all families of patients with chronic critical illness. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01230099.",2016,10.1001/jama.2016.8474,316,1,51-62,eng,1538-3598 0098-7484,"*Critical Illness and *Family and *Palliative Care and Anxiety/diagnosis/*therapy and Caregivers/*psychology and Chronic Disease and Decision Making and Depression/diagnosis/*therapy and Female and Humans and Intensive Care Units and Length of Stay and Male and Middle Aged and Pamphlets and Patient Preference and Proxy and Stress Disorders, Post-Traumatic/etiology/psychology",NA,NA,2016/07/05/,JAMA,NA,NA,NA,NA
Babl_2017_Lanc.LonEngl,JOUR,"Accuracy of PECARN, CATCH, and CHALICE head injury decision rules in children: a prospective cohort study","Babl, Franz E. and Borland, Meredith L. and Phillips, Natalie and Kochar, Amit and Dalton, Sarah and McCaskill, Mary and Cheek, John A. and Gilhotra, Yuri and Furyk, Jeremy and Neutze, Jocelyn and Lyttle, Mark D. and Bressan, Silvia and Donath, Susan and Molesworth, Charlotte and Jachno, Kim and Ward, Brenton and Williams, Amanda and Baylis, Amy and Crowe, Louise and Oakley, Ed and Dalziel, Stuart R.","Lancet (London, England)","BACKGROUND: Clinical decision rules can help to determine the need for CT imaging in children with head injuries. We aimed to validate three clinical decision rules (PECARN, CATCH, and CHALICE) in a large sample of children. METHODS: In this prospective observational study, we included children and adolescents (aged <18 years) with head injuries of any severity who presented to the emergency departments of ten Australian and New Zealand hospitals. We assessed the diagnostic accuracy of PECARN (stratified into children aged <2 years and <e2><89><a5>2 years), CATCH, and CHALICE in predicting each rule-specific outcome measure (clinically important traumatic brain injury [TBI], need for neurological intervention, and clinically significant intracranial injury, respectively). For each calculation we used rule-specific predictor variables in populations that satisfied inclusion and exclusion criteria for each rule (validation cohort). In a secondary analysis, we compiled a comparison cohort of patients with mild head injuries (Glasgow Coma Scale score 13-15) and calculated accuracy using rule-specific predictor variables for the standardised outcome of clinically important TBI. This study is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12614000463673. FINDINGS: Between April 11, 2011, and Nov 30, 2014, we analysed 20 137 children and adolescents attending with head injuries. CTs were obtained for 2106 (10%) patients, 4544 (23%) were admitted, 83 (<1%) underwent neurosurgery, and 15 (<1%) died. PECARN was applicable for 4011 (75%) of 5374 patients younger than 2 years and 11 152 (76%) of 14 763 patients aged 2 years and older. CATCH was applicable for 4957 (25%) patients and CHALICE for 20 029 (99%). The highest point validation sensitivities were shown for PECARN in children younger than 2 years (100<c2><b7>0%, 95% CI 90<c2><b7>7-100<c2><b7>0; 38 patients identified of 38 with outcome [38/38]) and PECARN in children 2 years and older (99<c2><b7>0%, 94<c2><b7>4-100<c2><b7>0; 97/98), followed by CATCH (high-risk predictors only; 95<c2><b7>2%; 76<c2><b7>2-99<c2><b7>9; 20/21; medium-risk and high-risk predictors 88<c2><b7>7%; 82<c2><b7>2-93<c2><b7>4; 125/141) and CHALICE (92<c2><b7>3%, 89<c2><b7>2-94<c2><b7>7; 370/401). In the comparison cohort of 18 913 patients with mild injuries, sensitivities for clinically important TBI were similar. Negative predictive values in both analyses were higher than 99% for all rules. INTERPRETATION: The sensitivities of three clinical decision rules for head injuries in children were high when used as designed. The findings are an important starting point for clinicians considering the introduction of one of the rules. FUNDING: National Health and Medical Research Council, Emergency Medicine Foundation, Perpetual Philanthropic Services, WA Health Targeted Research Funds, Townsville Hospital Private Practice Fund, Auckland Medical Research Foundation, A + Trust.",2017,10.1016/S0140-6736(17)30555-X,389,10087,2393-2402,eng,1474-547X 0140-6736,"*Decision Support Techniques and Adolescent and Age Factors and Australia and Child and Child, Preschool and Clinical Decision-Making/methods and Craniocerebral Trauma/*diagnosis/etiology and Emergency Service, Hospital and Female and Glasgow Coma Scale and Humans and Infant and Male and New Zealand and Prospective Studies and Tomography, X-Ray Computed and Triage/*methods",NA,NA,2017/06/17/,Lancet,NA,NA,NA,NA
Abrams_2020_ProfthNaAcofScofthUnStofAm,JOUR,Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors,"Abrams, Rachel P. M. and Yasgar, Adam and Teramoto, Tadahisa and Lee, Myoung-Hwa and Dorjsuren, Dorjbal and Eastman, Richard T. and Malik, Nasir and Zakharov, Alexey V. and Li, Wenxue and Bachani, Muzna and Brimacombe, Kyle and Steiner, Joseph P. and Hall, Matthew D. and Balasubramanian, Anuradha and Jadhav, Ajit and Padmanabhan, Radhakrishnan and Simeonov, Anton and Nath, Avindra",Proceedings of the National Academy of Sciences of the United States of America,"When Zika virus emerged as a public health emergency there were no drugs or vaccines approved for its prevention or treatment. We used a high-throughput screen for Zika virus protease inhibitors to identify several inhibitors of Zika virus infection. We expressed the NS2B-NS3 Zika virus protease and conducted a biochemical screen for small-molecule inhibitors. A quantitative structure-activity relationship model was employed to virtually screen <e2><88><bc>138,000 compounds, which increased the identification of active compounds, while decreasing screening time and resources. Candidate inhibitors were validated in several viral infection assays. Small molecules with favorable clinical profiles, especially the five-lipoxygenase-activating protein inhibitor, MK-591, inhibited the Zika virus protease and infection in neural stem cells. Members of the tetracycline family of antibiotics were more potent inhibitors of Zika virus infection than the protease, suggesting they may have multiple mechanisms of action. The most potent tetracycline, methacycline, reduced the amount of Zika virus present in the brain and the severity of Zika virus-induced motor deficits in an immunocompetent mouse model. As Food and Drug Administration-approved drugs, the tetracyclines could be quickly translated to the clinic. The compounds identified through our screening paradigm have the potential to be used as prophylactics for patients traveling to endemic regions or for the treatment of the neurological complications of Zika virus infection.",2020,10.1073/pnas.2005463117,117,49,31365-31375,eng,1091-6490 0027-8424,"*Drug Evaluation, Preclinical and *encephalitis and *flavivirus and *high-throughput screening and *High-Throughput Screening Assays and *serine protease and *Zika virus and Animals and Antiviral Agents/*analysis/*pharmacology/therapeutic use and Artificial Intelligence and Chlorocebus aethiops and Disease Models, Animal and encephalitis and flavivirus and high-throughput screening and Immunocompetence and Inhibitory Concentration 50 and Methacycline/pharmacology and Mice, Inbred C57BL and Protease Inhibitors/*analysis/*pharmacology/therapeutic use and Quantitative Structure-Activity Relationship and serine protease and Small Molecule Libraries and Vero Cells and Zika virus and Zika Virus Infection/drug therapy/virology and Zika Virus/*drug effects",NA,NA,2020/12/08/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Bodilsen_2020_JAMA,JOUR,Association of Lumbar Puncture With Spinal Hematoma in Patients With and Without Coagulopathy,"Bodilsen, Jacob and Mariager, Theis and Vestergaard, Hannah Holm and Christiansen, Mikkel Hojberg and Kunwald, Mikkel and Luttichau, Hans Rudolf and Kristensen, Bo Traberg and Bjarkam, Carsten Reidies and Nielsen, Henrik",JAMA,"IMPORTANCE: Coagulopathy may deter physicians from performing a lumbar puncture. OBJECTIVE: To determine the risk of spinal hematoma after lumbar puncture in patients with and without coagulopathy. DESIGN, SETTING, AND PARTICIPANTS: Danish nationwide, population-based cohort study using medical registries to identify persons who underwent lumbar puncture and had cerebrospinal fluid analysis (January 1, 2008-December 31, 2018; followed up through October 30, 2019). Coagulopathy was defined as platelets lower than 150 * 109/L, international normalized ratio (INR) greater than 1.4, or activated partial thromboplastin time (APTT) longer than 39 seconds. EXPOSURES: Coagulopathy at the time of lumbar puncture. MAIN OUTCOMES AND MEASURES: Thirty-day risk of spinal hematoma. Risks were provided as numbers and percentages with 95% CIs. Secondary analyses included risks of traumatic lumbar puncture (>300 * 106 erythrocytes/L after excluding patients diagnosed with subarachnoid hemorrhage). Adjusted hazard rate ratios (HRs) were computed using Cox regression models. RESULTS: A total of 83<e2><80><af>711 individual lumbar punctures were identified among 64<e2><80><af>730 persons (51% female; median age, 43 years [interquartile range, 22-62 years]) at the time of the procedure. Thrombocytopenia was present in 7875 patients (9%), high INR levels in 1393 (2%), and prolonged APTT in 2604 (3%). Follow-up was complete for more than 99% of the study participants. Overall, spinal hematoma occurred within 30 days for 99 of 49<e2><80><af>526 patients (0.20%; 95% CI, 0.16%-0.24%) without coagulopathy vs 24 of 10<e2><80><af>371 patients (0.23%; 95% CI, 0.15%-0.34%) with coagulopathy. Independent risk factors for spinal hematoma were male sex (adjusted hazard ratio [HR], 1.72; 95% CI, 1.15-2.56), those aged 41 through 60 years (adjusted HR, 1.96; 95% CI, 1.01-3.81) and those aged 61 through 80 years (adjusted HR, 2.20; 95% CI, 1.12-4.33). Risks did not increase significantly according to overall severity of coagulopathy, in subgroup analyses of severity of coagulopathy by pediatric specialty or medical indication (infection, neurological condition, and hematological malignancy), nor by cumulative number of procedures. Traumatic lumbar punctures occurred more frequently among patients with INR levels of 1.5 to 2.0 (36.8%; 95% CI, 33.3%-40.4%), 2.1 to 2.5 (43.7%; 95% CI, 35.8%-51.8%), and 2.6 to 3.0 (41.9% 95% CI 30.5-53.9) vs those with normal INR (28.2%; 95% CI, 27.7%-28.75%). Traumatic spinal tap occurred more often in patients with an APTT of 40 to 60 seconds (26.3%; 95% CI, 24.2%-28.5%) vs those with normal APTT (21.3%; 95% CI, 20.6%-21.9%) yielding a risk difference of 5.1% (95% CI, 2.9%-7.2%). CONCLUSIONS AND RELEVANCE: In this Danish cohort study, risk of spinal hematoma following lumbar puncture was 0.20% among patients without coagulopathy and 0.23% among those with coagulopathy. Although these findings may inform decision-making about lumbar puncture by describing rates in this sample, the observed rates may reflect bias due to physicians selecting relatively low-risk patients for lumbar puncture.",2020,10.1001/jama.2020.14895,324,14,1419-1428,eng,1538-3598 0098-7484,"Adolescent and Adult and Aged and Aged, 80 and over and Blood Coagulation Disorders/blood/*complications and Cerebrospinal Fluid/chemistry and Child and Cohort Studies and Denmark/epidemiology and Female and Hematoma/*etiology and Humans and International Normalized Ratio and Male and Middle Aged and Partial Thromboplastin Time and Proportional Hazards Models and Registries/statistics & numerical data and Risk Factors and Spinal Diseases/*etiology and Spinal Puncture/*adverse effects/statistics & numerical data and Thrombocytopenia/epidemiology and Time Factors and Young Adult",NA,NA,2020/10/13/,JAMA,NA,NA,NA,NA
Ndumele_2017_JAMA,JOUR,"Association Between Health Plan Exit From Medicaid Managed Care and Quality of Care, 2006-2014","Ndumele, Chima D. and Schpero, William L. and Schlesinger, Mark J. and Trivedi, Amal N.",JAMA,"IMPORTANCE: State Medicaid programs have increasingly contracted with insurers to provide medical care services for enrollees (Medicaid managed care plans). Insurers that provide these plans can exit Medicaid programs each year, with unclear effects on quality of care and health care experiences. OBJECTIVE: To determine the frequency and interstate variation of health plan exit from Medicaid managed care and evaluate the relationship between health plan exit and market-level quality. DESIGN, SETTING, AND PARTICIPANTS: Retrospective cohort of all comprehensive Medicaid managed care plans (N = 390) during the interval 2006-2014. EXPOSURES: Plan exit, defined as the withdrawal of a managed care plan from a state's Medicaid program. MAIN OUTCOMES AND MEASURES: Eight measures from the Healthcare Effectiveness Data and Information Set were used to construct 3 composite indicators of quality (preventive care, chronic disease care management, and maternity care). Four measures from the Consumer Assessment of Healthcare Providers and Systems were combined into a composite indicator of patient experience, reflecting the proportion of beneficiaries rating experiences as 8 or above on a 0-to-10-point scale. Outcome data were available for 248 plans (68% of plans operating prior to 2014, representing 78% of beneficiaries). RESULTS: Of the 366 comprehensive Medicaid managed care plans operating prior to 2014, 106 exited Medicaid. These exiting plans enrolled 4<e2><80><af>848<e2><80><af>310 Medicaid beneficiaries, with a mean of 606<e2><80><af>039 beneficiaries affected by plan exits annually. Six states had a mean of greater than 10% of Medicaid managed care recipients enrolled in plans that exited, whereas 10 states experienced no plan exits. Plans that exited from a state's Medicaid market performed significantly worse prior to exiting than those that remained in terms of preventive care (57.5% vs 60.4%; difference, 2.9% [95% CI, 0.3% to 5.5%]), maternity care (69.7% vs 73.6%; difference, 3.8% [95% CI, 1.7% to 6.0%]), and patient experience (73.5% vs 74.8%; difference, 1.3% [95% CI, 0.6% to 1.9%]). There was no significant difference between exiting and nonexiting plans for the quality of chronic disease care management (76.2% vs 77.1%; difference, 1.0% [95% CI, -2.1% to 4.0%]). There was also no significant change in overall market performance before and after the exit of a plan: 0.7-percentage point improvement in preventive care quality (95% CI, -4.9 to 6.3); 0.2-percentage point improvement in chronic disease care management quality (95% CI, -5.8 to 6.2); 0.7-percentage point decrease in maternity care quality (95% CI, -6.4 to 5.0]); and a 0.6-percentage point improvement in patient experience ratings (95% CI, -3.9 to 5.1). Medicaid beneficiaries enrolled in exiting plans had access to coverage for a higher-quality plan, with 78% of plans in the same county having higher quality for preventive care, 71.1% for chronic disease management, 65.5% for maternity care, and 80.8% for patient experience. CONCLUSIONS AND RELEVANCE: Between 2006 and 2014, health plan exit from the US Medicaid program was frequent. Plans that exited generally had lower quality ratings than those that remained, and the exits were not associated with significant overall changes in quality or patient experience in the plans in the Medicaid market.",2017,10.1001/jama.2017.7118,317,24,2524-2531,eng,1538-3598 0098-7484,"Chronic Disease/epidemiology/therapy and Consumer Advocacy and Decision Making, Organizational and Humans and Insurance Carriers/*standards/statistics & numerical data and Managed Care Programs/*standards/statistics & numerical data and Maternal Health Services/standards/statistics & numerical data and Medicaid/*standards/statistics & numerical data and Preventive Health Services/standards/statistics & numerical data and Quality Assurance, Health Care and Quality of Health Care/*standards/statistics & numerical data and Retrospective Studies and State Health Plans/*standards/statistics & numerical data and United States",NA,NA,2017/06/27/,JAMA,NA,NA,NA,NA
Yang_2015_ProfthNaAcofScofthUnStofAm_1,JOUR,Accurate estimation of influenza epidemics using Google search data via ARGO,"Yang, Shihao and Santillana, Mauricio and Kou, S. C.",Proceedings of the National Academy of Sciences of the United States of America,"Accurate real-time tracking of influenza outbreaks helps public health officials make timely and meaningful decisions that could save lives. We propose an influenza tracking model, ARGO (AutoRegression with GOogle search data), that uses publicly available online search data. In addition to having a rigorous statistical foundation, ARGO outperforms all previously available Google-search-based tracking models, including the latest version of Google Flu Trends, even though it uses only low-quality search data as input from publicly available Google Trends and Google Correlate websites. ARGO not only incorporates the seasonality in influenza epidemics but also captures changes in people's online search behavior over time. ARGO is also flexible, self-correcting, robust, and scalable, making it a potentially powerful tool that can be used for real-time tracking of other social events at multiple temporal and spatial resolutions.",2015,10.1073/pnas.1515373112,112,47,14473-14478,eng,1091-6490 0027-8424,"*Epidemics and autoregressive exogenous model and big data and digital disease detection and Humans and influenza-like illnesses activity real-time estimation and Influenza, Human/*epidemiology and Internet and Retrospective Studies and Search Engine and seasonal influenza",NA,NA,2015/11/24/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
X2020_Lanc.LonEngl,JOUR,Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study,NA,"Lancet (London, England)","BACKGROUND: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. METHODS: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. FINDINGS: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74<c2><b7>0%) had emergency surgery and 280 (24<c2><b7>8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26<c2><b7>1%) patients. 30-day mortality was 23<c2><b7>8% (268 of 1128). Pulmonary complications occurred in 577 (51<c2><b7>2%) of 1128 patients; 30-day mortality in these patients was 38<c2><b7>0% (219 of 577), accounting for 81<c2><b7>7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1<c2><b7>75 [95% CI 1<c2><b7>28-2<c2><b7>40], p<0<c2><b7>0001), age 70 years or older versus younger than 70 years (2<c2><b7>30 [1<c2><b7>65-3<c2><b7>22], p<0<c2><b7>0001), American Society of Anesthesiologists grades 3-5 versus grades 1-2 (2<c2><b7>35 [1<c2><b7>57-3<c2><b7>53], p<0<c2><b7>0001), malignant versus benign or obstetric diagnosis (1<c2><b7>55 [1<c2><b7>01-2<c2><b7>39], p=0<c2><b7>046), emergency versus elective surgery (1<c2><b7>67 [1<c2><b7>06-2<c2><b7>63], p=0<c2><b7>026), and major versus minor surgery (1<c2><b7>52 [1<c2><b7>01-2<c2><b7>31], p=0<c2><b7>047). INTERPRETATION: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. FUNDING: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research.",2020,10.1016/S0140-6736(20)31182-X,396,10243,27-38,eng,1474-547X 0140-6736,"SARS-CoV-2 and COVID-19 and Humans and Female and Male and Adult and Middle Aged and Young Adult and Retrospective Studies and Aged and Hospital Mortality and Pandemics and Postoperative Complications and Emergency Medical Services and Betacoronavirus and Coronavirus Infections/*complications and Pneumonia, Viral/*complications and Elective Surgical Procedures/adverse effects/mortality and Respiratory Tract Diseases/*etiology and Surgical Procedures, Operative/*adverse effects/*mortality",NA,NA,2020/07/04/,Lancet,NA,NA,NA,NA
Hersch_2015_Lanc.LonEngl,JOUR,Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial,"Hersch, Jolyn and Barratt, Alexandra and Jansen, Jesse and Irwig, Les and McGeechan, Kevin and Jacklyn, Gemma and Thornton, Hazel and Dhillon, Haryana and Houssami, Nehmat and McCaffery, Kirsten","Lancet (London, England)","BACKGROUND: Mammography screening can reduce breast cancer mortality. However, most women are unaware that inconsequential disease can also be detected by screening, leading to overdiagnosis and overtreatment. We aimed to investigate whether including information about overdetection of breast cancer in a decision aid would help women aged around 50 years to make an informed choice about breast screening. METHODS: We did a community-based, parallel-group, randomised controlled trial in New South Wales, Australia, using a random cohort of women aged 48-50 years. Recruitment to the study was done by telephone; women were eligible if they had not had mammography in the past 2 years and did not have a personal or strong family history of breast cancer. With a computer program, we randomly assigned 879 participants to either the intervention decision aid (comprising evidence-based explanatory and quantitative information on overdetection, breast cancer mortality reduction, and false positives) or a control decision aid (including information on breast cancer mortality reduction and false positives). Participants and interviewers were masked to group assignment. The primary outcome was informed choice (defined as adequate knowledge and consistency between attitudes and screening intentions), which we assessed by telephone interview about 3 weeks after random allocation. The primary outcome was analysed in all women who completed the relevant follow-up interview questions fully. This trial is registered with the Australian New Zealand Clinical Trials Registry, number ACTRN12613001035718. FINDINGS: Between January, 2014, and July, 2014, 440 women were allocated to the intervention group and 439 were assigned to the control group. 21 women in the intervention group and 20 controls were lost to follow-up; a further ten women assigned to the intervention and 11 controls did not answer all questions on attitudes. Therefore, 409 women in the intervention group and 408 controls were analysed for the primary outcome. 99 (24%) of 409 women in the intervention group made an informed choice compared with 63 (15%) of 408 in the control group (difference 9%, 95% CI 3-14; p=0<c2><b7>0017). Compared with controls, more women in the intervention group met the threshold for adequate overall knowledge (122/419 [29%] vs 71/419 [17%]; difference 12%, 95% CI 6-18; p<0<c2><b7>0001), fewer women expressed positive attitudes towards screening (282/409 [69%] vs 340/408 [83%]; 14%, 9-20; p<0<c2><b7>0001), and fewer women intended to be screened (308/419 [74%] vs 363/419 [87%]; 13%, 8-19; p<0<c2><b7>0001). When conceptual knowledge alone was considered, 203 (50%) of 409 women in the intervention group made an informed choice compared with 79 (19%) of 408 in the control group (p<0<c2><b7>0001). INTERPRETATION: Information on overdetection of breast cancer provided within a decision aid increased the number of women making an informed choice about breast screening. Becoming better informed might mean women are less likely to choose screening. FUNDING: Australian National Health and Medical Research Council.",2015,10.1016/S0140-6736(15)60123-4,385,9978,1642-1652,eng,1474-547X 0140-6736,"*Decision Support Techniques and *Health Knowledge, Attitudes, Practice and Breast Neoplasms/diagnostic imaging/prevention & control and Decision Making and Female and Humans and Mammography/*statistics & numerical data and Middle Aged and Patient Education as Topic and Patient Participation",NA,NA,2015/04/25/,Lancet,NA,NA,NA,NA
Csete_2016_Lanc.LonEngl,JOUR,Public health and international drug policy,"Csete, Joanne and Kamarulzaman, Adeeba and Kazatchkine, Michel and Altice, Frederick and Balicki, Marek and Buxton, Julia and Cepeda, Javier and Comfort, Megan and Goosby, Eric and Goulao, Joao and Hart, Carl and Kerr, Thomas and Lajous, Alejandro Madrazo and Lewis, Stephen and Martin, Natasha and Mejia, Daniel and Camacho, Adriana and Mathieson, David and Obot, Isidore and Ogunrombi, Adeolu and Sherman, Susan and Stone, Jack and Vallath, Nandini and Vickerman, Peter and Zabransky, Tomas and Beyrer, Chris","Lancet (London, England)","In September 2015, the member states of the United Nations endorsed sustainable development goals (SDG) for 2030 that aspire to human rights-centered approaches to ensuring the health and well-being of all people. The SDGs embody both the UN Charter values of rights and justice for all and the responsibility of states to rely on the best scientific evidence as they seek to better humankind. In April 2016, these same states will consider control of illicit drugs, an area of social policy that has been fraught with controversy, seen as inconsistent with human rights norms, and for which scientific evidence and public health approaches have arguably played too limited a role. The previous UN General Assembly Special Session (UNGASS) on drugs in 1998 - convened under the theme ""a drug-free world, we can do it!"" - endorsed drug control policies based on the goal of prohibiting all use, possession, production, and trafficking of illicit drugs. This goal is enshrined in national law in many countries. In pronouncing drugs a ""grave threat to the health and well-being of all mankind,"" the 1998 UNGASS echoed the foundational 1961 convention of the international drug control regime, which justified eliminating the ""evil"" of drugs in the name of ""the health and welfare of mankind."" But neither of these international agreements refers to the ways in which pursuing drug prohibition itself might affect public health. The ""war on drugs"" and ""zero-tolerance"" policies that grew out of the prohibitionist consensus are now being challenged on multiple fronts, including their health, human rights, and development impact. The Johns Hopkins - Lancet Commission on Drug Policy and Health has sought to examine the emerging scientific evidence on public health issues arising from drug control policy and to inform and encourage a central focus on public health evidence and outcomes in drug policy debates, such as the important deliberations of the 2016 UNGASS on drugs. The Johns Hopkins-Lancet Commission is concerned that drug policies are often colored by ideas about drug use and drug dependence that are not scientifically grounded. The 1998 UNGASS declaration, for example, like the UN drug conventions and many national drug laws, does not distinguish between drug use and drug abuse. A 2015 report by the UN High Commissioner for Human Rights, by contrast, found it important to emphasize that ""[d]rug use is neither a medical condition nor does it necessarily lead to drug dependence."" The idea that all drug use is dangerous and evil has led to enforcement-heavy policies and has made it difficult to see potentially dangerous drugs in the same light as potentially dangerous foods, tobacco, alcohol for which the goal of social policy is to reduce potential harms. HEALTH IMPACT OF DRUG POLICY BASED ON ENFORCEMENT OF PROHIBITION: The pursuit of drug prohibition has generated a parallel economy run by criminal networks. Both these networks, which resort to violence to protect their markets, and the police and sometimes military or paramilitary forces that pursue them contribute to violence and insecurity in communities affected by drug transit and sales. In Mexico, the dramatic increase in homicides since the government decided to use military forces against drug traffickers in 2006 has been so great that it reduced life expectancy in the country. Injection of drugs with contaminated equipment is a well-known route of HIV exposure and viral hepatitis transmission. People who inject drugs (PWID) are also at high risk of tuberculosis. The continued spread of unsafe injection-linked HIV contrasts the progress that has been seen in reducing sexual and vertical transmission of HIV in the last three decades. The Commission found that that repressive drug policing greatly contributes to the risk of HIV linked to injection. Policing may be a direct barrier to services such as needle and syringe programmes (NSP) and use of non-injected opioids to treat dependence among those who inject opioids, known as opioid substitution therapy (OST). Police seeking to boost arrest totals have been found to target facilities that provide these services to find, harass, and detain large numbers of people who use drugs. Drug paraphernalia laws that prohibit possession of injecting equipment lead PWID to fear carrying syringes and force them to share equipment or dispose of it unsafely. Policing practices undertaken in the name of the public good have demonstrably worsened public health outcomes. Amongst the most significant impacts of pursuit of drug prohibition identified by the Commission with respect to infectious disease is the excessive use of incarceration as a drug-control measure. Many national laws impose lengthy custodial sentences for minor, non-violent drug offenses; people who use drugs (PWUD) are over-represented in prison and pretrial detention. Drug use and drug injection occur in prisons, though their occurrence is often denied by officials. HIV and hepatitis C virus (HCV) transmission occurs among prisoners and detainees, often complicated by co-infection with TB and in many places multidrug-resistant TB, and too few states offer prevention or treatment services in spite of international guidelines that urge comprehensive measures, including provision of injection equipment, for people in state custody. Mathematical modelling undertaken by the Commission illustrates that incarceration and high HCV risk in the post-incarceration period can contribute importantly to national HCV incidence amongst PWID in a range of countries with varying levels of incarceration, different average prison sentences, durations of injection, and OST coverage levels in prison and following release. For example, in Thailand where PWID may spend nearly half their injection careers in prison, an estimated 63% of incident HCV infection could occur in prison. In Scotland, where prison sentences are shorter for PWUD and OST coverage is relatively high in prison, an estimated 54% of incident HCV infection occurs in prison, but as much as 21% may occur in the high-risk post-release period. These results underscore the importance of alternatives to prison for minor drug offences, ensuring access to OST in prison, and a seamless link from prison services to OST in the community. The evidence also clearly demonstrates that drug law enforcement has been applied in a discriminatory way against racial and ethnic minorities in a number of countries. The US is perhaps the best documented but not the only case of racial biases in policing, arrest, and sentencing. In 2014, African American men were more than five times more likely than whites to be incarcerated in their lifetime, though there is no significant difference in rates of drug use among these populations. The impact of this bias on communities of people of color is inter-generational and socially and economically devastating. The Commission also found significant gender biases in current drug policies. Of women in prison and pretrial detention around the world, a higher percentage are detained because of drug infractions than is the case for men. Women involved in drug markets are often on the bottom rungs - as couriers or drivers - and may not have information about major traffickers to trade as leverage with prosecutors. Gender and racial biases have marked overlap, making this an intersectional threat to women of color, their children, families, and communities. In both prison and the community, HIV, HCV and TB programmes for PWUD - including testing, prevention and treatment - are gravely underfunded at the cost of preventable death and disease. In a number of middle-income countries where large numbers of PWUD live, HIV and TB programmes for PWUD that were expanded with support from the Global Fund to Fight AIDS, TB and Malaria have lost funding due to changes in the Fund's eligibility criteria. There is an unfortunate failure to emulate the example of Western European countries that have eliminated unsafe injection-linked HIV as a public health problem by sustainably scaling up prevention and care and enabling minor offenders to avert prison. Political resistance to harm reduction measures dismisses strong evidence of their effectiveness and cost-effectiveness. Mathematical modeling shows that if OST, NSP and antiretroviral therapy for HIV are all available, even if the coverage of each of them is not over 50%, their synergy can lead to effective prevention in a foreseeable future. PWUD are often not seen to be worthy of costly treatments, or they are thought not to be able to adhere to treatment regimens in spite of evidence to the contrary. Lethal drug overdose is an important public health problem, particularly in light of rising consumption of heroin and prescription opioids in some parts of the world. Yet the Commission found that the pursuit of drug prohibition can contribute to overdose risks in numerous ways. It creates unregulated illegal markets in which it is impossible to control adulterants of street drugs that add to overdose risk. Several studies also link aggressive policing to rushed injection and overdose risk. People with a history of drug use, over-represented in prison because of prohibitionist policies, are at extremely high risk of overdose when released from state custody. Lack of ready access to OST also contributes to injection of opioids, and bans on supervised injection sites cut off an intervention that has proven very effective in reducing overdose deaths. Restrictive drug policies also contribute to unnecessary controls on naloxone, a medicine that can reverse overdose very effectively. Though a small percentage of PWUD will ever need treatment for drug dependence, that minority faces enormous barriers to humane and affordable treatment in many countries. There are often no national standards for quality of drug dependence treatment and no regular monitoring of practices. In too many countries, beatings, forced labor, and denial of health care and adequate sanitation are offered in the name of treatment, including in compulsory detention centres that are more like prisons than treatment facilities. Where there are humane treatment options, it is often the case that those most in need of it cannot afford it. In many countries, there is no treatment designed particularly for women, though it is known that women's motivations for and physiological reactions to drug use differ from those of men. The pursuit of the elimination of drugs has led to aggressive and harmful practices targeting people who grow crops used in the manufacture of drugs, especially coca leaf, opium poppy, and cannabis. Aerial spraying of coca fields in the Andes with the defoliant glyphosate (N-(phosphonomethyl glycine) has been associated with respiratory and dermatological disorders and with miscarriages. Forced displacement of poor rural families who have no secure land tenure exacerbates their poverty and food insecurity and in some cases forces them to move their cultivation to more marginal land. Geographic isolation makes it difficult for state authorities to reach drug crop cultivators in public health and education campaigns and it cuts cultivators off from basic health services. Alternative development programmes meant to offer other livelihood opportunities have poor records and have rarely been conceived, implemented, or evaluated with respect to their impact on people's health. Research on drugs and drug policy has suffered from the lack of a diversified funding base and assumptions about drug use and drug pathologies on the part of the dominant funder, the US government. At a time when drug policy discussions are opening up around the world, there is an urgent to bring the best of non-ideologically-driven health science, social science and policy analysis to the study of drugs and the potential for policy reform. POLICY ALTERNATIVES IN REAL LIFE: Concrete experiences from many countries that have modified or rejected prohibitionist approaches in their response to drugs can inform discussions of drug policy reform. A number of countries, such as Portugal and the Czech Republic, decriminalised minor drug offenses years ago, with significant savings of money, less incarceration, significant public health benefits, and no significant increase in drug use. Decriminalisation of minor offenses along with scaling up low-threshold HIV prevention services enabled Portugal to control an explosive unsafe injection-linked HIV epidemic and likely enabled the Czech Republic to prevent one from happening. Where formal decriminalisation may not be an immediate possibility, scaling up health services for PWUD can demonstrate the value to society of responding with support rather than punishment to people who commit minor drug infractions. A pioneering OST program in Tanzania is encouraging communities and officials to consider non-criminal responses to heroin injection. In Switzerland and the city of Vancouver, Canada, dramatic improvements in access to comprehensive harm reduction services, including supervised injection sites and heroin-assisted treatment, transformed the health picture for PWUD. Vancouver's experience also illustrates the importance of meaningful participation of PWUD in decision-making on policies and programmes affecting their communities. CONCLUSIONS AND RECOMMENDATIONS: Policies meant to prohibit or greatly suppress drugs present a paradox. They are portrayed and defended vigorously by many policy-makers as necessary to preserve public health and safety, and yet the evidence suggests they have contributed directly and indirectly to lethal violence, communicable disease transmission, discrimination, forced displacement, unnecessary physical pain, and the undermining of people's right to health. Some would argue that the threat of drugs to society may justify some level of abrogation of human rights for protection of collective security, as is also foreseen by human rights law in case of emergencies. International human rights standards dictate that in such cases, societies still must choose the least harmful way to address the emergency and that emergency measures must be proportionate and designed specifically to meet transparently defined and realistic goals. The pursuit of drug prohibition meets none of these criteria. Standard public health and scientific approaches that should be part of policy-making on drugs have been rejected in the pursuit of prohibition. The idea of reducing the harm of many kinds of human behavior is central to public policy in the areas of traffic safety, tobacco and alcohol regulation, food safety, safety in sports and recreation, and many other areas of human life where the behavior in question is not prohibited. But explicitly seeking to reduce drug-related harms through policy and programmes and to balance prohibition with harm reduction is regularly resisted in drug control. The persistence of unsafe injection-linked HIV and HCV transmission that could be stopped with proven, cost-effective measures remains one of the great failures of the global responses to these diseases. Drug policy that is dismissive of extensive evidence of its own negative impact and of approaches that could improve health outcomes is bad for all concerned. Countries have failed to recognise and correct the health and human rights harms that pursuit of prohibition and drug suppression have caused and in so doing neglect their legal responsibilities. They readily incarcerate people for minor offenses but then neglect their duty to provide health services in custodial settings. They recognize uncontrolled illegal markets as the consequence of their policies, but they do little to protect people from toxic, adulterated drugs that are inevitable in illegal markets or the violence of organized criminals, often made worse by policing. They waste public resources on policies that do not demonstrably impede the functioning of drug markets, and they miss opportunities to invest public resources wisely in proven health services for people often too frightened to seek services. To move toward the balanced policy that UN member states have called for, we offer the following recommendations: Decriminalisation: Decriminalise minor, non-violent drug offenses - use, possession, and petty sale - and strengthen health and social-sector alternatives to criminal sanctions. Reducing violence and discrimination in policing: Reduce the violence and other harms of drug policing, including phasing out the use of military forces in drug policing, better targeting of policing on the most violent armed criminals, allowing possession of syringes, not targeting harm reduction services to boost arrest totals, and eliminating racial and ethnic discrimination in policing. Reducing harms: Ensure easy access for all who need them to harm reduction services as a part of responding to drugs, recognizing the effectiveness and cost-effectiveness of scaling up and sustaining these services. OST, NSP, supervised injection sites, and access to naloxone - brought to a scale adequate to meet demand - should all figure in health services and should include meaningful participation of PWUD in planning and implementation. Harm reduction services are crucial in prison and pretrial detention and should be scaled up in these settings. The 2016 UNGASS should do better than the UN Commission on Narcotic Drugs (CND) in naming harm reduction explicitly and endorsing its centrality to drug policy. Treatment and care for PWUD: Prioritize PWUD in treatment for HIV, HCV, TB, and ensure that services are adequate to ensure access for all who need care. Ensure availability of humane and scientifically sound treatment for drug dependence, including scaled-up OST in the community as well as in prisons, rejecting compulsory detention and abuse in the name of treatment. Access to controlled medicines: Ensure access to controlled medicines, establishing inter-sectoral national authorities to determine levels of need and giving the World Health Organization (WHO) the resources to assist the International Narcotics Control Board (INCB) in using the best science to determine the level of need for controlled medicines in all countries. Gender-responsive policies: Reduce the negative impact of drug policy and law on women and their families, especially minimizing custodial sentences for women who commit non-violent offenses and developing appropriate health and social support, including gender-appropriate treatment of drug dependence, for those who need it. Crop production: Efforts to address drug crop production must take health into account. Aerial spraying of toxic herbicides should be stopped, and alternative development programmes should be part of integrated development strategies, developed and implemented in meaningful consultation with the people affected. Improve research: There is a need for a more diverse donor base to fund the best new science on drug policy experiences in a non-ideological way that, among other things, interrogates and moves beyond the excessive pathologising of drug use. UN governance of drug control: UN governance of drug policy must be improved, including by respecting WHO's authority to determine the dangerousness of drugs. Countries should be urged to include high-level health officials in their delegations to CND. Improved representation of health officials in national delegations to CND would, in turn, be a likely result of giving health authorities an important day-to-day role in multi-sectoral national drug policy-making bodies. Better metrics: Health, development, and human rights indicators should be included in metrics to judge success of drug policy; WHO and UNDP should help formulate them. UNDP has already suggested that indicators such as access to treatment, rate of overdose deaths, and access to social welfare programmes for people who use drugs would be useful indicators. All drug policies should also be monitored and evaluated as to their impact on racial and ethnic minorities, women, children and young people, and people living in poverty. Scientific approach to regulated markets: Move gradually toward regulated drug markets and apply the scientific method to their evaluation. While regulated legal drug markets are not politically possible in the short term in some places, the harms of criminal markets and other consequences of prohibition catalogued in this report are likely to lead more countries (and more US states) to move gradually in that direction, a direction we endorse. As those decisions are taken, we urge governments and researchers to apply the scientific method and ensure independent, multidisciplinary and rigorous evaluation of regulated markets to draw lessons and inform improvements in regulatory practices, and to continue evaluating and improving. We urge health professionals in all countries to inform themselves and join debates on drug policy at all levels. True to the stated goals of the international drug control regime, it is possible to have drug policy that contributes to the health and well-being of humankind, but not without bringing to bear the evidence of the health sciences and the voices of health professionals.",2016,10.1016/S0140-6736(16)00619-X,387,10026,1427-1480,eng,1474-547X 0140-6736,"*Internationality and *Social Control Policies and Congresses as Topic and Drug and Narcotic Control/*legislation & jurisprudence and Equipment Contamination and Health Services Accessibility and Hepatitis, Viral, Human/transmission and HIV Infections/transmission and Humans and Law Enforcement and Public Health and Risk-Taking and Substance Abuse Treatment Centers and Substance-Related Disorders/epidemiology/*prevention & control/rehabilitation and United Nations",NA,NA,2016/04/02/,Lancet,NA,NA,NA,NA
Price_2019_Natumedi,JOUR,Privacy in the age of medical big data,"Price, W. Nicholson 2nd and Cohen, I. Glenn",Nature medicine,"Big data has become the ubiquitous watch word of medical innovation. The rapid development of machine-learning techniques and artificial intelligence in particular has promised to revolutionize medical practice from the allocation of resources to the diagnosis of complex diseases. But with big data comes big risks and challenges, among them significant questions about patient privacy. Here, we outline the legal and ethical challenges big data brings to patient privacy. We discuss, among other topics, how best to conceive of health privacy; the importance of equity, consent, and patient governance in data collection; discrimination in data uses; and how to handle data breaches. We close by sketching possible ways forward for the regulatory system.",2019,10.1038/s41591-018-0272-7,25,1,37-43,eng,1546-170X 1078-8956,United States and Humans and Health Insurance Portability and Accountability Act and *Privacy and *Delivery of Health Care and *Big Data,NA,NA,2019/01//undefined,Nat Med,NA,NA,NA,NA
Topol_2019_Natumedi,JOUR,High-performance medicine: the convergence of human and artificial intelligence,"Topol, Eric J.",Nature medicine,"The use of artificial intelligence, and the deep-learning subtype in particular, has been enabled by the use of labeled big data, along with markedly enhanced computing power and cloud storage, across all sectors. In medicine, this is beginning to have an impact at three levels: for clinicians, predominantly via rapid, accurate image interpretation; for health systems, by improving workflow and the potential for reducing medical errors; and for patients, by enabling them to process their own data to promote health. The current limitations, including bias, privacy and security, and lack of transparency, along with the future directions of these applications will be discussed in this article. Over time, marked improvements in accuracy, productivity, and workflow will likely be actualized, but whether that will be used to improve the patient-doctor relationship or facilitate its erosion remains to be seen.",2019,10.1038/s41591-018-0300-7,25,1,44-56,eng,1546-170X 1078-8956,Physicians and Humans and Algorithms and Deep Learning and *Artificial Intelligence and Data Analysis and *Medicine,NA,NA,2019/01//undefined,Nat Med,NA,NA,NA,NA
Liang_2019_Natumedi,JOUR,Evaluation and accurate diagnoses of pediatric diseases using artificial intelligence,"Liang, Huiying and Tsui, Brian Y. and Ni, Hao and Valentim, Carolina C. S. and Baxter, Sally L. and Liu, Guangjian and Cai, Wenjia and Kermany, Daniel S. and Sun, Xin and Chen, Jiancong and He, Liya and Zhu, Jie and Tian, Pin and Shao, Hua and Zheng, Lianghong and Hou, Rui and Hewett, Sierra and Li, Gen and Liang, Ping and Zang, Xuan and Zhang, Zhiqi and Pan, Liyan and Cai, Huimin and Ling, Rujuan and Li, Shuhua and Cui, Yongwang and Tang, Shusheng and Ye, Hong and Huang, Xiaoyan and He, Waner and Liang, Wenqing and Zhang, Qing and Jiang, Jianmin and Yu, Wei and Gao, Jianqun and Ou, Wanxing and Deng, Yingmin and Hou, Qiaozhen and Wang, Bei and Yao, Cuichan and Liang, Yan and Zhang, Shu and Duan, Yaou and Zhang, Runze and Gibson, Sarah and Zhang, Charlotte L. and Li, Oulan and Zhang, Edward D. and Karin, Gabriel and Nguyen, Nathan and Wu, Xiaokang and Wen, Cindy and Xu, Jie and Xu, Wenqin and Wang, Bochu and Wang, Winston and Li, Jing and Pizzato, Bianca and Bao, Caroline and Xiang, Daoman and He, Wanting and He, Suiqin and Zhou, Yugui and Haw, Weldon and Goldbaum, Michael and Tremoulet, Adriana and Hsu, Chun-Nan and Carter, Hannah and Zhu, Long and Zhang, Kang and Xia, Huimin",Nature medicine,"Artificial intelligence (AI)-based methods have emerged as powerful tools to transform medical care. Although machine learning classifiers (MLCs) have already demonstrated strong performance in image-based diagnoses, analysis of diverse and massive electronic health record (EHR) data remains challenging. Here, we show that MLCs can query EHRs in a manner similar to the hypothetico-deductive reasoning used by physicians and unearth associations that previous statistical methods have not found. Our model applies an automated natural language processing system using deep learning techniques to extract clinically relevant information from EHRs. In total, 101.6 million data points from 1,362,559 pediatric patient visits presenting to a major referral center were analyzed to train and validate the framework. Our model demonstrates high diagnostic accuracy across multiple organ systems and is comparable to experienced pediatricians in diagnosing common childhood diseases. Our study provides a proof of concept for implementing an AI-based system as a means to aid physicians in tackling large amounts of data, augmenting diagnostic evaluations, and to provide clinical decision support in cases of diagnostic uncertainty or complexity. Although this impact may be most evident in areas where healthcare providers are in relative shortage, the benefits of such an AI system are likely to be universal.",2019,10.1038/s41591-018-0335-9,25,3,433-438,eng,1546-170X 1078-8956,"China and Humans and Female and Male and Adolescent and Child and Child, Preschool and Infant and Retrospective Studies and Machine Learning and Reproducibility of Results and Artificial Intelligence and Infant, Newborn and *Natural Language Processing and *Pediatrics and *Electronic Health Records and *Diagnosis, Computer-Assisted and *Deep Learning and Proof of Concept Study",NA,NA,2019/03//undefined,Nat Med,NA,NA,NA,NA
Shilo_2020_Natumedi,JOUR,Axes of a revolution: challenges and promises of big data in healthcare,"Shilo, Smadar and Rossman, Hagai and Segal, Eran",Nature medicine,"Health data are increasingly being generated at a massive scale, at various levels of phenotyping and from different types of resources. Concurrent with recent technological advances in both data-generation infrastructure and data-analysis methodologies, there have been many claims that these events will revolutionize healthcare, but such claims are still a matter of debate. Addressing the potential and challenges of big data in healthcare requires an understanding of the characteristics of the data. Here we characterize various properties of medical data, which we refer to as 'axes' of data, describe the considerations and tradeoffs taken when such data are generated, and the types of analyses that may achieve the tasks at hand. We then broadly describe the potential and challenges of using big data in healthcare resources, aiming to contribute to the ongoing discussion of the potential of big data resources to advance the understanding of health and disease.",2020,10.1038/s41591-019-0727-5,26,1,29-38,eng,1546-170X 1078-8956,Medicine and Humans and Cohort Studies and Disease Progression and Reference Standards and *Delivery of Health Care and *Big Data,NA,NA,2020/01//undefined,Nat Med,NA,NA,NA,NA
Owens_2020_Natumedi,JOUR,Those designing healthcare algorithms must become actively anti-racist,"Owens, Kellie and Walker, Alexis",Nature medicine,"Many widely used health algorithms have been shown to encode and reinforce racial health inequities, prioritizing the needs of white patients over those of patients of color. Because automated systems are becoming so crucial to access to health, researchers in the field of artificial intelligence must become actively anti-racist. Here we list some concrete steps to enable anti-racist practices in medical research and practice.",2020,10.1038/s41591-020-1020-3,26,9,1327-1328,eng,1546-170X 1078-8956,Humans and Algorithms and Delivery of Health Care/*ethics and Racism/*ethics,NA,NA,2020/09//undefined,Nat Med,NA,NA,NA,NA
Ting_2020_Natumedi,JOUR,Digital technology and COVID-19,"Ting, Daniel Shu Wei and Carin, Lawrence and Dzau, Victor and Wong, Tien Y.",Nature medicine,The past decade has allowed the development of a multitude of digital tools. Now they can be used to remediate the COVID-19 outbreak.,2020,10.1038/s41591-020-0824-5,26,4,459-461,eng,1546-170X 1078-8956,"SARS-CoV-2 and China and Public Health and Communication and COVID-19 and Humans and Telemedicine and Forecasting and Algorithms and User-Computer Interface and Artificial Intelligence and Mass Screening and Epidemiological Monitoring and *Social Media and *Models, Statistical and *Triage and *Big Data and *Betacoronavirus and COVID-19 Testing and Clinical Laboratory Techniques and *Internet of Things and *Blockchain and *Pandemics/prevention & control and *Coronavirus Infections/diagnosis/epidemiology/prevention & control and *Pneumonia, Viral/diagnosis/epidemiology/prevention & control",NA,NA,2020/04//undefined,Nat Med,NA,NA,NA,NA
Wiens_2019_Natumedi,JOUR,Do no harm: a roadmap for responsible machine learning for health care,"Wiens, Jenna and Saria, Suchi and Sendak, Mark and Ghassemi, Marzyeh and Liu, Vincent X. and Doshi-Velez, Finale and Jung, Kenneth and Heller, Katherine and Kale, David and Saeed, Mohammed and Ossorio, Pilar N. and Thadaney-Israni, Sonoo and Goldenberg, Anna",Nature medicine,"Interest in machine-learning applications within medicine has been growing, but few studies have progressed to deployment in patient care. We present a framework, context and ultimately guidelines for accelerating the translation of machine-learning-based interventions in health care. To be successful, translation will require a team of engaged stakeholders and a systematic process from beginning (problem formulation) to end (widespread deployment).",2019,10.1038/s41591-019-0548-6,25,9,1337-1340,eng,1546-170X 1078-8956,Humans and Clinical Decision-Making/ethics and Delivery of Health Care/ethics/*trends and Machine Learning/ethics/*trends,NA,NA,2019/09//undefined,Nat Med,NA,NA,NA,NA
Chen_2019_Natumedi,JOUR,An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis,"Chen, Po-Hsuan Cameron and Gadepalli, Krishna and MacDonald, Robert and Liu, Yun and Kadowaki, Shiro and Nagpal, Kunal and Kohlberger, Timo and Dean, Jeffrey and Corrado, Greg S. and Hipp, Jason D. and Mermel, Craig H. and Stumpe, Martin C.",Nature medicine,"The microscopic assessment of tissue samples is instrumental for the diagnosis and staging of cancer, and thus guides therapy. However, these assessments demonstrate considerable variability and many regions of the world lack access to trained pathologists. Though artificial intelligence (AI) promises to improve the access and quality of healthcare, the costs of image digitization in pathology and difficulties in deploying AI solutions remain as barriers to real-world use. Here we propose a cost-effective solution: the augmented reality microscope (ARM). The ARM overlays AI-based information onto the current view of the sample in real time, enabling seamless integration of AI into routine workflows. We demonstrate the utility of ARM in the detection of metastatic breast cancer and the identification of prostate cancer, with latency compatible with real-time use. We anticipate that the ARM will remove barriers towards the use of AI designed to improve the accuracy and efficiency of cancer diagnosis.",2019,10.1038/s41591-019-0539-7,25,9,1453-1457,eng,1546-170X 1078-8956,Humans and Female and Male and Neoplasm Staging and *Artificial Intelligence and Breast Neoplasms/*diagnosis/pathology and Microscopy/methods and Neoplasms/*diagnosis/pathology and Prostatic Neoplasms/*diagnosis/pathology,NA,NA,2019/09//undefined,Nat Med,NA,NA,NA,NA
Schussler.Fiorenza.Rose_2019_Natumedi,JOUR,A longitudinal big data approach for precision health,"Schussler-Fiorenza Rose, Sophia Miryam and Contrepois, Kevin and Moneghetti, Kegan J. and Zhou, Wenyu and Mishra, Tejaswini and Mataraso, Samson and Dagan-Rosenfeld, Orit and Ganz, Ariel B. and Dunn, Jessilyn and Hornburg, Daniel and Rego, Shannon and Perelman, Dalia and Ahadi, Sara and Sailani, M. Reza and Zhou, Yanjiao and Leopold, Shana R. and Chen, Jieming and Ashland, Melanie and Christle, Jeffrey W. and Avina, Monika and Limcaoco, Patricia and Ruiz, Camilo and Tan, Marilyn and Butte, Atul J. and Weinstock, George M. and Slavich, George M. and Sodergren, Erica and McLaughlin, Tracey L. and Haddad, Francois and Snyder, Michael P.",Nature medicine,"Precision health relies on the ability to assess disease risk at an individual level, detect early preclinical conditions and initiate preventive strategies. Recent technological advances in omics and wearable monitoring enable deep molecular and physiological profiling and may provide important tools for precision health. We explored the ability of deep longitudinal profiling to make health-related discoveries, identify clinically relevant molecular pathways and affect behavior in a prospective longitudinal cohort (n = 109) enriched for risk of type 2 diabetes mellitus. The cohort underwent integrative personalized omics profiling from samples collected quarterly for up to 8 years (median, 2.8 years) using clinical measures and emerging technologies including genome, immunome, transcriptome, proteome, metabolome, microbiome and wearable monitoring. We discovered more than 67 clinically actionable health discoveries and identified multiple molecular pathways associated with metabolic, cardiovascular and oncologic pathophysiology. We developed prediction models for insulin resistance by using omics measurements, illustrating their potential to replace burdensome tests. Finally, study participation led the majority of participants to implement diet and exercise changes. Altogether, we conclude that deep longitudinal profiling can lead to actionable health discoveries and provide relevant information for precision health.",2019,10.1038/s41591-019-0414-6,25,5,792-804,eng,1546-170X 1078-8956,"Humans and Female and Male and Adult and Middle Aged and Aged and Longitudinal Studies and Cohort Studies and Risk Factors and Insulin Resistance and Models, Biological and *Big Data and Transcriptome and Gastrointestinal Microbiome and Cardiovascular Diseases/etiology and Diabetes Mellitus, Type 2/*etiology and Exome and Metabolome and Precision Medicine/*statistics & numerical data",NA,NA,2019/05//undefined,Nat Med,NA,NA,NA,NA
Courtiol_2019_Natumedi,JOUR,Deep learning-based classification of mesothelioma improves prediction of patient outcome,"Courtiol, Pierre and Maussion, Charles and Moarii, Matahi and Pronier, Elodie and Pilcer, Samuel and Sefta, Meriem and Manceron, Pierre and Toldo, Sylvain and Zaslavskiy, Mikhail and Le Stang, Nolwenn and Girard, Nicolas and Elemento, Olivier and Nicholson, Andrew G. and Blay, Jean-Yves and Galateau-Salle, Francoise and Wainrib, Gilles and Clozel, Thomas",Nature medicine,"Malignant mesothelioma (MM) is an aggressive cancer primarily diagnosed on the basis of histological criteria(1). The 2015 World Health Organization classification subdivides mesothelioma tumors into three histological types: epithelioid, biphasic and sarcomatoid MM. MM is a highly complex and heterogeneous disease, rendering its diagnosis and histological typing difficult and leading to suboptimal patient care and decisions regarding treatment modalities(2). Here we have developed a new approach-based on deep convolutional neural networks-called MesoNet to accurately predict the overall survival of mesothelioma patients from whole-slide digitized images, without any pathologist-provided locally annotated regions. We validated MesoNet on both an internal validation cohort from the French MESOBANK and an independent cohort from The Cancer Genome Atlas (TCGA). We also demonstrated that the model was more accurate in predicting patient survival than using current pathology practices. Furthermore, unlike classical black-box deep learning methods, MesoNet identified regions contributing to patient outcome prediction. Strikingly, we found that these regions are mainly located in the stroma and are histological features associated with inflammation, cellular diversity and vacuolization. These findings suggest that deep learning models can identify new features predictive of patient survival and potentially lead to new biomarker discoveries.",2019,10.1038/s41591-019-0583-3,25,10,1519-1525,eng,1546-170X 1078-8956,"Humans and Female and Male and Deep Learning and Neural Networks, Computer and *Prognosis and Neoplasm Grading and Lung Neoplasms/classification/*diagnosis/*pathology and Mesothelioma, Malignant and Mesothelioma/classification/*diagnosis/*pathology",NA,NA,2019/10//undefined,Nat Med,NA,NA,NA,NA
Wiens_2019_Natumedi_1,JOUR,Author Correction: Do no harm: a roadmap for responsible machine learning for health care,"Wiens, Jenna and Saria, Suchi and Sendak, Mark and Ghassemi, Marzyeh and Liu, Vincent X. and Doshi-Velez, Finale and Jung, Kenneth and Heller, Katherine and Kale, David and Saeed, Mohammed and Ossorio, Pilar N. and Thadaney-Israni, Sonoo and Goldenberg, Anna",Nature medicine,An amendment to this paper has been published and can be accessed via a link at the top of the paper.,2019,10.1038/s41591-019-0609-x,25,10,1627,eng,1546-170X 1078-8956,NA,NA,NA,2019/10//undefined,Nat Med,NA,NA,NA,NA
Liu_2020_Natumedi,JOUR,Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension,"Liu, Xiaoxuan and Cruz Rivera, Samantha and Moher, David and Calvert, Melanie J. and Denniston, Alastair K.",Nature medicine,"The CONSORT 2010 statement provides minimum guidelines for reporting randomized trials. Its widespread use has been instrumental in ensuring transparency in the evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate impact on health outcomes. The CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trials evaluating interventions with an AI component. It was developed in parallel with its companion statement for clinical trial protocols: SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 29 candidate items, which were assessed by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a two-day consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The CONSORT-AI extension includes 14 new items that were considered sufficiently important for AI interventions that they should be routinely reported in addition to the core CONSORT 2010 items. CONSORT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention is integrated, the handling of inputs and outputs of the AI intervention, the human-AI interaction and provision of an analysis of error cases. CONSORT-AI will help promote transparency and completeness in reporting clinical trials for AI interventions. It will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the quality of clinical trial design and risk of bias in the reported outcomes.",2020,10.1038/s41591-020-1034-x,26,9,1364-1374,eng,1546-170X 1078-8956,"Humans and *Artificial Intelligence and Randomized Controlled Trials as Topic/*methods and Research Design/*standards and Peer Review, Research/*standards and Research Report/standards",NA,NA,2020/09//undefined,Nat Med,NA,NA,NA,NA
Budd_2020_Natumedi,JOUR,Digital technologies in the public-health response to COVID-19,"Budd, Jobie and Miller, Benjamin S. and Manning, Erin M. and Lampos, Vasileios and Zhuang, Mengdie and Edelstein, Michael and Rees, Geraint and Emery, Vincent C. and Stevens, Molly M. and Keegan, Neil and Short, Michael J. and Pillay, Deenan and Manley, Ed and Cox, Ingemar J. and Heymann, David and Johnson, Anne M. and McKendry, Rachel A.",Nature medicine,"Digital technologies are being harnessed to support the public-health response to COVID-19 worldwide, including population surveillance, case identification, contact tracing and evaluation of interventions on the basis of mobility data and communication with the public. These rapid responses leverage billions of mobile phones, large online datasets, connected devices, relatively low-cost computing resources and advances in machine learning and natural language processing. This Review aims to capture the breadth of digital innovations for the public-health response to COVID-19 worldwide and their limitations, and barriers to their implementation, including legal, ethical and privacy barriers, as well as organizational and workforce barriers. The future of public health is likely to become increasingly digital, and we review the need for the alignment of international strategies for the regulation, evaluation and use of digital technologies to strengthen pandemic management, and future preparedness for COVID-19 and other infectious diseases.",2020,10.1038/s41591-020-1011-4,26,8,1183-1192,eng,1546-170X 1078-8956,"SARS-CoV-2 and COVID-19 and Humans and Machine Learning and Privacy and Natural Language Processing and Public Health/*statistics & numerical data and *Population Surveillance and Betacoronavirus/pathogenicity and Coronavirus Infections/epidemiology/*prevention & control/virology and Pandemics/prevention & control/*statistics & numerical data and Pneumonia, Viral/epidemiology/*prevention & control/virology",NA,NA,2020/08//undefined,Nat Med,NA,NA,NA,NA
Cruz.Rivera_2020_Natumedi,JOUR,Guidelines for clinical trial protocols for interventions involving artificial intelligence: the SPIRIT-AI extension,"Cruz Rivera, Samantha and Liu, Xiaoxuan and Chan, An-Wen and Denniston, Alastair K. and Calvert, Melanie J.",Nature medicine,"The SPIRIT 2013 statement aims to improve the completeness of clinical trial protocol reporting by providing evidence-based recommendations for the minimum set of items to be addressed. This guidance has been instrumental in promoting transparent evaluation of new interventions. More recently, there has been a growing recognition that interventions involving artificial intelligence (AI) need to undergo rigorous, prospective evaluation to demonstrate their impact on health outcomes. The SPIRIT-AI (Standard Protocol Items: Recommendations for Interventional Trials-Artificial Intelligence) extension is a new reporting guideline for clinical trial protocols evaluating interventions with an AI component. It was developed in parallel with its companion statement for trial reports: CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence). Both guidelines were developed through a staged consensus process involving literature review and expert consultation to generate 26 candidate items, which were consulted upon by an international multi-stakeholder group in a two-stage Delphi survey (103 stakeholders), agreed upon in a consensus meeting (31 stakeholders) and refined through a checklist pilot (34 participants). The SPIRIT-AI extension includes 15 new items that were considered sufficiently important for clinical trial protocols of AI interventions. These new items should be routinely reported in addition to the core SPIRIT 2013 items. SPIRIT-AI recommends that investigators provide clear descriptions of the AI intervention, including instructions and skills required for use, the setting in which the AI intervention will be integrated, considerations for the handling of input and output data, the human-AI interaction and analysis of error cases. SPIRIT-AI will help promote transparency and completeness for clinical trial protocols for AI interventions. Its use will assist editors and peer reviewers, as well as the general readership, to understand, interpret and critically appraise the design and risk of bias for a planned clinical trial.",2020,10.1038/s41591-020-1037-7,26,9,1351-1363,eng,1546-170X 1078-8956,Humans and *Artificial Intelligence and Clinical Trials as Topic/*methods and Research Design/*standards,NA,NA,2020/09//undefined,Nat Med,NA,NA,NA,NA
Obermeyer_2019_Natumedi,JOUR,Putting decisions under the microscope,"Obermeyer, Ziad",Nature medicine,"Ziad Obermeyer is an acting associate professor at the University of California, Berkeley, and an emergency physician. His teaching and research focus on how algorithms can aid in human decision-making in health care. Previously, he taught at Harvard Medical School, where he received the Early Independence Award, the most prestigious award for early-career scientists given by the US National Institutes of Health.",2019,10.1038/s41591-019-0591-3,25,11,1656,eng,1546-170X 1078-8956,Humans and Awards and Prizes and Microscopy/*trends,NA,NA,2019/11//undefined,Nat Med,NA,NA,NA,NA
Raghunath_2020_Natumedi,JOUR,Prediction of mortality from 12-lead electrocardiogram voltage data using a deep neural network,"Raghunath, Sushravya and Ulloa Cerna, Alvaro E. and Jing, Linyuan and vanMaanen, David P. and Stough, Joshua and Hartzel, Dustin N. and Leader, Joseph B. and Kirchner, H. Lester and Stumpe, Martin C. and Hafez, Ashraf and Nemani, Arun and Carbonati, Tanner and Johnson, Kipp W. and Young, Katelyn and Good, Christopher W. and Pfeifer, John M. and Patel, Aalpen A. and Delisle, Brian P. and Alsaid, Amro and Beer, Dominik and Haggerty, Christopher M. and Fornwalt, Brandon K.",Nature medicine,"The electrocardiogram (ECG) is a widely used medical test, consisting of voltage versus time traces collected from surface recordings over the heart(1). Here we hypothesized that a deep neural network (DNN) can predict an important future clinical event, 1-year all-cause mortality, from ECG voltage-time traces. By using ECGs collected over a 34-year period in a large regional health system, we trained a DNN with 1,169,662 12-lead resting ECGs obtained from 253,397 patients, in which 99,371 events occurred. The model achieved an area under the curve (AUC) of 0.88 on a held-out test set of 168,914 patients, in which 14,207 events occurred. Even within the large subset of patients (n = 45,285) with ECGs interpreted as 'normal' by a physician, the performance of the model in predicting 1-year mortality remained high (AUC = 0.85). A blinded survey of cardiologists demonstrated that many of the discriminating features of these normal ECGs were not apparent to expert reviewers. Finally, a Cox proportional-hazard model revealed a hazard ratio of 9.5 (P < 0.005) for the two predicted groups (dead versus alive 1 year after ECG) over a 25-year follow-up period. These results show that deep learning can add substantial prognostic information to the interpretation of 12-lead resting ECGs, even in cases that are interpreted as normal by physicians.",2020,10.1038/s41591-020-0870-z,26,6,886-891,eng,1546-170X 1078-8956,"Humans and Female and Male and Adult and Middle Aged and Retrospective Studies and Aged and Algorithms and Prognosis and Aged, 80 and over and Area Under Curve and ROC Curve and Proportional Hazards Models and Cause of Death and *Electrocardiography and Neural Networks, Computer and *Risk Assessment and *Deep Learning and *Mortality and Cardiologists",NA,NA,2020/06//undefined,Nat Med,NA,NA,NA,NA
Bai_2020_Natumedi,JOUR,A population-based phenome-wide association study of cardiac and aortic structure and function,"Bai, Wenjia and Suzuki, Hideaki and Huang, Jian and Francis, Catherine and Wang, Shuo and Tarroni, Giacomo and Guitton, Florian and Aung, Nay and Fung, Kenneth and Petersen, Steffen E. and Piechnik, Stefan K. and Neubauer, Stefan and Evangelou, Evangelos and Dehghan, Abbas and O'Regan, Declan P. and Wilkins, Martin R. and Guo, Yike and Matthews, Paul M. and Rueckert, Daniel",Nature medicine,"Differences in cardiac and aortic structure and function are associated with cardiovascular diseases and a wide range of other types of disease. Here we analyzed cardiovascular magnetic resonance images from a population-based study, the UK Biobank, using an automated machine-learning-based analysis pipeline. We report a comprehensive range of structural and functional phenotypes for the heart and aorta across 26,893 participants, and explore how these phenotypes vary according to sex, age and major cardiovascular risk factors. We extended this analysis with a phenome-wide association study, in which we tested for correlations of a wide range of non-imaging phenotypes of the participants with imaging phenotypes. We further explored the associations of imaging phenotypes with early-life factors, mental health and cognitive function using both observational analysis and Mendelian randomization. Our study illustrates how population-based cardiac and aortic imaging phenotypes can be used to better define cardiovascular disease risks as well as heart-brain health interactions, highlighting new opportunities for studying disease mechanisms and developing image-based biomarkers.",2020,10.1038/s41591-020-1009-y,26,10,1654-1662,eng,1546-170X 1078-8956,"Humans and Female and Male and Sex Factors and Machine Learning and Age Factors and Phenotype and Polymorphism, Single Nucleotide and Structure-Activity Relationship and Genetic Predisposition to Disease and Genome-Wide Association Study and United Kingdom/epidemiology and Image Processing, Computer-Assisted/methods and Biological Specimen Banks/statistics & numerical data and *Phenomics/methods and Anatomy, Cross-Sectional and Aorta/*anatomy & histology/diagnostic imaging/pathology/*physiology and Cardiovascular Diseases/diagnostic imaging/genetics/pathology/physiopathology and Heart Function Tests and Heart/*anatomy & histology/diagnostic imaging/*physiology and Magnetic Resonance Imaging/statistics & numerical data and Myocardium/pathology",NA,NA,2020/10//undefined,Nat Med,NA,NA,NA,NA
X2013_Natumedi,JOUR,A victory for genes,NA,Nature medicine,"The ability to patent human genes has been costly to researchers and patients, and has restricted competition in the biotech marketplace. The recent US Supreme Court decision making isolated human genes unpatentable will bring freedom of choice to the patient, and level the playing field for research and development.",2013,10.1038/nm.3279,19,7,792,eng,1546-170X 1078-8956,"United States and Humans and Female and *Genes and Genes, BRCA2 and Ethics, Research and *Patient Rights and Legislation, Medical and *Supreme Court Decisions and Biomedical Research/ethics/*legislation & jurisprudence and Breast Neoplasms/diagnosis/genetics and Carcinoma/diagnosis/genetics and DNA Mutational Analysis/ethics/methods and Early Detection of Cancer/ethics/methods and Genes, BRCA1 and Ovarian Neoplasms/diagnosis/genetics and Patents as Topic/ethics/*legislation & jurisprudence",NA,NA,2013/07//undefined,Nat Med,NA,NA,NA,NA
Williams_2019_Natumedi,JOUR,Plasma protein patterns as comprehensive indicators of health,"Williams, Stephen A. and Kivimaki, Mika and Langenberg, Claudia and Hingorani, Aroon D. and Casas, J. P. and Bouchard, Claude and Jonasson, Christian and Sarzynski, Mark A. and Shipley, Martin J. and Alexander, Leigh and Ash, Jessica and Bauer, Tim and Chadwick, Jessica and Datta, Gargi and DeLisle, Robert Kirk and Hagar, Yolanda and Hinterberg, Michael and Ostroff, Rachel and Weiss, Sophie and Ganz, Peter and Wareham, Nicholas J.",Nature medicine,"Proteins are effector molecules that mediate the functions of genes(1,2) and modulate comorbidities(3-10), behaviors and drug treatments(11). They represent an enormous potential resource for personalized, systemic and data-driven diagnosis, prevention, monitoring and treatment. However, the concept of using plasma proteins for individualized health assessment across many health conditions simultaneously has not been tested. Here, we show that plasma protein expression patterns strongly encode for multiple different health states, future disease risks and lifestyle behaviors. We developed and validated protein-phenotype models for 11 different health indicators: liver fat, kidney filtration, percentage body fat, visceral fat mass, lean body mass, cardiopulmonary fitness, physical activity, alcohol consumption, cigarette smoking, diabetes risk and primary cardiovascular event risk. The analyses were prospectively planned, documented and executed at scale on archived samples and clinical data, with a total of ~85 million protein measurements in 16,894 participants. Our proof-of-concept study demonstrates that protein expression patterns reliably encode for many different health issues, and that large-scale protein scanning(12-16) coupled with machine learning is viable for the development and future simultaneous delivery of multiple measures of health. We anticipate that, with further validation and the addition of more protein-phenotype models, this approach could enable a single-source, individualized so-called liquid health check.",2019,10.1038/s41591-019-0665-2,25,12,1851-1857,eng,1546-170X 1078-8956,Humans and Female and Male and Risk Factors and Life Style and *Exercise and *Precision Medicine and Adipose Tissue/metabolism and Blood Proteins/*genetics and Body Composition/*genetics/physiology and Intra-Abdominal Fat/metabolism and Liver/metabolism,NA,NA,2019/12//undefined,Nat Med,NA,NA,NA,NA
Bhattacharyya_2019_Natumedi,JOUR,Simultaneous detection of genotype and phenotype enables rapid and accurate antibiotic susceptibility determination,"Bhattacharyya, Roby P. and Bandyopadhyay, Nirmalya and Ma, Peijun and Son, Sophie S. and Liu, Jamin and He, Lorrie L. and Wu, Lidan and Khafizov, Rustem and Boykin, Rich and Cerqueira, Gustavo C. and Pironti, Alejandro and Rudy, Robert F. and Patel, Milesh M. and Yang, Rui and Skerry, Jennifer and Nazarian, Elizabeth and Musser, Kimberly A. and Taylor, Jill and Pierce, Virginia M. and Earl, Ashlee M. and Cosimi, Lisa A. and Shoresh, Noam and Beechem, Joseph and Livny, Jonathan and Hung, Deborah T.",Nature medicine,"Multidrug resistant organisms are a serious threat to human health(1,2). Fast, accurate antibiotic susceptibility testing (AST) is a critical need in addressing escalating antibiotic resistance, since delays in identifying multidrug resistant organisms increase mortality(3,4) and use of broad-spectrum antibiotics, further selecting for resistant organisms. Yet current growth-based AST assays, such as broth microdilution(5), require several days before informing key clinical decisions. Rapid AST would transform the care of patients with infection while ensuring that our antibiotic arsenal is deployed as efficiently as possible. Growth-based assays are fundamentally constrained in speed by doubling time of the pathogen, and genotypic assays are limited by the ever-growing diversity and complexity of bacterial antibiotic resistance mechanisms. Here we describe a rapid assay for combined genotypic and phenotypic AST through RNA detection, GoPhAST-R, that classifies strains with 94-99% accuracy by coupling machine learning analysis of early antibiotic-induced transcriptional changes with simultaneous detection of key genetic resistance determinants to increase accuracy of resistance detection, facilitate molecular epidemiology and enable early detection of emerging resistance mechanisms. This two-pronged approach provides phenotypic AST 24-36 h faster than standard workflows, with <4 h assay time on a pilot instrument for hybridization-based multiplexed RNA detection implemented directly from positive blood cultures.",2019,10.1038/s41591-019-0650-9,25,12,1858-1864,eng,1546-170X 1078-8956,"Humans and Machine Learning and Phenotype and Genotype and *Microbial Sensitivity Tests and Anti-Bacterial Agents/adverse effects/*pharmacology and Drug Resistance, Bacterial/*genetics and RNA, Bacterial/drug effects/*isolation & purification",NA,NA,2019/12//undefined,Nat Med,NA,NA,NA,NA
Artzi_2020_Natumedi,JOUR,Prediction of gestational diabetes based on nationwide electronic health records,"Artzi, Nitzan Shalom and Shilo, Smadar and Hadar, Eran and Rossman, Hagai and Barbash-Hazan, Shiri and Ben-Haroush, Avi and Balicer, Ran D. and Feldman, Becca and Wiznitzer, Arnon and Segal, Eran",Nature medicine,"Gestational diabetes mellitus (GDM) poses increased risk of short- and long-term complications for mother and offspring(1-4). GDM is typically diagnosed at 24-28 weeks of gestation, but earlier detection is desirable as this may prevent or considerably reduce the risk of adverse pregnancy outcomes(5,6). Here we used a machine-learning approach to predict GDM on retrospective data of 588,622 pregnancies in Israel for which comprehensive electronic health records were available. Our models predict GDM with high accuracy even at pregnancy initiation (area under the receiver operating curve (auROC) = 0.85), substantially outperforming a baseline risk score (auROC = 0.68). We validated our results on both a future validation set and a geographical validation set from the most populated city in Israel, Jerusalem, thereby emulating real-world performance. Interrogating our model, we uncovered previously unreported risk factors, including results of previous pregnancy glucose challenge tests. Finally, we devised a simpler model based on just nine questions that a patient could answer, with only a modest reduction in accuracy (auROC = 0.80). Overall, our models may allow early-stage intervention in high-risk women, as well as a cost-effective screening approach that could avoid the need for glucose tolerance tests by identifying low-risk women. Future prospective studies and studies on additional populations are needed to assess the real-world clinical utility of the model.",2020,10.1038/s41591-019-0724-8,26,1,71-76,eng,1546-170X 1078-8956,"Humans and Female and Surveys and Questionnaires and Cohort Studies and Prognosis and Pregnancy and Reproducibility of Results and Area Under Curve and ROC Curve and Mass Screening and *Electronic Health Records and Israel and Diabetes, Gestational/*diagnosis",NA,NA,2020/01//undefined,Nat Med,NA,NA,NA,NA
Raiten_2012_ThNeEnjoofme,JOUR,"""If I had only known""--on choice and uncertainty in the ICU","Raiten, Jesse M. and Neuman, Mark D.",The New England journal of medicine,"After receiving a ventricular assist device, a patient experiences months of advances and setbacks in the ICU. She's one of a new subcategory of ICU patients: the chronically critically ill. Their stories reveal shortcomings of common perspectives on medical decision making.",2012,10.1056/NEJMp1209698,367,19,1779-1781,eng,1533-4406 0028-4793,Humans and Female and Decision Making and Family and Intensive Care Units and General Surgery and Chronic Disease/*therapy and Patients/psychology and *Choice Behavior and *Uncertainty and *Critical Care/psychology and Heart Failure/therapy and Heart-Assist Devices,NA,NA,2012/11/08/,N Engl J Med,NA,NA,NA,NA
Sessums_2011_JAMA,JOUR,Does this patient have medical decision-making capacity?,"Sessums, Laura L. and Zembrzuska, Hanna and Jackson, Jeffrey L.",JAMA,"CONTEXT: Evaluation of the capacity of a patient to make medical decisions should occur in the context of specific medical decisions when incapacity is considered. OBJECTIVE: To determine the prevalence of incapacity and assessment accuracy in adult medicine patients without severe mental illnesses. DATA SOURCES: MEDLINE and EMBASE (from their inception through April 2011) and bibliographies of retrieved articles. STUDY SELECTION: We included high-quality prospective studies (n = 43) of instruments that evaluated medical decision-making capacity for treatment decisions. DATA EXTRACTION: Two authors independently appraised study quality, extracted relevant data, and resolved disagreements by consensus. DATA SYNTHESIS: Incapacity was uncommon in healthy elderly control participants (2.8%; 95% confidence interval [CI], 1.7%-3.9%) compared with medicine inpatients (26%; 95% CI, 18%-35%). Clinicians accurately diagnosed incapacity (positive likelihood ratio [LR+] of 7.9; 95% CI, 2.7-13), although they recognized it in only 42% (95% CI, 30%-53%) of affected patients. Although not designed to assess incapacity, Mini-Mental State Examination (MMSE) scores less than 20 increased the likelihood of incapacity (LR, 6.3; 95% CI, 3.7-11), scores of 20 to 24 had no effect (LR, 0.87; 95% CI, 0.53-1.2), and scores greater than 24 significantly lowered the likelihood of incapacity (LR, 0.14; 95% CI, 0.06-0.34). Of 9 instruments compared with a gold standard, only 3 are easily performed and have useful test characteristics: the Aid to Capacity Evaluation (ACE) (LR+, 8.5; 95% CI, 3.9-19; negative LR [LR-], 0.21; 95% CI, 0.11-0.41), the Hopkins Competency Assessment Test (LR+, 54; 95% CI, 3.5-846; LR-, 0; 95% CI, 0.0-0.52), and the Understanding Treatment Disclosure (LR+, 6.0; 95% CI, 2.1-17; LR-, 0.16; 95% CI, 0.06-0.41). The ACE was validated in the largest study; it is freely available online and includes a training module. CONCLUSIONS: Incapacity is common and often not recognized. The MMSE is useful only at extreme scores. The ACE is the best available instrument to assist physicians in making assessments of medical decision-making capacity.",2011,10.1001/jama.2011.1023,306,4,420-427,eng,1538-3598 0098-7484,United States and Humans and Female and Aged and Physician's Role and Sensitivity and Specificity and Prevalence and Patient Care and Informed Consent and *Decision Making and *Cognition Disorders and *Mental Competency and *Mental Status Schedule,NA,NA,2011/07/27/,JAMA,NA,NA,NA,NA
Haider_2011_JAMA,JOUR,Association of unconscious race and social class bias with vignette-based clinical assessments by medical students,"Haider, Adil H. and Sexton, Janel and Sriram, N. and Cooper, Lisa A. and Efron, David T. and Swoboda, Sandra and Villegas, Cassandra V. and Haut, Elliott R. and Bonds, Morgan and Pronovost, Peter J. and Lipsett, Pamela A. and Freischlag, Julie A. and Cornwell, Edward E. 3rd",JAMA,"CONTEXT: Studies involving physicians suggest that unconscious bias may be related to clinical decision making and may predict poor patient-physician interaction. The presence of unconscious race and social class bias and its association with clinical assessments or decision making among medical students is unknown. OBJECTIVE: To estimate unconscious race and social class bias among first-year medical students and investigate its relationship with assessments made during clinical vignettes. DESIGN, SETTING, AND PARTICIPANTS: A secure Web-based survey was administered to 211 medical students entering classes at Johns Hopkins School of Medicine, Baltimore, Maryland, in August 2009 and August 2010. The survey included the Implicit Association Test (IAT) to assess unconscious preferences, direct questions regarding students' explicit race and social class preferences, and 8 clinical assessment vignettes focused on pain assessment, informed consent, patient reliability, and patient trust. Adjusting for student demographics, multiple logistic regression was used to determine whether responses to the vignettes were associated with unconscious race or social class preferences. MAIN OUTCOME MEASURES: Association of scores on an established IAT for race and a novel IAT for social class with vignette responses. RESULTS: Among the 202 students who completed the survey, IAT responses were consistent with an implicit preference toward white persons among 140 students (69%, 95% CI, 61%-75%). Responses were consistent with a preference toward those in the upper class among 174 students (86%, 95% CI, 80%-90%). Assessments generally did not vary by patient race or occupation, and multivariable analyses for all vignettes found no significant relationship between implicit biases and clinical assessments. Regression coefficient for the association between pain assessment and race IAT scores was -0.49 (95% CI, -1.00 to 0.03) and for social class, the coefficient was -0.04 (95% CI, -0.50 to 0.41). Adjusted odds ratios for other vignettes ranged from 0.69 to 3.03 per unit change in IAT score, but none were statistically significant. Analysis stratified by vignette patient race or class status yielded similarly negative results. Tests for interactions between patient race or class status and student IAT D scores in predicting clinical assessments were not statistically significant. CONCLUSIONS: The majority of first-year medical students at a single school had IAT scores consistent with implicit preference for white persons and possibly for those in the upper class. However, overall vignette-based clinical assessments were not associated with patient race or occupation, and no association existed between implicit preferences and the assessments.",2011,10.1001/jama.2011.1248,306,9,942-951,eng,1538-3598 0098-7484,"Humans and Data Collection and Female and Male and Adult and Young Adult and Cross-Sectional Studies and Internet and Decision Making and Physician-Patient Relations and Baltimore and Physicians/psychology and *Unconscious, Psychology and Students, Medical/*psychology and Schools, Medical and *Social Class and *Prejudice and *Whites and *Blacks",NA,NA,2011/09/07/,JAMA,NA,NA,NA,NA
Hauer_2008_JAMA,JOUR,Factors associated with medical students' career choices regarding internal medicine,"Hauer, Karen E. and Durning, Steven J. and Kernan, Walter N. and Fagan, Mark J. and Mintz, Matthew and O'Sullivan, Patricia S. and Battistone, Michael and DeFer, Thomas and Elnicki, Michael and Harrell, Heather and Reddy, Shalini and Boscardin, Christy K. and Schwartz, Mark D.",JAMA,"CONTEXT: Shortfalls in the US physician workforce are anticipated as the population ages and medical students' interest in careers in internal medicine (IM) has declined (particularly general IM, the primary specialty serving older adults). The factors influencing current students' career choices regarding IM are unclear. OBJECTIVES: To describe medical students' career decision making regarding IM and to identify modifiable factors related to this decision making. DESIGN, SETTING, AND PARTICIPANTS: Web-based cross-sectional survey of 1177 fourth-year medical students (82% response rate) at 11 US medical schools in spring 2007. MAIN OUTCOME MEASURES: Demographics, debt, educational experiences, and number who chose or considered IM careers were measured. Factor analysis was performed to assess influences on career chosen. Logistic regression analysis was conducted to assess independent association of variables with IM career choice. RESULTS: Of 1177 respondents, 274 (23.2%) planned careers in IM, including 24 (2.0%) in general IM. Only 228 (19.4%) responded that their core IM clerkship made a career in general IM seem more attractive, whereas 574 (48.8%) responded that it made a career in subspecialty IM more attractive. Three factors influenced career choice regarding IM: educational experiences in IM, the nature of patient care in IM, and lifestyle. Students were more likely to pursue careers in IM if they were male (odds ratio [OR] 1.75; 95% confidence interval [CI], 1.20-2.56), were attending a private school (OR, 1.88; 95% CI, 1.26-2.83), were favorably impressed with their educational experience in IM (OR, 4.57; 95% CI, 3.01-6.93), reported favorable feelings about caring for IM patients (OR, 8.72; 95% CI, 6.03-12.62), or reported a favorable impression of internists' lifestyle (OR, 2.00; 95% CI, 1.39-2.87). CONCLUSIONS: Medical students valued the teaching during IM clerkships but expressed serious reservations about IM as a career. Students who reported more favorable impressions of the patients cared for by internists, the IM practice environment, and internists' lifestyle were more likely to pursue a career in IM.",2008,10.1001/jama.300.10.1154,300,10,1154-1164,eng,1538-3598 0098-7484,"United States and Humans and Female and Male and Adult and Cross-Sectional Studies and Logistic Models and Surveys and Questionnaires and Life Style and Factor Analysis, Statistical and Internship and Residency and *Education, Medical and *Career Choice and *Specialization and Health Workforce and Internal Medicine/education and Students, Medical/*psychology/*statistics & numerical data",NA,NA,2008/09/10/,JAMA,NA,NA,NA,NA
Tamblyn_2007_JAMA,JOUR,Physician scores on a national clinical skills examination as predictors of complaints to medical regulatory authorities,"Tamblyn, Robyn and Abrahamowicz, Michal and Dauphinee, Dale and Wenghofer, Elizabeth and Jacques, Andre and Klass, Daniel and Smee, Sydney and Blackmore, David and Winslade, Nancy and Girard, Nadyne and Du Berger, Roxane and Bartman, Ilona and Buckeridge, David L. and Hanley, James A.",JAMA,"CONTEXT: Poor patient-physician communication increases the risk of patient complaints and malpractice claims. To address this problem, licensure assessment has been reformed in Canada and the United States, including a national standardized assessment of patient-physician communication and clinical history taking and examination skills. OBJECTIVE: To assess whether patient-physician communication examination scores in the clinical skills examination predicted future complaints in medical practice. DESIGN, SETTING, AND PARTICIPANTS: Cohort study of all 3424 physicians taking the Medical Council of Canada clinical skills examination between 1993 and 1996 who were licensed to practice in Ontario and/or Quebec. Participants were followed up until 2005, including the first 2 to 12 years of practice. MAIN OUTCOME MEASURE: Patient complaints against study physicians that were filed with medical regulatory authorities in Ontario or Quebec and retained after investigation. Multivariate Poisson regression was used to estimate the relationship between complaint rate and scores on the clinical skills examination and traditional written examination. Scores are based on a standardized mean (SD) of 500 (100). RESULTS: Overall, 1116 complaints were filed for 3424 physicians, and 696 complaints were retained after investigation. Of the physicians, 17.1% had at least 1 retained complaint, of which 81.9% were for communication or quality-of-care problems. Patient-physician communication scores for study physicians ranged from 31 to 723 (mean [SD], 510.9 [91.1]). A 2-SD decrease in communication score was associated with 1.17 more retained complaints per 100 physicians per year (relative risk [RR], 1.38; 95% confidence interval [CI], 1.18-1.61) and 1.20 more communication complaints per 100 practice-years (RR, 1.43; 95% CI, 1.15-1.77). After adjusting for the predictive ability of the clinical decision-making score in the traditional written examination, the patient-physician communication score in the clinical skills examination remained significantly predictive of retained complaints (likelihood ratio test, P < .001), with scores in the bottom quartile explaining an additional 9.2% (95% CI, 4.7%-13.1%) of complaints. CONCLUSION: Scores achieved in patient-physician communication and clinical decision making on a national licensing examination predicted complaints to medical regulatory authorities.",2007,10.1001/jama.298.9.993,298,9,1001-993,eng,1538-3598 0098-7484,"Humans and Ontario and Poisson Distribution and Medical History Taking and *Communication and Quebec and *Physician-Patient Relations and *Dissent and Disputes and *Quality Indicators, Health Care and Clinical Competence/*statistics & numerical data and Educational Measurement/methods and Licensure, Medical/*statistics & numerical data and Malpractice/statistics & numerical data and Patient Satisfaction/*statistics & numerical data",NA,NA,2007/09/05/,JAMA,NA,NA,NA,NA
Beckman_2013_JAMA,JOUR,Management of asymptomatic internal carotid artery stenosis,"Beckman, Joshua A.",JAMA,"Optimal management of patients with asymptomatic carotid artery stenosis remains unclear. Although 2 high-quality randomized clinical trials demonstrated reductions in ispsilateral stroke rates in patients without symptoms after carotid endarterectomy, medical therapy of asymptomatic carotid artery stenosis has reduced rates of stroke to approximately 1% per year, raising questions about the generalizability of these previous trials to current medical practice. However, reductions in adverse events after revascularization can make revascularization more attractive. The emergence of percutaneous revascularization for carotid artery stenosis has raised further questions about optimal management of asymptomatic carotid artery stenosis. This Grand Rounds summarizes the factors to consider when counseling patients and making clinical decisions regarding medical therapy and revascularization for patients with asymptomatic carotid artery stenosis. This information should provide clinicians with the knowledge base to counsel patients about the risks and benefits of treatment options.",2013,10.1001/jama.2013.280039,310,15,1612-1618,eng,1538-3598 0098-7484,"Humans and Female and Aged and *Decision Making and *Endarterectomy, Carotid/adverse effects and Carotid Artery, Internal/surgery and Carotid Stenosis/complications/*surgery and Stroke/etiology/prevention & control",NA,NA,2013/10/16/,JAMA,NA,NA,NA,NA
von.Winterfeldt_2013_ProfthNaAcofScofthUnStofAm,JOUR,Bridging the gap between science and decision making,"von Winterfeldt, Detlof",Proceedings of the National Academy of Sciences of the United States of America,"All decisions, whether they are personal, public, or business-related, are based on the decision maker's beliefs and values. Science can and should help decision makers by shaping their beliefs. Unfortunately, science is not easily accessible to decision makers, and scientists often do not understand decision makers' information needs. This article presents a framework for bridging the gap between science and decision making and illustrates it with two examples. The first example is a personal health decision. It shows how a formal representation of the beliefs and values can reflect scientific inputs by a physician to combine with the values held by the decision maker to inform a medical choice. The second example is a public policy decision about managing a potential environmental hazard. It illustrates how controversial beliefs can be reflected as uncertainties and informed by science to make better decisions. Both examples use decision analysis to bridge science and decisions. The conclusions suggest that this can be a helpful process that requires skills in both science and decision making.",2013,10.1073/pnas.1213532110,110 Suppl 3,Suppl 3,14055-14061,eng,1091-6490 0027-8424,science communication and Humans and risk analysis and risk communication and Choice Behavior and *Communication and *Decision Making and Information Dissemination/*methods and decision analysis and Science/*methods,NA,NA,2013/08/20/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Konstantinopoulos_2012_JAMA,JOUR,Management of ovarian cancer: a 75-year-old woman who has completed treatment,"Konstantinopoulos, Panagiotis A. and Awtrey, Christopher S.",JAMA,"Ovarian cancer includes primary tumors of epithelial, sex cord-stromal, or germ cell origin as well as metastatic tumors that frequently originate in the gastrointestinal tract. Approximately 90% of ovarian cancer is epithelial in origin and constitutes a major therapeutic challenge because of its advanced stage of presentation in most patients. Epithelial ovarian cancer is the most lethal gynecologic malignancy and the fifth most common cause of female cancer death in the United States, with approximately 1 in 70 women developing this disease in their lifetime. Several important advances in surgical and medical management of this disease have led to prolongation of survival and improvement of quality of life of patients with ovarian cancer. Using the case of Ms W, we discuss the signs, symptoms, risk factors, and prognostic factors of epithelial ovarian cancer; review the evidence for surgical and postoperative medical management; and present the current recommendations for screening and follow-up.",2012,10.1001/jama.2012.269,307,13,1420-1429,eng,1538-3598 0098-7484,"Humans and Female and Aged and Decision Making and Risk Factors and Prognosis and Chemotherapy, Adjuvant and Hysterectomy and Maintenance Chemotherapy and Ovarian Neoplasms/*diagnosis/epidemiology/genetics/*therapy",NA,NA,2012/04/04/,JAMA,NA,NA,NA,NA
Paasche.Orlow_2011_JAMA,JOUR,Caring for patients with limited health literacy: a 76-year-old man with multiple medical problems,"Paasche-Orlow, Michael",JAMA,"Health literacy is the degree to which individuals have the capacity to obtain, process, and understand health information, skills, and services needed to make informed health decisions and take informed actions. Narratives from Mr J, a 76-year-old man with multiple medical problems and limited health literacy, and his physician exhibit some of the difficulties experienced by patients with limited health literacy. Clinicians can help patients with limited health literacy by removing unneeded complexity in their treatment regimens and in the health care system and by using teach-back methods to assess and improve understanding. Rather than a selective screening approach for limited health literacy, a patient-based universal precaution approach for confirming patient comprehension of critical self-care activities helps ensure that all patients have their health literacy needs identified.",2011,10.1001/jama.2011.1203,306,10,1122-1129,eng,1538-3598 0098-7484,"Humans and Male and Patient Compliance and Aged and Hypertension and Physician-Patient Relations and Obesity and Self Care and Diabetes Mellitus, Type 2 and Sleep Apnea Syndromes and Informed Consent and Hyperlipidemias and *Decision Making and *Patient Participation and *Health Literacy and *Physician's Role and *Chronic Disease",NA,NA,2011/09/14/,JAMA,NA,NA,NA,NA
Eva_2012_JAMA,JOUR,Association between a medical school admission process using the multiple mini-interview and national licensing examination scores,"Eva, Kevin W. and Reiter, Harold I. and Rosenfeld, Jack and Trinh, Kien and Wood, Timothy J. and Norman, Geoffrey R.",JAMA,"CONTEXT: There has been difficulty designing medical school admissions processes that provide valid measurement of candidates' nonacademic qualities. OBJECTIVE: To determine whether students deemed acceptable through a revised admissions protocol using a 12-station multiple mini-interview (MMI) outperform others on the 2 parts of the Canadian national licensing examinations (Medical Council of Canada Qualifying Examination [MCCQE]). The MMI process requires candidates to rotate through brief sequential interviews with structured tasks and independent assessment within each interview. DESIGN, SETTING, AND PARTICIPANTS: Cohort study comparing potential medical students who were interviewed at McMaster University using an MMI in 2004 or 2005 and accepted (whether or not they matriculated at McMaster) with those who were interviewed and rejected but gained entry elsewhere. The computer-based MCCQE part I (aimed at assessing medical knowledge and clinical decision making) can be taken on graduation from medical school; MCCQE part II (involving simulated patient interactions testing various aspects of practice) is based on the objective structured clinical examination and typically completed 16 months into postgraduate training. Interviews were granted to 1071 candidates, and those who gained entry could feasibly complete both parts of their licensure examination between May 2007 and March 2011. Scores could be matched on the examinations for 751 (part I) and 623 (part II) interviewees. INTERVENTION: Admissions decisions were made by combining z score transformations of scores assigned to autobiographical essays, grade point average, and MMI performance. Academic and nonacademic measures contributed equally to the final ranking. MAIN OUTCOME MEASURES: Scores on MCCQE part I (standardized cut-score, 390 [SD, 100]) and part II (standardized mean, 500 [SD, 100]). RESULTS: Candidates accepted by the admissions process had higher scores than those who were rejected for part I (mean total score, 531 [95% CI, 524-537] vs 515 [95% CI, 507-522]; P = .003) and for part II (mean total score, 563 [95% CI, 556-570] vs 544 [95% CI, 534-554]; P = .007). Among the accepted group, those who matriculated at McMaster did not outperform those who matriculated elsewhere for part I (mean total score, 524 [95% CI, 515-533] vs 546 [95% CI, 535-557]; P = .004) and for part II (mean total score, 557 [95% CI, 548-566] vs 582 [95% CI, 569-594]; P = .003). CONCLUSION: Compared with students who were rejected by an admission process that used MMI assessment, students who were accepted scored higher on Canadian national licensing examinations.",2012,10.1001/jama.2012.36914,308,21,2233-2240,eng,1538-3598 0098-7484,"Humans and Cohort Studies and Ontario and *Educational Measurement and *Interviews as Topic and *School Admission Criteria and *Schools, Medical and Education, Medical, Undergraduate/*standards and Licensure",NA,NA,2012/12/05/,JAMA,NA,NA,NA,NA
Rizzo_2011_JAMA,JOUR,Impaired driving from medical conditions: a 70-year-old man trying to decide if he should continue driving,"Rizzo, Matthew",JAMA,"Some medical disorders can impair performance, increasing the risk of driving safety errors that can lead to vehicle crashes. The causal pathway often involves a concatenation of factors or events, some of which can be prevented or controlled. Effective interventions can operate before, during, or after a crash occurs at the levels of driver capacity, vehicle and road design, and public policy. A variety of systemic, neurological, psychiatric, and developmental disorders put drivers at potential increased risk of a car crash in the short or long term. Medical diagnosis and age alone are usually insufficient criteria for determining fitness to drive. Strategies are needed for determining what types and levels of reduced function provide a threshold for disqualification in drivers with medical disorders. Evidence of decreased mileage, self-restriction to driving in certain situations, collisions, moving violations, aggressive driving, sleepiness, alcohol abuse, metabolic disorders, and multiple medications may trigger considerations of driver safety. A general framework for evaluating driver fitness relies on a functional evaluation of multiple domains (cognitive, motor, perceptual, and psychiatric) that are important for safe driving and can be applied across many disorders, including conditions that have rarely been studied with respect to driving, and in patients with multiple conditions and medications. Neurocognitive tests, driving simulation, and road tests provide complementary sources of evidence to evaluate driver safety. No single test is sufficient to determine who should drive and who should not.",2011,10.1001/jama.2011.252,305,10,1018-1026,eng,1538-3598 0098-7484,"Safety and Disease and Humans and Male and Aged and Causality and Aging and *Decision Making and *Automobile Driver Examination and *Automobile Driving and Accidents, Traffic/*prevention & control and Cognition Disorders/physiopathology and Motor Skills and Parkinson Disease/*physiopathology and Reaction Time",NA,NA,2011/03/09/,JAMA,NA,NA,NA,NA
Birkmeyer_2013_Lanc.LonEngl,JOUR,Understanding of regional variation in the use of surgery,"Birkmeyer, John D. and Reames, Bradley N. and McCulloch, Peter and Carr, Andrew J. and Campbell, W. Bruce and Wennberg, John E.","Lancet (London, England)","The use of common surgical procedures varies widely across regions. Differences in illness burden, diagnostic practices, and patient attitudes about medical intervention explain only a small degree of regional variation in surgery rates. Evidence suggests that surgical variation results mainly from differences in physician beliefs about the indications for surgery, and the extent to which patient preferences are incorporated into treatment decisions. These two components of clinical decision making help to explain the so-called surgical signatures of specific procedures, and why some consistently vary more than others. Variation in clinical decision making is, in turn, affected by broad environmental factors, including technology diffusion, supply of specialists, local training frameworks, financial incentives, and regulatory factors, which vary across countries. Better scientific evidence about the comparative effectiveness of surgical and non-surgical interventions could help to mitigate regional variation, but broader dissemination of shared decision aids will be essential to reduce variation in preference-sensitive disorders.",2013,10.1016/S0140-6736(13)61215-5,382,9898,1121-1129,eng,1474-547X 0140-6736,"Humans and Attitude to Health and Attitude of Health Personnel and Residence Characteristics and Geography, Medical/statistics & numerical data and Patient Acceptance of Health Care/statistics & numerical data and Patient Participation/statistics & numerical data and Practice Patterns, Physicians'/statistics & numerical data and Surgical Procedures, Operative/*statistics & numerical data",NA,NA,2013/09/28/,Lancet,NA,NA,NA,NA
Prasad_2011_JAMA,JOUR,Clinical protocols and trainee knowledge about mechanical ventilation,"Prasad, Meeta and Holmboe, Eric S. and Lipner, Rebecca S. and Hess, Brian J. and Christie, Jason D. and Bellamy, Scarlett L. and Rubenfeld, Gordon D. and Kahn, Jeremy M.",JAMA,"CONTEXT: Clinical protocols are associated with improved patient outcomes; however, they may negatively affect medical education by removing trainees from clinical decision making. OBJECTIVE: To study the relationship between critical care training with mechanical ventilation protocols and subsequent knowledge about ventilator management. DESIGN, SETTING, AND PARTICIPANTS: A retrospective cohort equivalence study, linking a national survey of mechanical ventilation protocol availability in accredited US pulmonary and critical care fellowship programs with knowledge about mechanical ventilation among first-time examinees of the American Board of Internal Medicine (ABIM) Critical Care Medicine Certification Examination in 2008 and 2009. Exposure to protocols was defined as high intensity if an examinee's training intensive care unit had 2 or more protocols for at least 3 years and as low intensity if 0 or 1 protocol. MAIN OUTCOME MEASURES: Knowledge, measured by performance on examination questions specific to mechanical ventilation management, calculated as a mechanical ventilation score using item response theory. The score is standardized to a mean (SD) of 500 (100), and a clinically important difference is defined as 25. Variables included in adjusted analyses were birth country, residency training country, and overall first-attempt score on the ABIM Internal Medicine Certification Examination. RESULTS: Ninety of 129 programs (70%) responded to the survey. Seventy-seven programs (86%) had protocols for ventilation liberation, 66 (73%) for sedation management, and 54 (60%) for lung-protective ventilation at the time of the survey. Eighty-eight (98%) of these programs had trainees who completed the ABIM Critical Care Medicine Certification Examination, totaling 553 examinees. Of these 88 programs, 27 (31%) had 0 protocols, 19 (22%) had 1 protocol, 24 (27%) had 2 protocols, and 18 (20%) had 3 protocols for at least 3 years. Forty-two programs (48%) were classified as high intensity and 46 (52%) as low intensity, with 304 trainees (55%) and 249 trainees (45%), respectively. In bivariable analysis, no difference in mean scores was observed in high-intensity (497; 95% CI, 486-507) vs low-intensity programs (497; 95% CI, 485-509). Mean difference was 0 (95% CI, -16 to 16), with a positive value indicating a higher score in the high-intensity group. In multivariable analyses, no association of training was observed in a high-intensity program with mechanical ventilation score (adjusted mean difference, -5.36; 95% CI, -20.7 to 10.0). CONCLUSION: Among first-time ABIM Critical Care Medicine Certification Examination examinees, training in a high-intensity ventilator protocol environment compared with a low-intensity environment was not associated with worse performance on examination questions about mechanical ventilation management.",2011,10.1001/jama.2011.1226,306,9,935-941,eng,1538-3598 0098-7484,"United States and Humans and Data Collection and Female and Male and Adult and Retrospective Studies and Decision Making and Cohort Studies and Certification and Decision Support Systems, Clinical and *Respiration, Artificial and *Critical Care and Internal Medicine/education and *Clinical Competence and *Clinical Protocols and *Education, Medical, Graduate and Fellowships and Scholarships",NA,NA,2011/09/07/,JAMA,NA,NA,NA,NA
X2012_JAMA,JOUR,Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective,NA,JAMA,"Rigorous methodological standards help to ensure that medical research produces information that is valid and generalizable, and are essential in patient-centered outcomes research (PCOR). Patient-centeredness refers to the extent to which the preferences, decision-making needs, and characteristics of patients are addressed, and is the key characteristic differentiating PCOR from comparative effectiveness research. The Patient Protection and Affordable Care Act signed into law in 2010 created the Patient-Centered Outcomes Research Institute (PCORI), which includes an independent, federally appointed Methodology Committee. The Methodology Committee is charged to develop methodological standards for PCOR. The 4 general areas identified by the committee in which standards will be developed are (1) prioritizing research questions, (2) using appropriate study designs and analyses, (3) incorporating patient perspectives throughout the research continuum, and (4) fostering efficient dissemination and implementation of results. A Congressionally mandated PCORI methodology report (to be issued in its first iteration in May 2012) will begin to provide standards in each of these areas, and will inform future PCORI funding announcements and review criteria. The work of the Methodology Committee is intended to enable generation of information that is relevant and trustworthy for patients, and to enable decisions that improve patient-centered outcomes.",2012,10.1001/jama.2012.466,307,15,1636-1640,eng,1538-3598 0098-7484,"United States and Humans and Decision Making and Practice Guidelines as Topic and Information Dissemination and *Research and *Patient Participation and *Patient Preference and Chronic Disease/therapy and Comparative Effectiveness Research/legislation & jurisprudence/*methods/*standards and Outcome Assessment, Health Care/*methods/standards and Patient Protection and Affordable Care Act/legislation & jurisprudence",NA,NA,2012/04/18/,JAMA,NA,NA,NA,NA
Sah_2010_JAMA,JOUR,Effect of reminders of personal sacrifice and suggested rationalizations on residents' self-reported willingness to accept gifts: a randomized trial,"Sah, Sunita and Loewenstein, George",JAMA,"CONTEXT: Despite expanding research on the prevalence and consequences of conflicts of interest in medicine, little attention has been given to the psychological processes that enable physicians to rationalize the acceptance of gifts. OBJECTIVE: To determine whether reminding resident physicians of the sacrifices made to obtain training, as well as suggesting this as a potential rationalization, increases self-stated willingness to accept gifts from industry. DESIGN, SETTING, AND PARTICIPANTS: Three hundred one US resident physicians from 2 sample populations (pediatrics and family medicine) who were recruited during March-July 2009 participated in a survey presented as evaluating quality of life and values. INTERVENTION: Physicians were randomly assigned to receive 1 of 3 different online surveys. The sacrifice reminders survey (n = 120) asked questions about sacrifices made in medical training, followed by questions regarding the acceptability of receiving gifts from industry. The suggested rationalization survey (n = 121) presented the same sacrifice questions, followed by a suggested possible rationalization (based on sacrifices made in medical training) for acceptance of gifts, before the questions regarding the acceptability of gifts. The control survey (n = 60) asked about the acceptability of gifts before asking questions about sacrifices or suggesting a rationalization. MAIN OUTCOME MEASURES: Physician self-stated acceptability of receiving gifts from industry. RESULTS: Reminding physicians of sacrifices made in obtaining their education resulted in gifts being evaluated as more acceptable: 21.7% (13/60) in the control group vs 47.5% (57/120) in the sacrifice reminders group (odds ratio, 1.81; 95% confidence interval, 1.27-2.58; P = .001). Although most residents disagreed with the suggested rationalization, exposure to it further increased the perceived acceptability of gifts to 60.3% (73/121) in that group (odds ratio relative to sacrifice reminders group, 1.45; 95% confidence interval, 1.22-1.72; P < .001). CONCLUSIONS: Providing resident physicians with reminders of sacrifices increased the perceived acceptability of industry-sponsored gifts. Including a rationalization statement further increased gift acceptability.",2010,10.1001/jama.2010.1310,304,11,1204-1211,eng,1538-3598 0098-7484,"Humans and Data Collection and Female and Male and Decision Making and Pennsylvania and Reminder Systems and Quality of Life and Drug Industry and Education, Medical and Internship and Residency and Physicians/*psychology and *Conflict of Interest and Gift Giving/*ethics",NA,NA,2010/09/15/,JAMA,NA,NA,NA,NA
Mulla_2012_JAMA,JOUR,How to use a noninferiority trial: users' guides to the medical literature,"Mulla, Sohail M. and Scott, Ian A. and Jackevicius, Cynthia A. and You, John J. and Guyatt, Gordon H.",JAMA,"Clinical investigators are increasingly testing treatments that have the primary benefit of decreased burden or harms relative to an existing standard. The goal of the resulting randomized trials--called noninferiority trials--is to establish that the novel treatment's effectiveness is not substantially less than the existing standard. Conclusions from these trials are, however, based on noninferiority thresholds specified by authors whose judgments may not coincide with those of patients and clinicians. This article highlights issues related to validity, interpretation, and applicability of results specific to noninferiority trials. Suboptimal administration of standard treatment or exclusive reliance on the analyze-as-randomized approach that is standard for conventional superiority trials may produce misleading results in noninferiority trials. Clinicians should judge whether the novel treatment's impact on effectiveness outcomes--the prime reason for wanting to prescribe it--is sufficiently close to that of standard treatment that they are comfortable substituting it for the existing standard. Trading off desirable and undesirable consequences is an individual decision: given the benefits of a novel treatment, some patients may perceive the uncertainty regarding a reduction in treatment effectiveness as acceptable while others may not.",2012,10.1001/2012.jama.11235,308,24,2605-2611,eng,1538-3598 0098-7484,"Humans and Evidence-Based Medicine and Female and Middle Aged and Data Interpretation, Statistical and Patient Care and Endpoint Determination and *Decision Making and *Randomized Controlled Trials as Topic and *Treatment Outcome and Pulmonary Embolism/therapy",NA,NA,2012/12/26/,JAMA,NA,NA,NA,NA
Wennberg_2010_ThNeEnjoofme,JOUR,A randomized trial of a telephone care-management strategy,"Wennberg, David E. and Marr, Amy and Lang, Lance and O'Malley, Stephen and Bennett, George",The New England journal of medicine,"BACKGROUND: Studies have shown that telephone interventions designed to promote patients' self-management skills and improve patient-physician communication can increase patients' satisfaction and their use of preventive services. The effect of such a strategy on health care costs remains controversial. METHODS: We conducted a stratified, randomized study of 174,120 subjects to assess the effect of a telephone-based care-management strategy on medical costs and resource utilization. Health coaches contacted subjects with selected medical conditions and predicted high health care costs to instruct them about shared decision making, self-care, and behavioral change. The subjects were randomly assigned to either a usual-support group or an enhanced-support group. Although the same telephone intervention was delivered to the two groups, a greater number of subjects in the enhanced-support group were made eligible for coaching through the lowering of cutoff points for predicted future costs and expansion of the number of qualifying health conditions. Primary outcome measures at 1 year were total medical costs and number of hospital admissions. RESULTS: At baseline, medical costs and resource utilization were similar in the two groups. After 12 months, 10.4% of the enhanced-support group and 3.7% of the usual-support group received the telephone intervention. The average monthly medical and pharmacy costs per person in the enhanced-support group were 3.6% ($7.96) lower than those in the usual-support group ($213.82 vs. $221.78, P=0.05); a 10.1% reduction in annual hospital admissions (P<0.001) accounted for the majority of savings. The cost of this intervention program was less than $2.00 per person per month. CONCLUSIONS: A targeted telephone care-management program was successful in reducing medical costs and hospitalizations in this population-based study. (Funded by Health Dialog Services; ClinicalTrials.gov number, NCT00793260.)",2010,10.1056/NEJMsa0902321,363,13,1245-1255,eng,1533-4406 0028-4793,"Humans and Adolescent and Adult and Middle Aged and Young Adult and Child and Child, Preschool and Infant and Aged and Cost-Benefit Analysis and Models, Theoretical and Physician-Patient Relations and Telephone and *Telemedicine and Health Care Costs/*statistics & numerical data and Emergency Service, Hospital/statistics & numerical data and Health Resources/economics/*statistics & numerical data and Hospitalization/statistics & numerical data and Patient Care Management/economics/*methods",NA,NA,2010/09/23/,N Engl J Med,NA,NA,NA,NA
Kutner_2010_JAMA,JOUR,An 86-year-old woman with cardiac cachexia contemplating the end of her life: review of hospice care,"Kutner, Jean S.",JAMA,"Mrs H is an 86-year-old woman with progressive congestive heart failure and multiple chronic conditions who is experiencing worsening function and quality of life despite maximum medical therapies. She seeks advice regarding control over the circumstances of the end of her life, be it by suicide or under hospice care. Typical of US populations older than 65 years with multiple chronic health conditions and functional decline who are facing the end of life, Mrs H's concerns are particularly about quality of life, not being a burden on loved ones, and maintaining control. As she demonstrates, psychological, existential, and social factors, particularly fear of being a burden, are more common reasons for desiring hastened death than those related directly to physical symptoms. Hospice, which provides a multidisciplinary approach to care at the end of life, can assist Mrs H and her family in making decisions that are consistent with her goals.",2010,10.1001/jama.2009.2015,303,4,349-356,eng,1538-3598 0098-7484,"Humans and Female and Aged and Decision Making and Prognosis and Aged, 80 and over and Quality of Life and Family Health and *Hospice Care and Cachexia/*etiology and Heart Failure/*complications/therapy",NA,NA,2010/01/27/,JAMA,NA,NA,NA,NA
West_2012_JAMA,JOUR,General medicine vs subspecialty career plans among internal medicine residents,"West, Colin P. and Dupras, Denise M.",JAMA,"CONTEXT: Current medical training models in the United States are unlikely to produce sufficient numbers of general internists and primary care physicians. Differences in general internal medicine (GIM) career plans between internal medicine residency program types and across resident demographics are not well understood. OBJECTIVE: To evaluate the general medicine career plans of internal medicine residents and how career plans evolve during training. DESIGN, SETTING, AND PARTICIPANTS: A study of US internal medicine residents using an annual survey linked to the Internal Medicine In-Training Examination taken in October of 2009-2011 to evaluate career plans by training program, sex, and medical school location. Of 67,207 US eligible categorical and primary care internal medicine residents, 57,087 (84.9%) completed and returned the survey. Demographic data provided by the National Board of Medical Examiners were available for 52,035 (77.4%) of these residents, of whom 51,390 (76.5%) responded to all survey items and an additional 645 (1.0%) responded to at least 1 survey item. Data were analyzed from the 16,781 third-year residents (32.2%) in this sample. MAIN OUTCOME MEASURES: Self-reported ultimate career plans of internal medicine residents. RESULTS: A GIM career plan was reported by 3605 graduating residents (21.5%). A total of 562 primary care program (39.6%) and 3043 categorical (19.9%) residents reported GIM as their ultimate career plan (adjusted odds ratio [AOR], 2.76; 99% CI, 2.35-3.23; P < .001). Conversely, 10 008 categorical (65.3%) and 745 primary care program (52.5%) residents reported a subspecialty career plan (AOR, 1.90; 99% CI, 1.62-2.23; P < .001). GIM career plans were reported more frequently by women than men (26.7% vs 17.3%, respectively; AOR, 1.69; 99% CI, 1.53-1.87; P < .001). US medical graduates were slightly more likely to report GIM career plans than international medical graduates (22.0% vs 21.1%, respectively; AOR, 1.76; 99% CI, 1.50-2.06; P < .001). Within primary care programs, US medical graduates were much more likely to report GIM career plans than international medical graduates (57.3% vs 27.3%, respectively; AOR, 3.48; 99% CI, 2.58-4.70; P < .001). Compared with their counterparts, maintaining a first-year GIM career plan over the course of their training was more likely among primary care program residents (68.2% vs 52.3%; AOR, 1.81; 99% CI, 1.25-2.64; P < .001), women (62.4% vs 47.2%; AOR, 1.75; 99% CI, 1.34-2.29; P < .001), and US medical graduates (60.9% vs 49.2%; AOR, 1.48; 99% CI, 1.13-1.93; P < .001). CONCLUSION: Reported GIM career plans were markedly less common than subspecialty career plans among internal medicine residents, including those in primary care training programs, and differed according to resident sex, medical school location, and program type.",2012,10.1001/jama.2012.47535,308,21,2241-2247,eng,1538-3598 0098-7484,Medicine and United States and Humans and Data Collection and Female and Male and Primary Health Care and Decision Making and Sex Factors and Workforce and *Career Choice and Foreign Medical Graduates and Internal Medicine/*education and Internship and Residency/*statistics & numerical data,NA,NA,2012/12/05/,JAMA,NA,NA,NA,NA
Harrington_2008_JAMA,JOUR,"The role of chemotherapy at the end of life: ""when is enough, enough?""","Harrington, Sarah Elizabeth and Smith, Thomas J.",JAMA,"Patients face difficult decisions about chemotherapy near the end of life. Such treatment might prolong survival or reduce symptoms but cause adverse effects, prevent the patient from engaging in meaningful life review and preparing for death, and preclude entry into hospice. Palliative care and oncology clinicians should be logical partners in caring for patients with serious cancers for which symptom control, medically appropriate goal setting, and communication are paramount, but some studies have shown limited cooperation. We illustrate how clinicians involved in palliative care and oncology can more effectively work together with the story of Mr L, a previously healthy 56-year-old man, who wanted to survive his lung cancer at all costs. He lived 14 months with 3 types of chemotherapy, received chemotherapy just 6 days before his death, and resisted entering hospice until his prognosis and options were explicitly communicated. Approaches to communication about prognosis and treatment options and questions that patients may want to ask are discussed.",2008,10.1001/jama.299.22.2667,299,22,2667-2678,eng,1538-3598 0098-7484,Humans and Male and Middle Aged and Decision Making and Prognosis and Attitude to Death and Hospices and *Patient Acceptance of Health Care and *Physician-Patient Relations and *Medical Oncology and *Interprofessional Relations and *Palliative Care and Antineoplastic Agents/*therapeutic use and Lung Neoplasms/*drug therapy/*psychology and Terminally Ill/*psychology,NA,NA,2008/06/11/,JAMA,NA,NA,NA,NA
Kane_2011_JAMA,JOUR,"Finding the right level of posthospital care: ""We didn't realize there was any other option for him""","Kane, Robert L.",JAMA,"Many families considering posthospital care options are ill-prepared and in need of guidance. They may not know the range of available options, the relative benefits of each, or have considered their therapeutic goals. Physicians should be informants, advocates, and facilitators of this big leap for their patients. Making a good long-term care decision requires information and structure, but such decisions are often made under great time pressure as part of a hospital discharge. Professional intervention and guidance by an informed but disinterested facilitator may be needed, but hospital discharge planners may not be well suited for this role because their mandate is a rapid discharge. Physicians have 2 crucial roles in these transitions: to ensure the seamless delivery of primary care and to advocate for and facilitate, however possible, better decision making. Physicians need at least a rudimentary knowledge of the array of options and the implications of each. Even if the physician cannot serve as the planning facilitator, the physician should ensure that this task is done well. This review describes the range of options and the implications of each option for long-term care in the United States. It suggests the need for evaluating each patient's care goals, family circumstances and resources, and clinical status to determine if more aggressive medical care might improve an individual's clinical trajectory.",2011,10.1001/jama.2010.2015,305,3,284-293,eng,1538-3598 0098-7484,United States and Hospitalization and Humans and Aged and Physician's Role and Rehabilitation Centers and Case Management and Continuity of Patient Care and *Patient Discharge and Skilled Nursing Facilities and *Aging and *Long-Term Care and Assisted Living Facilities,NA,NA,2011/01/19/,JAMA,NA,NA,NA,NA
Bodenheimer_2007_JAMA,JOUR,A 63-year-old man with multiple cardiovascular risk factors and poor adherence to treatment plans,"Bodenheimer, Thomas",JAMA,"Mr P has long-standing hypertension, obesity, and diabetes mellitus and has experienced life-threatening cardiovascular events. Mr P is receiving evidence-based clinical care but has adhered to his medical regimen poorly and remains at considerable risk of future catastrophic cardiovascular events. Practicing evidence-based medicine should be a 5-step process: research uncovers the evidence, clinicians learn the evidence, clinicians use the evidence at every visit for every patient, clinicians make sure patients understand the evidence, and clinicians help patients incorporate the evidence into their lives. Research demonstrates, however, that clinicians do not use the evidence at every visit, patients may misunderstand what took place in the visit, and clinicians are not always effective in helping patients incorporate the evidence into their lives. These failures reflect the difficulty faced by clinicians attempting to address multiple issues while providing sufficient information and engaging in collaborative decision making during a brief clinical visit.",2007,10.1001/jama.298.16.jrr70000,298,17,2048-2055,eng,1538-3598 0098-7484,Humans and Evidence-Based Medicine and Male and Middle Aged and Patient Compliance and Patient Care Team and Risk Factors and Comorbidity and Patient Education as Topic and Family Practice and Treatment Refusal and *Self Care and *Health Behavior and Cardiovascular Diseases/epidemiology/*prevention & control and *Physician's Role and Diabetes Mellitus/epidemiology/*therapy and Hyperlipidemias/epidemiology/*therapy and Hypertension/epidemiology/*therapy and Obesity/epidemiology/*therapy,NA,NA,2007/11/07/,JAMA,NA,NA,NA,NA
Weeks_2012_ThNeEnjoofme,JOUR,Patients' expectations about effects of chemotherapy for advanced cancer,"Weeks, Jane C. and Catalano, Paul J. and Cronin, Angel and Finkelman, Matthew D. and Mack, Jennifer W. and Keating, Nancy L. and Schrag, Deborah",The New England journal of medicine,"BACKGROUND: Chemotherapy for metastatic lung or colorectal cancer can prolong life by weeks or months and may provide palliation, but it is not curative. METHODS: We studied 1193 patients participating in the Cancer Care Outcomes Research and Surveillance (CanCORS) study (a national, prospective, observational cohort study) who were alive 4 months after diagnosis and received chemotherapy for newly diagnosed metastatic (stage IV) lung or colorectal cancer. We sought to characterize the prevalence of the expectation that chemotherapy might be curative and to identify the clinical, sociodemographic, and health-system factors associated with this expectation. Data were obtained from a patient survey by professional interviewers in addition to a comprehensive review of medical records. RESULTS: Overall, 69% of patients with lung cancer and 81% of those with colorectal cancer did not report understanding that chemotherapy was not at all likely to cure their cancer. In multivariable logistic regression, the risk of reporting inaccurate beliefs about chemotherapy was higher among patients with colorectal cancer, as compared with those with lung cancer (odds ratio, 1.75; 95% confidence interval [CI], 1.29 to 2.37); among nonwhite and Hispanic patients, as compared with non-Hispanic white patients (odds ratio for Hispanic patients, 2.82; 95% CI, 1.51 to 5.27; odds ratio for black patients, 2.93; 95% CI, 1.80 to 4.78); and among patients who rated their communication with their physician very favorably, as compared with less favorably (odds ratio for highest third vs. lowest third, 1.90; 95% CI, 1.33 to 2.72). Educational level, functional status, and the patient's role in decision making were not associated with such inaccurate beliefs about chemotherapy. CONCLUSIONS: Many patients receiving chemotherapy for incurable cancers may not understand that chemotherapy is unlikely to be curative, which could compromise their ability to make informed treatment decisions that are consonant with their preferences. Physicians may be able to improve patients' understanding, but this may come at the cost of patients' satisfaction with them. (Funded by the National Cancer Institute and others.).",2012,10.1056/NEJMoa1204410,367,17,1616-1625,eng,1533-4406 0028-4793,"Humans and Data Collection and Female and Male and Adult and Middle Aged and Aged and Logistic Models and Decision Making and Cohort Studies and Aged, 80 and over and Informed Consent and Neoplasm Staging and *Attitude to Health and Colorectal Neoplasms/*drug therapy/pathology and Drug Therapy/*psychology and Lung Neoplasms/*drug therapy/pathology",NA,NA,2012/10/25/,N Engl J Med,NA,NA,NA,NA
Solomon_2013_ProfthNaAcofScofthUnStofAm,JOUR,Clinical genomic database,"Solomon, Benjamin D. and Nguyen, Anh-Dao and Bear, Kelly A. and Wolfsberg, Tyra G.",Proceedings of the National Academy of Sciences of the United States of America,"Technological advances have greatly increased the availability of human genomic sequencing. However, the capacity to analyze genomic data in a clinically meaningful way lags behind the ability to generate such data. To help address this obstacle, we reviewed all conditions with genetic causes and constructed the Clinical Genomic Database (CGD) (http://research.nhgri.nih.gov/CGD/), a searchable, freely Web-accessible database of conditions based on the clinical utility of genetic diagnosis and the availability of specific medical interventions. The CGD currently includes a total of 2,616 genes organized clinically by affected organ systems and interventions (including preventive measures, disease surveillance, and medical or surgical interventions) that could be reasonably warranted by the identification of pathogenic mutations. To aid independent analysis and optimize new data incorporation, the CGD also includes all genetic conditions for which genetic knowledge may affect the selection of supportive care, informed medical decision-making, prognostic considerations, reproductive decisions, and allow avoidance of unnecessary testing, but for which specific interventions are not otherwise currently available. For each entry, the CGD includes the gene symbol, conditions, allelic conditions, clinical categorization (for both manifestations and interventions), mode of inheritance, affected age group, description of interventions/rationale, links to other complementary databases, including databases of variants and presumed pathogenic mutations, and links to PubMed references (>20,000). The CGD will be regularly maintained and updated to keep pace with scientific discovery. Further content-based expert opinions are actively solicited. Eventually, the CGD may assist the rapid curation of individual genomes as part of active medical care.",2013,10.1073/pnas.1302575110,110,24,9851-9855,eng,1091-6490 0027-8424,"Humans and Internet and Genome-Wide Association Study and *Mutation and *Databases, Genetic and Genetic Predisposition to Disease/*genetics and genome sequencing and Genome, Human/*genetics and genomic medicine and whole-genome sequencing",NA,NA,2013/06/11/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Fischhoff_2014_ProfthNaAcofScofthUnStofAm,JOUR,Communicating scientific uncertainty,"Fischhoff, Baruch and Davis, Alex L.",Proceedings of the National Academy of Sciences of the United States of America,"All science has uncertainty. Unless that uncertainty is communicated effectively, decision makers may put too much or too little faith in it. The information that needs to be communicated depends on the decisions that people face. Are they (i) looking for a signal (e.g., whether to evacuate before a hurricane), (ii) choosing among fixed options (e.g., which medical treatment is best), or (iii) learning to create options (e.g., how to regulate nanotechnology)? We examine these three classes of decisions in terms of how to characterize, assess, and convey the uncertainties relevant to each. We then offer a protocol for summarizing the many possible sources of uncertainty in standard terms, designed to impose a minimal burden on scientists, while gradually educating those whose decisions depend on their work. Its goals are better decisions, better science, and better support for science.",2014,10.1073/pnas.1317504111,111 Suppl 4,Suppl 4,13664-13671,eng,1091-6490 0027-8424,"risk and science communication and Humans and Models, Theoretical and mental models and *Communication and Decision Making/*physiology and Information Dissemination/*methods and *Science and *Uncertainty and expert elicitation and expert judgment",NA,NA,2014/09/16/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Tarsy_2012_JAMA,JOUR,Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease,"Tarsy, Daniel",JAMA,"In early stages, Parkinson disease typically begins with asymmetric or unilateral motor symptoms due to combinations of mild bradykinesia, rigidity, and tremor. In most cases, with progression, signs of more generalized bradykinesia appear, which include facial masking, reduced voice volume, and slowing of activities of daily living. In more advanced Parkinson disease, other disabling manifestations may follow, such as impaired balance, gait freezing, falls, speech disturbance, and cognitive impairment. Levodopa is the most effective medical treatment for Parkinson disease. However, motor complications uniquely related to levodopa treatment may emerge that may be difficult to manage. These include fluctuating levodopa responses and involuntary movements and postures known as dyskinesia and dystonia. Medication adjustments are usually effective, but in some cases surgical intervention with deep brain stimulation becomes necessary to alleviate motor complications. The case of Mr L, a man with an 11-year history of Parkinson disease, illustrates these emerging motor complications and the manner in which they may be managed both medically and surgically.",2012,10.1001/jama.2012.4829,307,21,2305-2314,eng,1538-3598 0098-7484,"Humans and Male and Middle Aged and Decision Making and Quality of Life and Disease Progression and *Deep Brain Stimulation and *Dyskinesia, Drug-Induced/drug therapy and Amantadine/administration & dosage and Antiparasitic Agents/*administration & dosage/adverse effects and Carbidopa/administration & dosage/adverse effects and Catechols/administration & dosage/adverse effects and Gait Disorders, Neurologic/etiology and Globus Pallidus and Levodopa/administration & dosage/adverse effects and Nitriles/administration & dosage/adverse effects and Parkinson Disease/*complications/*drug therapy/epidemiology/physiopathology/therapy and Subthalamus",NA,NA,2012/06/06/,JAMA,NA,NA,NA,NA
Mosqueda_2011_JAMA,JOUR,"Elder abuse and self-neglect: ""I don't care anything about going to the doctor, to be honest...""","Mosqueda, Laura and Dong, XinQi",JAMA,"Elder mistreatment encompasses a range of behaviors including emotional, financial, physical, and sexual abuse, neglect by other individuals, and self-neglect. This article discusses the range of elder mistreatment in community-living older adults, associated factors, and consequences. Although self-neglect is not considered a type of abuse in many research definitions, it is the most commonly reported form of elder mistreatment and is associated with increased morbidity and mortality. The case on which this article is based describes a 70-year-old woman who neglects herself and dies despite multiple contacts with the medical community. Despite significant gaps in research, enough is known to guide clinical practice. This article presents the practical approaches a health care professional can take when a reasonable suspicion of elder mistreatment arises. Public health and interdisciplinary team approaches are needed to manage what is becoming an increasing problem as the number of older adults around the world increases.",2011,10.1001/jama.2011.1085,306,5,532-540,eng,1538-3598 0098-7484,"Humans and Female and Decision Making and Physician's Role and Aged, 80 and over and Social Isolation and Accidental Falls and Fatal Outcome and Geriatric Assessment and United States/epidemiology and *Primary Health Care and *Self Care and *Social Support and Mental Competency and *Elder Abuse/diagnosis/prevention & control/statistics & numerical data and *Patient Compliance and Alcoholism/complications and Osteoporosis/complications",NA,NA,2011/08/03/,JAMA,NA,NA,NA,NA
Widera_2011_JAMA,JOUR,"Finances in the older patient with cognitive impairment: ""He didn't want me to take over""","Widera, Eric and Steenpass, Veronika and Marson, Daniel and Sudore, Rebecca",JAMA,"Financial capacity can be defined as the ability to independently manage one's financial affairs in a manner consistent with personal self-interest. Financial capacity is essential for an individual to function independently in society; however, Alzheimer disease and other progressive dementias eventually lead to a complete loss of financial capacity. Many patients with cognitive impairment and their families seek guidance from their primary care clinician for help with financial impairment, yet most clinicians do not understand their role or know how to help. We review the prevalence and impact of diminished financial capacity in older adults with cognitive impairment. We also articulate the role of the primary care clinician, which includes (1) educating older adult patients and their families about the need for advance financial planning; (2) recognizing signs of possible impaired financial capacity; (3) assessing financial impairments in cognitively impaired adults; (4) recommending interventions to help patients maintain financial independence; and (5) knowing when and to whom to make medical and legal referrals. Clearly delineating the clinician's role regarding identification of financial impairment could establish for patients and families effective financial protections and limit the economic, psychological, and legal hardships of financial incapacity on patients with dementia and their families.",2011,10.1001/jama.2011.164,305,7,698-706,eng,1538-3598 0098-7484,"Humans and Male and Aged and Decision Making and Physician's Role and Prevalence and Activities of Daily Living and Family Health and *Financing, Personal and *Mental Competency and Alzheimer Disease/complications/epidemiology/*physiopathology and Cognition Disorders/epidemiology/etiology/*physiopathology and Dementia/epidemiology/*physiopathology and Legal Guardians",NA,NA,2011/02/16/,JAMA,NA,NA,NA,NA
Manski_2013_ProfthNaAcofScofthUnStofAm,JOUR,Diagnostic testing and treatment under ambiguity: using decision analysis to inform clinical practice,"Manski, Charles F.",Proceedings of the National Academy of Sciences of the United States of America,"Partial knowledge of patient health status and treatment response is a pervasive concern in medical decision making. Clinical practice guidelines (CPGs) make recommendations intended to optimize patient care, but optimization typically is infeasible with partial knowledge. Decision analysis shows that a clinician's objective, knowledge, and decision criterion should jointly determine the care he prescribes. To demonstrate, this paper studies a common scenario regarding diagnostic testing and treatment. A patient presents to a clinician, who obtains initial evidence on health status. The clinician can prescribe a treatment immediately or he can order a test yielding further evidence that may be useful in predicting treatment response. In the latter case, he prescribes a treatment after observation of the test result. I analyze this scenario in three steps. The first poses a welfare function and characterizes optimal care. The second describes partial knowledge of response to testing and treatment that might realistically be available. The third considers decision criteria. I conclude with reconsideration of clinical practice guidelines.",2013,10.1073/pnas.1221405110,110,6,2064-2069,eng,1091-6490 0027-8424,"Diagnosis and Humans and Health Status and Models, Theoretical and Practice Guidelines as Topic and Patient Care and Diagnostic Tests, Routine and Therapeutics and *Decision Support Techniques",NA,NA,2013/02/05/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Coburn_2012_JAMA,JOUR,Does this adult patient with suspected bacteremia require blood cultures?,"Coburn, Bryan and Morris, Andrew M. and Tomlinson, George and Detsky, Allan S.",JAMA,"CONTEXT: Clinicians order blood cultures liberally among patients in whom bacteremia is suspected, though a small proportion of blood cultures yield true-positive results. Ordering blood cultures inappropriately may be both wasteful and harmful. OBJECTIVE: To review the accuracy of easily obtained clinical and laboratory findings to inform the decision to obtain blood cultures in suspected bacteremia. DATA SOURCES AND STUDY SELECTION: A MEDLINE and EMBASE search (inception to April 2012) yielded 35 studies that met inclusion criteria for evaluating the accuracy of clinical variables for bacteremia in adult immunocompetent patients, representing 4566 bacteremia and 25,946 negative blood culture episodes. DATA EXTRACTION: Data were extracted to determine the prevalence and likelihood ratios (LRs) of findings for bacteremia. DATA SYNTHESIS: The pretest probability of bacteremia varies depending on the clinical context, from low (eg, cellulitis: 2%) to high (eg, septic shock: 69%). Elevated temperatures alone do not accurately predict bacteremia (for <e2><89><a5>38<c2><b0>C [>100.3<c2><b0>F], LR, 1.9 [95% CI, 1.4-2.4]; for <e2><89><a5>38.5<c2><b0>C [>101.2<c2><b0>F], LR, 1.4 [95% CI, 1.1-2.0]), nor does isolated leukocytosis (LR, <1.7). The severity of chills graded on an ordinal scale (shaking chills, LR, 4.7; 95% CI, 3.0-7.2) may be more useful. Both the systemic inflammatory response syndrome (SIRS) and a multivariable decision rule with major and minor criteria are sensitive (but not specific) predictors of bacteremia (SIRS, negative LR, 0.09 [95% CI, 0.03-0.26]; decision rule, negative LR, 0.08 [95% CI, 0.04-0.17]). CONCLUSIONS: Blood cultures should not be ordered for adult patients with isolated fever or leukocytosis without considering the pretest probability. SIRS and the decision rule may be helpful in identifying patients who do not need blood cultures. These conclusions do not apply to immunocompromised patients or when endocarditis is suspected.",2012,10.1001/jama.2012.8262,308,5,502-511,eng,1538-3598 0098-7484,"Humans and Female and Male and Middle Aged and Sensitivity and Specificity and Prevalence and Medical History Taking and Blood Specimen Collection and *Decision Making and Bacteremia/complications/*diagnosis and Bacteria/*isolation & purification and Bacteriological Techniques and Blood/*microbiology and Chills/etiology and Fever/etiology and Immunocompetence and Immunocompromised Host and Physical Examination and Shock, Septic/complications and Unnecessary Procedures",NA,NA,2012/08/01/,JAMA,NA,NA,NA,NA
Allen_2008_JAMA,JOUR,Discordance between patient-predicted and model-predicted life expectancy among ambulatory patients with heart failure,"Allen, Larry A. and Yager, Jonathan E. and Funk, Michele Jonsson and Levy, Wayne C. and Tulsky, James A. and Bowers, Margaret T. and Dodson, Gwen C. and O'Connor, Christopher M. and Felker, G. Michael",JAMA,"CONTEXT: Patients with chronic heart failure have impaired long-term survival, but their own expectations regarding prognosis have not been well studied. OBJECTIVES: To quantify expectations for survival in patients with heart failure, to compare patient expectations to model predictions, and to identify factors associated with discrepancies between patient-predicted and model-predicted prognosis. DESIGN, SETTING, AND PARTICIPANTS: Prospective face-to-face survey of patients from the single-center Duke Heart Failure Disease Management Program between July and December 2004, with follow-up through February 2008. Patient-predicted life expectancy was obtained using a visual analog scale. Model-predicted life expectancy was calculated using the Seattle Heart Failure Model. Actuarial-predicted life expectancy, based on age and sex alone, was calculated using life tables. Observed survival was determined from review of medical records and search of the Social Security Death Index. MAIN OUTCOME MEASURE: Life expectancy ratio (LER), defined as the ratio of patient-predicted to model-predicted life expectancy. RESULTS: The cohort consisted of 122 patients (mean age, 62 years; 47% African American, 42% New York Heart Association [NYHA] class III or IV). On average, patients overestimated their life expectancy relative to model-predicted life expectancy (median patient-predicted life expectancy, 13.0 years; model-predicted expectancy, 10.0 years). Median LER was 1.4 (interquartile range, 0.8-2.5). Younger age, increased NYHA class, lower ejection fraction, and less depression were the most significant predictors of higher LER. During a median follow-up of 3.1 years, 29% of the original cohort died. There was no association between higher LER and improved survival (adjusted hazard ratio for overestimated compared with concordant LER, 1.05; 95% confidence interval, 0.46-2.42). CONCLUSIONS: Ambulatory patients with heart failure tended to substantially overestimate their life expectancy compared with model-based predictions for survival. Because differences in perceived survival could affect decision making regarding advanced therapies and end-of-life planning, the causes of these discordant predictions warrant further study.",2008,10.1001/jama.299.21.2533,299,21,2533-2542,eng,1538-3598 0098-7484,"Humans and Female and Male and Middle Aged and Aged and Chronic Disease and Surveys and Questionnaires and Prognosis and Aged, 80 and over and Survival Analysis and *Attitude to Health and *Models, Cardiovascular and *Life Expectancy and Actuarial Analysis and Heart Failure/*mortality/*psychology",NA,NA,2008/06/04/,JAMA,NA,NA,NA,NA
Flegal_2013_JAMA,JOUR,Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis,"Flegal, Katherine M. and Kit, Brian K. and Orpana, Heather and Graubard, Barry I.",JAMA,"IMPORTANCE: Estimates of the relative mortality risks associated with normal weight, overweight, and obesity may help to inform decision making in the clinical setting. OBJECTIVE: To perform a systematic review of reported hazard ratios (HRs) of all-cause mortality for overweight and obesity relative to normal weight in the general population. DATA SOURCES: PubMed and EMBASE electronic databases were searched through September 30, 2012, without language restrictions. STUDY SELECTION: Articles that reported HRs for all-cause mortality using standard body mass index (BMI) categories from prospective studies of general populations of adults were selected by consensus among multiple reviewers. Studies were excluded that used nonstandard categories or that were limited to adolescents or to those with specific medical conditions or to those undergoing specific procedures. PubMed searches yielded 7034 articles, of which 141 (2.0%) were eligible. An EMBASE search yielded 2 additional articles. After eliminating overlap, 97 studies were retained for analysis, providing a combined sample size of more than 2.88 million individuals and more than 270,000 deaths. DATA EXTRACTION: Data were extracted by 1 reviewer and then reviewed by 3 independent reviewers. We selected the most complex model available for the full sample and used a variety of sensitivity analyses to address issues of possible overadjustment (adjusted for factors in causal pathway) or underadjustment (not adjusted for at least age, sex, and smoking). RESULTS: Random-effects summary all-cause mortality HRs for overweight (BMI of 25-<30), obesity (BMI of <e2><89><a5>30), grade 1 obesity (BMI of 30-<35), and grades 2 and 3 obesity (BMI of <e2><89><a5>35) were calculated relative to normal weight (BMI of 18.5-<25). The summary HRs were 0.94 (95% CI, 0.91-0.96) for overweight, 1.18 (95% CI, 1.12-1.25) for obesity (all grades combined), 0.95 (95% CI, 0.88-1.01) for grade 1 obesity, and 1.29 (95% CI, 1.18-1.41) for grades 2 and 3 obesity. These findings persisted when limited to studies with measured weight and height that were considered to be adequately adjusted. The HRs tended to be higher when weight and height were self-reported rather than measured. CONCLUSIONS AND RELEVANCE: Relative to normal weight, both obesity (all grades) and grades 2 and 3 obesity were associated with significantly higher all-cause mortality. Grade 1 obesity overall was not associated with higher mortality, and overweight was associated with significantly lower all-cause mortality. The use of predefined standard BMI groupings can facilitate between-study comparisons.",2013,10.1001/jama.2012.113905,309,1,71-82,eng,1538-3598 0098-7484,Humans and Female and Male and Adult and Middle Aged and Aged and Body Mass Index and Cause of Death and Reference Values and Obesity/classification/*mortality and Overweight/*mortality,NA,NA,2013/01/02/,JAMA,NA,NA,NA,NA
Lau_2013_Lanc.LonEngl,JOUR,Challenges in the management of acute peptic ulcer bleeding,"Lau, James Y. W. and Barkun, Alan and Fan, Dai-ming and Kuipers, Ernst J. and Yang, Yun-sheng and Chan, Francis K. L.","Lancet (London, England)","Acute upper gastrointestinal bleeding is a common medical emergency worldwide, a major cause of which are bleeding peptic ulcers. Endoscopic treatment and acid suppression with proton-pump inhibitors are cornerstones in the management of the disease, and both treatments have been shown to reduce mortality. The role of emergency surgery continues to diminish. In specialised centres, radiological intervention is increasingly used in patients with severe and recurrent bleeding who do not respond to endoscopic treatment. Despite these advances, mortality from the disorder has remained at around 10%. The disease often occurs in elderly patients with frequent comorbidities who use antiplatelet agents, non-steroidal anti-inflammatory drugs, and anticoagulants. The management of such patients, especially those at high cardiothrombotic risk who are on anticoagulants, is a challenge for clinicians. We summarise the published scientific literature about the management of patients with bleeding peptic ulcers, identify directions for future clinical research, and suggest how mortality can be reduced.",2013,10.1016/S0140-6736(13)60596-6,381,9882,2033-2043,eng,1474-547X 0140-6736,"Humans and Decision Making and Treatment Outcome and Fibrinolytic Agents and Acute Disease and Secondary Prevention and Contraindications and Risk Assessment/methods and Antifibrinolytic Agents/therapeutic use and Blood Coagulation Disorders/complications and Blood Component Transfusion/statistics & numerical data and Endoscopy, Gastrointestinal/statistics & numerical data and Gastrointestinal Agents/therapeutic use and Peptic Ulcer Hemorrhage/diagnosis/mortality/*prevention & control and Proton Pump Inhibitors/therapeutic use and Resuscitation/methods/statistics & numerical data",NA,NA,2013/06/08/,Lancet,NA,NA,NA,NA
Kavousi_2014_JAMA,JOUR,"Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort","Kavousi, Maryam and Leening, Maarten J. G. and Nanchen, David and Greenland, Philip and Graham, Ian M. and Steyerberg, Ewout W. and Ikram, M. Arfan and Stricker, Bruno H. and Hofman, Albert and Franco, Oscar H.",JAMA,"IMPORTANCE: The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines introduced a prediction model and lowered the threshold for treatment with statins to a 7.5% 10-year hard atherosclerotic cardiovascular disease (ASCVD) risk. Implications of the new guideline's threshold and model have not been addressed in non-US populations or compared with previous guidelines. OBJECTIVE: To determine population-wide implications of the ACC/AHA, the Adult Treatment Panel III (ATP-III), and the European Society of Cardiology (ESC) guidelines using a cohort of Dutch individuals aged 55 years or older. DESIGN, SETTING, AND PARTICIPANTS: We included 4854 Rotterdam Study participants recruited in 1997-2001. We calculated 10-year risks for ""hard"" ASCVD events (including fatal and nonfatal coronary heart disease [CHD] and stroke) (ACC/AHA), hard CHD events (fatal and nonfatal myocardial infarction, CHD mortality) (ATP-III), and atherosclerotic CVD mortality (ESC). MAIN OUTCOMES AND MEASURES: Events were assessed until January 1, 2012. Per guideline, we calculated proportions of individuals for whom statins would be recommended and determined calibration and discrimination of risk models. RESULTS: The mean age was 65.5 (SD, 5.2) years. Statins would be recommended for 96.4% (95% CI, 95.4%-97.1%; n = 1825) of men and 65.8% (95% CI, 63.8%-67.7%; n = 1523) of women by the ACC/AHA, 52.0% (95% CI, 49.8%-54.3%; n = 985) of men and 35.5% (95% CI, 33.5%-37.5%; n = 821) of women by the ATP-III, and 66.1% (95% CI, 64.0%-68.3%; n = 1253) of men and 39.1% (95% CI, 37.1%-41.2%; n = 906) of women by ESC guidelines. With the ACC/AHA model, average predicted risk vs observed cumulative incidence of hard ASCVD events was 21.5% (95% CI, 20.9%-22.1%) vs 12.7% (95% CI, 11.1%-14.5%) for men (192 events) and 11.6% (95% CI, 11.2%-12.0%) vs 7.9% (95% CI, 6.7%-9.2%) for women (151 events). Similar overestimation occurred with the ATP-III model (98 events in men and 62 events in women) and ESC model (50 events in men and 37 events in women). The C statistic was 0.67 (95% CI, 0.63-0.71) in men and 0.68 (95% CI, 0.64-0.73) in women for hard ASCVD (ACC/AHA), 0.67 (95% CI, 0.62-0.72) in men and 0.69 (95% CI, 0.63-0.75) in women for hard CHD (ATP-III), and 0.76 (95% CI, 0.70-0.82) in men and 0.77 (95% CI, 0.71-0.83) in women for CVD mortality (ESC). CONCLUSIONS AND RELEVANCE: In this European population aged 55 years or older, proportions of individuals eligible for statins differed substantially among the guidelines. The ACC/AHA guideline would recommend statins for nearly all men and two-thirds of women, proportions exceeding those with the ATP-III or ESC guidelines. All 3 risk models provided poor calibration and moderate to good discrimination. Improving risk predictions and setting appropriate population-wide thresholds are necessary to facilitate better clinical decision making.",2014,10.1001/jama.2014.2632,311,14,1416-1423,eng,1538-3598 0098-7484,"United States and Cardiology and Humans and Female and Male and Middle Aged and Aged and Models, Theoretical and Europe and Cohort Studies and Risk Factors and American Heart Association and Societies, Medical and Netherlands and *Practice Guidelines as Topic and Risk Assessment/*methods and Cardiovascular Diseases/epidemiology/*prevention & control and Hydroxymethylglutaryl-CoA Reductase Inhibitors/*therapeutic use and Stroke/epidemiology",NA,NA,2014/04/09/,JAMA,NA,NA,NA,NA
Nigrovic_2007_JAMA,JOUR,Clinical prediction rule for identifying children with cerebrospinal fluid pleocytosis at very low risk of bacterial meningitis,"Nigrovic, Lise E. and Kuppermann, Nathan and Macias, Charles G. and Cannavino, Christopher R. and Moro-Sutherland, Donna M. and Schremmer, Robert D. and Schwab, Sandra H. and Agrawal, Dewesh and Mansour, Karim M. and Bennett, Jonathan E. and Katsogridakis, Yiannis L. and Mohseni, Michael M. and Bulloch, Blake and Steele, Dale W. and Kaplan, Ron L. and Herman, Martin I. and Bandyopadhyay, Subhankar and Dayan, Peter and Truong, Uyen T. and Wang, Vincent J. and Bonsu, Bema K. and Chapman, Jennifer L. and Kanegaye, John T. and Malley, Richard",JAMA,"CONTEXT: Children with cerebrospinal fluid (CSF) pleocytosis are routinely admitted to the hospital and treated with parenteral antibiotics, although few have bacterial meningitis. We previously developed a clinical prediction rule, the Bacterial Meningitis Score, that classifies patients at very low risk of bacterial meningitis if they lack all of the following criteria: positive CSF Gram stain, CSF absolute neutrophil count (ANC) of at least 1000 cells/microL, CSF protein of at least 80 mg/dL, peripheral blood ANC of at least 10,000 cells/microL, and a history of seizure before or at the time of presentation. OBJECTIVE: To validate the Bacterial Meningitis Score in the era of widespread pneumococcal conjugate vaccination. DESIGN, SETTING, AND PATIENTS: A multicenter, retrospective cohort study conducted in emergency departments of 20 US academic medical centers through the Pediatric Emergency Medicine Collaborative Research Committee of the American Academy of Pediatrics. All children aged 29 days to 19 years who presented at participating emergency departments between January 1, 2001, and June 30, 2004, with CSF pleocytosis (CSF white blood cells > or =10 cells/microL) and who had not received antibiotic treatment before lumbar puncture. MAIN OUTCOME MEASURE: The sensitivity and negative predictive value of the Bacterial Meningitis Score. RESULTS: Among 3295 patients with CSF pleocytosis, 121 (3.7%; 95% confidence interval [CI], 3.1%-4.4%) had bacterial meningitis and 3174 (96.3%; 95% CI, 95.5%-96.9%) had aseptic meningitis. Of the 1714 patients categorized as very low risk for bacterial meningitis by the Bacterial Meningitis Score, only 2 had bacterial meningitis (sensitivity, 98.3%; 95% CI, 94.2%-99.8%; negative predictive value, 99.9%; 95% CI, 99.6%-100%), and both were younger than 2 months old. A total of 2518 patients (80%) with aseptic meningitis were hospitalized. CONCLUSIONS: This large multicenter study validates the Bacterial Meningitis Score prediction rule in the era of conjugate pneumococcal vaccine as an accurate decision support tool. The risk of bacterial meningitis is very low (0.1%) in patients with none of the criteria. The Bacterial Meningitis Score may be helpful to guide clinical decision making for the management of children presenting to emergency departments with CSF pleocytosis.",2007,10.1001/jama.297.1.52,297,1,52-60,eng,1538-3598 0098-7484,"Humans and Female and Male and Adolescent and Child and Child, Preschool and Infant and Retrospective Studies and Sensitivity and Specificity and Risk Factors and Reproducibility of Results and Predictive Value of Tests and Infant, Newborn and Pneumococcal Vaccines and *Decision Support Techniques and Leukocytosis/*cerebrospinal fluid and Meningitis, Aseptic/epidemiology and Meningitis, Bacterial/*diagnosis/epidemiology",NA,NA,2007/01/03/,JAMA,NA,NA,NA,NA
Karesh_2012_Lanc.LonEngl,JOUR,Ecology of zoonoses: natural and unnatural histories,"Karesh, William B. and Dobson, Andy and Lloyd-Smith, James O. and Lubroth, Juan and Dixon, Matthew A. and Bennett, Malcolm and Aldrich, Stephen and Harrington, Todd and Formenty, Pierre and Loh, Elizabeth H. and Machalaba, Catherine C. and Thomas, Mathew Jason and Heymann, David L.","Lancet (London, England)","More than 60% of human infectious diseases are caused by pathogens shared with wild or domestic animals. Zoonotic disease organisms include those that are endemic in human populations or enzootic in animal populations with frequent cross-species transmission to people. Some of these diseases have only emerged recently. Together, these organisms are responsible for a substantial burden of disease, with endemic and enzootic zoonoses causing about a billion cases of illness in people and millions of deaths every year. Emerging zoonoses are a growing threat to global health and have caused hundreds of billions of US dollars of economic damage in the past 20 years. We aimed to review how zoonotic diseases result from natural pathogen ecology, and how other circumstances, such as animal production, extraction of natural resources, and antimicrobial application change the dynamics of disease exposure to human beings. In view of present anthropogenic trends, a more effective approach to zoonotic disease prevention and control will require a broad view of medicine that emphasises evidence-based decision making and integrates ecological and evolutionary principles of animal, human, and environmental factors. This broad view is essential for the successful development of policies and practices that reduce probability of future zoonotic emergence, targeted surveillance and strategic prevention, and engagement of partners outside the medical community to help improve health outcomes and reduce disease threats.",2012,10.1016/S0140-6736(12)61678-X,380,9857,1936-1945,eng,1474-547X 0140-6736,"Humans and Risk Factors and Animals and Pandemics and Food Supply and *Ecosystem and Animals, Domestic and Animals, Wild and Communicable Diseases, Emerging/epidemiology/transmission and Drug Resistance, Microbial and Extraction and Processing Industry/statistics & numerical data and HIV Infections/epidemiology/transmission and Influenza A Virus, H5N1 Subtype and Influenza, Human/epidemiology/transmission and Zoonoses/*epidemiology/transmission",NA,NA,2012/12/01/,Lancet,NA,NA,NA,NA
Stephansson_2013_JAMA,JOUR,Selective serotonin reuptake inhibitors during pregnancy and risk of stillbirth and infant mortality,"Stephansson, Olof and Kieler, Helle and Haglund, Bengt and Artama, Miia and Engeland, Anders and Furu, Kari and Gissler, Mika and Norgaard, Mette and Nielsen, Rikke Beck and Zoega, Helga and Valdimarsdottir, Unnur",JAMA,"IMPORTANCE: Maternal psychiatric disease is associated with adverse pregnancy outcomes. Use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy has been associated with congenital anomalies, neonatal withdrawal syndrome, and persistent pulmonary hypertension of the newborn. However, the risk of stillbirth and infant mortality when accounting for previous maternal psychiatric disease remains unknown. OBJECTIVE: To study risk of stillbirth and infant mortality associated with use of SSRIs during pregnancy. DESIGN, SETTING, AND PARTICIPANTS: Population-based cohort study from all Nordic countries (Denmark, Finland, Iceland, Norway, and Sweden) at different periods from 1996 through 2007. The study included women with singleton births. We obtained information on maternal use of SSRIs from prescription registries. Maternal characteristics, pregnancy, and neonatal outcomes were obtained from patient and medical birth registries. MAIN OUTCOME MEASURES: We used logistic regression to estimate relative risks of stillbirth, neonatal death, and postneonatal death associated with SSRI use during pregnancy taking into account maternal characteristics and previous psychiatric hospitalization. RESULTS: Among 1,633,877 singleton births in the study, 6054 were stillbirths; 3609, neonatal deaths; and 1578, postneonatal deaths. A total of 29,228 (1.79%) of mothers had filled a prescription for an SSRI during pregnancy. Women exposed to an SSRI presented with higher rates of stillbirth (4.62 vs 3.69 per 1000, P = .01) and postneonatal death (1.38 vs 0.96 per 1000, P = .03) than those who did not. The rate of neonatal death was similar between groups (2.54 vs 2.21 per 1000, P = .24). Yet in multivariable models, SSRI use was not associated with stillbirth (adjusted odds ratio [OR], 1.17; 95% CI, 0.96-1.41; P = .12), neonatal death (adjusted OR, 1.23; 95% CI, 0.96-1.57; P = .11), or postneonatal death (adjusted OR, 1.34; 95% CI, 0.97-1.86; P = .08). Estimates were further attenuated when stratified by previous hospitalization for psychiatric disease. The adjusted OR for stillbirth in women with a previous hospitalization for psychiatric disease was 0.92 (95% CI, 0.66-1.28; P = .62) and was 1.07 (95% CI, 0.84-1.36; P = .59) for those who had not been previously hospitalized. The corresponding ORs for neonatal death were 0.89 (95% CI, 0.58-1.39; P = .62) for women who were hospitalized and 1.14 (95% CI, 0.84-1.56; P = .39) for women who were not. For postneonatal death, the ORs were 1.02 (95% CI, 0.61-1.69; P = .95) for women who were hospitalized and 1.10 (95% CI, 0.71-1.72; P = .66) for women who were not. CONCLUSIONS AND RELEVANCE: Among women with singleton births in Nordic countries, no significant association was found between use of SSRIs during pregnancy and risk of stillbirth, neonatal mortality, or postneonatal mortality. However, decisions about use of SSRIs during pregnancy must take into account other perinatal outcomes and the risks associated with maternal mental illness.",2013,10.1001/jama.2012.153812,309,1,48-54,eng,1538-3598 0098-7484,"Risk and Humans and Female and Adult and Middle Aged and Young Adult and Infant and Logistic Models and Decision Making and Cohort Studies and Pregnancy and Odds Ratio and Infant, Newborn and Infant Mortality and Mental Disorders/*drug therapy and Pregnancy Complications/*drug therapy and Pregnancy Outcome and Scandinavian and Nordic Countries/epidemiology and Serotonin Uptake Inhibitors/*adverse effects/therapeutic use and Stillbirth/*epidemiology",NA,NA,2013/01/02/,JAMA,NA,NA,NA,NA
London_2013_JAMA,JOUR,Association of perioperative -blockade with mortality and cardiovascular morbidity following major noncardiac surgery,"London, Martin J. and Hur, Kwan and Schwartz, Gregory G. and Henderson, William G.",JAMA,"IMPORTANCE: The effectiveness of perioperative <ce><b2>-blockade in patients undergoing noncardiac surgery remains controversial. OBJECTIVE: To determine the associations of early perioperative exposure to <ce><b2>-blockers with 30-day postoperative outcome in patients undergoing noncardiac surgery. DESIGN, SETTING, AND PATIENTS: A retrospective cohort analysis evaluating exposure to <ce><b2>-blockers on the day of or following major noncardiac surgery among a population-based sample of 136,745 patients who were 1:1 matched on propensity scores (37,805 matched pairs) treated at 104 VA medical centers from January 2005 through August 2010. MAIN OUTCOMES AND MEASURES: All cause 30-day mortality and cardiac morbidity (cardiac arrest or Q-wave myocardial infarction). RESULTS: Overall 55,138 patients (40.3%) were exposed to <ce><b2>-blockers. Exposure was higher in the 66.7% of 13,863 patients undergoing vascular surgery (95% CI, 65.9%-67.5%) than in the 37.4% of 122,882 patients undergoing nonvascular surgery (95% CI, 37.1%-37.6%; P < .001). Exposure increased as Revised Cardiac Risk Index factors increased, with 25.3% (95% CI, 24.9%-25.6%) of those with no risk vs 71.3% (95% CI, 69.5%-73.2%) of those with 4 risk factors or more exposed to <ce><b2>-blockers (P < .001). Death occurred among 1.1% (95% CI, 1.1%-1.2%) and cardiac morbidity occurred among 0.9% (95% CI, 0.8%-0.9%) of patients. In the propensity matched cohort, exposure was associated with lower mortality (relative risk [RR], 0.73; 95% CI, 0.65-0.83; P < .001; number need to treat [NNT], 241; 95% CI, 173-397). When stratified by cumulative numbers of Revised Cardiac Risk Index factors, <ce><b2>-blocker exposure was associated with significantly lower mortality among patients with 2 factors (RR, 0.63 [95% CI, 0.50-0.80]; P < .001; NNT, 105 [95% CI, 69-212]), 3 factors (RR, 0.54 [95% CI, 0.39-0.73]; P < .001; NNT, 41 [95% CI, 28-80]), or 4 factors or more (RR, 0.40 [95% CI, 0.25-0.73]; P < .001; NNT, 18 [95% CI, 12-34]). This association was limited to patients undergoing nonvascular surgery. <ce><b2>-Blocker exposure was also associated with a lower rate of nonfatal Q-wave infarction or cardiac arrest (RR, 0.67 [95% CI, 0.57-0.79]; P < .001; NNT, 339 [95% CI, 240-582]), again limited to patients undergoing nonvascular surgery. CONCLUSIONS AND RELEVANCE: Among propensity-matched patients undergoing noncardiac, nonvascular surgery, perioperative <ce><b2>-blocker exposure was associated with lower rates of 30-day all-cause mortality in patients with 2 or more Revised Cardiac Risk Index factors. Our findings support use of a cumulative number of Revised Cardiac Risk Index predictors in decision making regarding institution and continuation of perioperative <ce><b2>-blockade. A multicenter randomized trial involving patients at a low to intermediate risk by these factors would be of interest to validate these observational findings.",2013,10.1001/jama.2013.4135,309,16,1704-1713,eng,1538-3598 0098-7484,"Risk and Morbidity and Humans and Female and Male and Middle Aged and Retrospective Studies and Aged and Databases, Factual and Cohort Studies and Treatment Outcome and Perioperative Period and United States/epidemiology and United States Department of Veterans Affairs/statistics & numerical data and *Surgical Procedures, Operative and Adrenergic beta-Antagonists/*therapeutic use and Heart Arrest/*mortality/prevention & control and Myocardial Infarction/*mortality/prevention & control",NA,NA,2013/04/24/,JAMA,NA,NA,NA,NA
Schwartz_2013_ProfthNaAcofScofthUnStofAm,JOUR,The Drug Facts Box: Improving the communication of prescription drug information,"Schwartz, Lisa M. and Woloshin, Steven",Proceedings of the National Academy of Sciences of the United States of America,"Communication about prescription drugs ought to be a paragon of public science communication. Unfortunately, it is not. Consumers see $4 billion of direct-to-consumer advertising annually, which typically fails to present data about how well drugs work. The professional label--the Food and Drug Administration's (FDA) mechanism to get physicians information needed for appropriate prescribing--may also fail to present benefit data. FDA labeling guidance, in fact, suggests that industry omit benefit data for new drugs in an existing class and for drugs approved on the basis of unfamiliar outcomes (such as depression rating scales). The medical literature is also problematic: there is selective reporting of favorable trials, favorable outcomes within trials, and ""spinning"" unfavorable results to maximize benefit and minimize harm. In contrast, publicly available FDA reviews always include the phase 3 trial data on benefit and harm, which are the basis of drug approval. However, these reviews are practically inaccessible: lengthy, poorly organized, and weakly summarized. To improve accessibility, we developed the Drug Facts Box: a one-page summary of benefit and harm data for each indication of a drug. A series of studies--including national randomized trials--demonstrates that most consumers understand the Drug Facts Box and that it improves decision-making. Despite calls from their own Risk Communication Advisory Committee and Congress (in the Affordable Care Act) to consider implementing boxes, the FDA announced it needs at least 3-5 y more to make a decision. Given its potential public health impact, physicians and the public should not have to wait that long for better drug information.",2013,10.1073/pnas.1214646110,110 Suppl 3,Suppl 3,14069-14074,eng,1091-6490 0027-8424,"Humans and *Communication and Information Dissemination/*methods and Science/*methods and data presentation and Drug Approval/methods/statistics & numerical data and Drug Labeling/methods/statistics & numerical data and evidence summaries and Outcome Assessment, Health Care/methods/statistics & numerical data and Patient Education as Topic/methods and physician-patient communication and Prescription Drugs/adverse effects/pharmacokinetics/*therapeutic use",NA,NA,2013/08/20/,Proc Natl Acad Sci U S A,NA,NA,NA,NA
Sheridan_2013_Lanc.LonEngl,JOUR,Risk factors for congenital anomaly in a multiethnic birth cohort: an analysis of the Born in Bradford study,"Sheridan, Eamonn and Wright, John and Small, Neil and Corry, Peter C. and Oddie, Sam and Whibley, Catherine and Petherick, Emily S. and Malik, Teena and Pawson, Nicole and McKinney, Patricia A. and Parslow, Roger C.","Lancet (London, England)","BACKGROUND: Congenital anomalies are a leading cause of infant death and disability and their incidence varies between ethnic groups in the UK. Rates of infant death are highest in children of Pakistani origin, and congenital anomalies are the most common cause of death in children younger than 12 in this ethnic group. We investigated the incidence of congenital anomalies in a large multiethnic birth cohort to identify the causes of the excess of congenital anomalies in this community. METHODS: We obtained questionnaire data from the mothers of children with one or more anomalies from the Born in Bradford study, a prospective birth cohort study of 13,776 babies and their families in which recruitment was undertaken between 2007 and 2011. Details of anomalies were prospectively reported to the study and we cross checked these details against medical records. We linked data for anomalies to maternal questionnaire and clinical data gathered as part of the Born in Bradford study. We calculated univariate and multivariate risk ratios (RRs) with 95% CIs for various maternal risk factors. FINDINGS: Of 11,396 babies for whom questionnaire data were available, 386 (3%) had a congenital anomaly. Rates for congenital anomaly were 305<c2><b7>74 per 10,000 livebirths, compared with a national rate of 165<c2><b7>90 per 10,000. The risk was greater for mothers of Pakistani origin than for those of white British origin (univariate RR 1<c2><b7>96, 95% CI 1<c2><b7>56-2<c2><b7>46). Overall, 2013 (18%) babies were the offspring of first-cousin unions. These babies were mainly of Pakistani origin--1922 (37%) of 5127 babies of Pakistani origin had parents in first-cousin unions. Consanguinity was associated with a doubling of risk for congenital anomaly (multivariate RR 2<c2><b7>19, 95% CI 1<c2><b7>67-2<c2><b7>85); we noted no association with increasing deprivation. 31% of all anomalies in children of Pakistani origin could be attributed to consanguinity. We noted a similar increase in risk for mothers of white British origin older than 34 years (multivariate RR 1<c2><b7>83, 95% CI 1<c2><b7>14-3<c2><b7>00). Maternal education to degree level was protective (0<c2><b7>53, 95% CI 0<c2><b7>38-0<c2><b7>75), irrespective of ethnic origin. INTERPRETATION: Consanguinity is a major risk factor for congenital anomaly. The risk remains even after adjustment for deprivation, and accounts for almost a third of anomalies in babies of Pakistani origin. High levels of educational attainment are associated with reduced risk in all ethnic groups. Our findings will be valuable in health promotion and public health, and to those commissioning antenatal, paediatric, and clinical genetic services. Sensitive advice about the risks should be provided to communities at increased risk, and to couples in consanguineous unions, to assist in reproductive decision making. FUNDING: National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care programme.",2013,10.1016/S0140-6736(13)61132-0,382,9901,1350-1359,eng,1474-547X 0140-6736,"Humans and Female and Adult and Educational Status and Prospective Studies and Risk Factors and Socioeconomic Factors and Infant, Newborn and Urban Health and Cities/ethnology and Congenital Abnormalities/epidemiology/*ethnology and Consanguinity and England/epidemiology and Pakistan/ethnology and Whites/ethnology",NA,NA,2013/10/19/,Lancet,NA,NA,NA,NA
Aiken_2014_Lanc.LonEngl,JOUR,Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study,"Aiken, Linda H. and Sloane, Douglas M. and Bruyneel, Luk and Van den Heede, Koen and Griffiths, Peter and Busse, Reinhard and Diomidous, Marianna and Kinnunen, Juha and Kozka, Maria and Lesaffre, Emmanuel and McHugh, Matthew D. and Moreno-Casbas, M. T. and Rafferty, Anne Marie and Schwendimann, Rene and Scott, P. Anne and Tishelman, Carol and van Achterberg, Theo and Sermeus, Walter","Lancet (London, England)","BACKGROUND: Austerity measures and health-system redesign to minimise hospital expenditures risk adversely affecting patient outcomes. The RN4CAST study was designed to inform decision making about nursing, one of the largest components of hospital operating expenses. We aimed to assess whether differences in patient to nurse ratios and nurses' educational qualifications in nine of the 12 RN4CAST countries with similar patient discharge data were associated with variation in hospital mortality after common surgical procedures. METHODS: For this observational study, we obtained discharge data for 422,730 patients aged 50 years or older who underwent common surgeries in 300 hospitals in nine European countries. Administrative data were coded with a standard protocol (variants of the ninth or tenth versions of the International Classification of Diseases) to estimate 30 day in-hospital mortality by use of risk adjustment measures including age, sex, admission type, 43 dummy variables suggesting surgery type, and 17 dummy variables suggesting comorbidities present at admission. Surveys of 26,516 nurses practising in study hospitals were used to measure nurse staffing and nurse education. We used generalised estimating equations to assess the effects of nursing factors on the likelihood of surgical patients dying within 30 days of admission, before and after adjusting for other hospital and patient characteristics. FINDINGS: An increase in a nurses' workload by one patient increased the likelihood of an inpatient dying within 30 days of admission by 7% (odds ratio 1<c2><b7>068, 95% CI 1<c2><b7>031-1<c2><b7>106), and every 10% increase in bachelor's degree nurses was associated with a decrease in this likelihood by 7% (0<c2><b7>929, 0<c2><b7>886-0<c2><b7>973). These associations imply that patients in hospitals in which 60% of nurses had bachelor's degrees and nurses cared for an average of six patients would have almost 30% lower mortality than patients in hospitals in which only 30% of nurses had bachelor's degrees and nurses cared for an average of eight patients. INTERPRETATION: Nurse staffing cuts to save money might adversely affect patient outcomes. An increased emphasis on bachelor's education for nurses could reduce preventable hospital deaths. FUNDING: European Union's Seventh Framework Programme, National Institute of Nursing Research, National Institutes of Health, the Norwegian Nurses Organisation and the Norwegian Knowledge Centre for the Health Services, Swedish Association of Health Professionals, the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet, Committee for Health and Caring Sciences and Strategic Research Program in Care Sciences at Karolinska Institutet, Spanish Ministry of Science and Innovation.",2014,10.1016/S0140-6736(13)62631-8,383,9931,1824-1830,eng,1474-547X 0140-6736,"Humans and Female and Male and Middle Aged and Retrospective Studies and Aged and Quality Indicators, Health Care and Educational Status and Workforce and Comorbidity and *Hospital Mortality and Europe/epidemiology and *Postanesthesia Nursing/standards/statistics & numerical data and Education, Nursing/*standards/statistics & numerical data and Nursing Administration Research/methods and Nursing Staff, Hospital/education/statistics & numerical data/*supply & distribution and Outcome Assessment, Health Care/methods and Personnel Staffing and Scheduling/*statistics & numerical data and Workload/statistics & numerical data",NA,NA,2014/05/24/,Lancet,NA,NA,NA,NA
Bhala_2013_Lanc.LonEngl,JOUR,Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials,"Bhala, N. and Emberson, J. and Merhi, A. and Abramson, S. and Arber, N. and Baron, J. A. and Bombardier, C. and Cannon, C. and Farkouh, M. E. and FitzGerald, G. A. and Goss, P. and Halls, H. and Hawk, E. and Hawkey, C. and Hennekens, C. and Hochberg, M. and Holland, L. E. and Kearney, P. M. and Laine, L. and Lanas, A. and Lance, P. and Laupacis, A. and Oates, J. and Patrono, C. and Schnitzer, T. J. and Solomon, S. and Tugwell, P. and Wilson, K. and Wittes, J. and Baigent, C.","Lancet (London, England)","BACKGROUND: The vascular and gastrointestinal effects of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors (coxibs) and traditional non-steroidal anti-inflammatory drugs (tNSAIDs), are not well characterised, particularly in patients at increased risk of vascular disease. We aimed to provide such information through meta-analyses of randomised trials. METHODS: We undertook meta-analyses of 280 trials of NSAIDs versus placebo (124,513 participants, 68,342 person-years) and 474 trials of one NSAID versus another NSAID (229,296 participants, 165,456 person-years). The main outcomes were major vascular events (non-fatal myocardial infarction, non-fatal stroke, or vascular death); major coronary events (non-fatal myocardial infarction or coronary death); stroke; mortality; heart failure; and upper gastrointestinal complications (perforation, obstruction, or bleed). FINDINGS: Major vascular events were increased by about a third by a coxib (rate ratio [RR] 1<c2><b7>37, 95% CI 1<c2><b7>14-1<c2><b7>66; p=0<c2><b7>0009) or diclofenac (1<c2><b7>41, 1<c2><b7>12-1<c2><b7>78; p=0<c2><b7>0036), chiefly due to an increase in major coronary events (coxibs 1<c2><b7>76, 1<c2><b7>31-2<c2><b7>37; p=0<c2><b7>0001; diclofenac 1<c2><b7>70, 1<c2><b7>19-2<c2><b7>41; p=0<c2><b7>0032). Ibuprofen also significantly increased major coronary events (2<c2><b7>22, 1<c2><b7>10-4<c2><b7>48; p=0<c2><b7>0253), but not major vascular events (1<c2><b7>44, 0<c2><b7>89-2<c2><b7>33). Compared with placebo, of 1000 patients allocated to a coxib or diclofenac for a year, three more had major vascular events, one of which was fatal. Naproxen did not significantly increase major vascular events (0<c2><b7>93, 0<c2><b7>69-1<c2><b7>27). Vascular death was increased significantly by coxibs (1<c2><b7>58, 99% CI 1<c2><b7>00-2<c2><b7>49; p=0<c2><b7>0103) and diclofenac (1<c2><b7>65, 0<c2><b7>95-2<c2><b7>85, p=0<c2><b7>0187), non-significantly by ibuprofen (1<c2><b7>90, 0<c2><b7>56-6<c2><b7>41; p=0<c2><b7>17), but not by naproxen (1<c2><b7>08, 0<c2><b7>48-2<c2><b7>47, p=0<c2><b7>80). The proportional effects on major vascular events were independent of baseline characteristics, including vascular risk. Heart failure risk was roughly doubled by all NSAIDs. All NSAID regimens increased upper gastrointestinal complications (coxibs 1<c2><b7>81, 1<c2><b7>17-2<c2><b7>81, p=0<c2><b7>0070; diclofenac 1<c2><b7>89, 1<c2><b7>16-3<c2><b7>09, p=0<c2><b7>0106; ibuprofen 3<c2><b7>97, 2<c2><b7>22-7<c2><b7>10, p<0<c2><b7>0001; and naproxen 4<c2><b7>22, 2<c2><b7>71-6<c2><b7>56, p<0<c2><b7>0001). INTERPRETATION: The vascular risks of high-dose diclofenac, and possibly ibuprofen, are comparable to coxibs, whereas high-dose naproxen is associated with less vascular risk than other NSAIDs. Although NSAIDs increase vascular and gastrointestinal risks, the size of these risks can be predicted, which could help guide clinical decision making. FUNDING: UK Medical Research Council and British Heart Foundation.",2013,10.1016/S0140-6736(13)60900-9,382,9894,769-779,eng,1474-547X 0140-6736,"Humans and Anti-Inflammatory Agents, Non-Steroidal/*adverse effects and Blood Vessels/drug effects and Coronary Disease/chemically induced and Cyclooxygenase 2 Inhibitors/adverse effects and Diclofenac/adverse effects and Gastrointestinal Diseases/*chemically induced and Gastrointestinal Tract/drug effects and Ibuprofen/adverse effects and Myocardial Infarction/chemically induced and Naproxen/adverse effects and Stroke/chemically induced and Vascular Diseases/*chemically induced",NA,NA,2013/08/31/,Lancet,NA,NA,NA,NA
